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Summary 
Streptococcus suis is an important opportunistic zoonotic pathogen, of which serotype 2 (ST2) is 
considered to be the most virulent for its natural host, the pig, as well as for humans. The most 
common clinical manifestations for pigs and humans are septicemia and meningitis. Previous in vivo 
observations in S. suis-infected pigs, revealed lesions at the choroid plexus (CP), which forms the 
interface at the blood-cerebrospinal fluid barrier to the central nervous system. In vitro experiments 
with primary porcine CP epithelial cells (PCPEC) and immortal human CP epithelial (HIBCPP) cells 
demonstrated that S. suis can invade and traverse the CP epithelial cells, and that the CP contributes 
to the immunological response via cytokine expression and secretion. In this study, a comparative 
approach to investigate the global transcriptome profile via RNA-seq of in vitro and in vivo S. suis ST2 
challenged PCPEC/HIBCPP cells and pigs, respectively, was performed. 
In a first step to process the RNA-seq generated data, significant differentially expressed genes 
(DEGs) were identified. The highest amount of DEGs was observed for the dataset obtained from the 
CP isolated from in vivo S. suis ST2 infected pigs which suffered from meningitis. The primary PCPEC, 
which were infected in vitro with S. suis ST2, exhibited a strong inflammatory response 6 h post-
infection, with a maximal differential regulation of 134-fold, whereas HIBCPP cells exhibited a 
predominant differential gene regulation of genes related to hypoxia, where a maximum of an 8-fold 
change was observed. In the Gene Set Enrichment Analysis (GSEA), which interpreted the data based 
on gene groups performing a common biological function, a significant enrichment of 18, 28, and 21 
hallmark gene sets (GSs) for infected HIBCPP cells, PCPEC, and in the CP of pigs suffering from S. suis 
ST2 meningitis, respectively, were identified. Of these significantly enriched GSs, 8 GSs overlapped 
between the three different sample sets. The majority of these GSs are involved in in cellular 
signaling (e.g. TNFα via NFκB) and pathways (e.g. hypoxia), immune response (e.g. inflammatory 
response), and development (e.g. epithelial-mesenchymal transition). In contrast, suppressed GSs 
observed during in vitro and in vivo S. suis ST2 infections included those, which were involved in 
cellular proliferation and metabolic processes. Furthermore, the RNA-seq method was validated via 
quantitative PCR. 
In a further comparative analysis using the CP samples obtained from the in vivo infection 
experiments, the conventional RNA-sequencing method was compared to the Massive Analysis of 
cDNA Ends (MACE) sequencing method. A concordance of approximately 50 % was observed for the 
significant DEGs, and the GSEA revealed an enrichment of the same 17 GSs. 
This study suggests that similar cellular processes occur in human and porcine infected CP (epithelial) 
cells, especially in terms of inflammatory response. However, further follow-up investigations need 
to be performed to gain specific insights to the cellular response at the CP during a S. suis infection.
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Zusammenfassung 
Streptococcus suis ist ein wichtiger opportunistischer zoonotischer Krankheitserreger, wobei der 
Serotyp 2 (ST2) die stärkste Virulenz im natürlichem Wirt, dem Schwein, sowie bei Menschen 
aufweist. Am häufigsten äußert sich die Infektion im Schwein und Mensch als Septikämie und 
Meningitis. Bisherige Beobachtungen aus in vivo S. suis-erkrankten Schweinen wiesen Läsionen am 
Choroid Plexus (CP) auf, welcher die Blut-Liquor-Schranke zum zentralen Nervensystem bildet. Durch 
den Einsatz von primären porzinen CP Epithelzellen (PCPEC) und humanen CP Papillom-Epithelzellen 
(HIBCPP) in in vitro Versuchen mit S. suis konnte gezeigt werden, dass der Erreger in der Lage ist die 
CP Epithelzellen zu invadieren und zu überqueren, und dass der CP sich an der Immunabwehr 
beteiligt indem er Zyktokine exprimiert und in die Umgebung ausschüttet. Ziel dieser Arbeit war es 
mittels Gesamt-Transkriptom-Shotgun-Sequenzierung (RNA-seq) die zelluläre Antwort von in vitro 
mit S. suis-infizierten HIBCPP Zellen und PCPEC, sowie die Antwort des CP aus experimentell mit 
S  suis-infizierten Schweinen, zu ermitteln und miteinander zu vergleichen. 
Im ersten Schritt der Auswertung der RNA-seq generierten Daten wurde eine Auflistung der 
signifikanten differenziell-exprimierten Gene (DEG) ermittelt. Die Daten, die aus den Gewebeproben 
von in vivo mit S. suis infizierten Schweinen mit einer Meningitis erworben wurden, wiesen die 
höchste Anzahl von DEG auf. Die primären PCPEC zeigten nach einer 6-stündigen Infektion mit S. suis 
in vitro eine starke Entzündungsreaktion, mit einer maximal 134-fachen differenziellen 
Genregulierung, während die infizierten HIBCPP Zellen hauptsächlich signifikante DEGs aufwiesen, 
die an der hypoxischen Stressantwort beteiligt sind, mit einer maximalen differenziellen 
Genregulierung von 8-fach. Durch eine „Gene Set Enrichment Analysis“ (GSEA), welche die 
differenziell exprimierten Gene anhand von gemeinsamen biologischen Funktionen in Gruppen 
zuordnet, wurden 18 signifikante Gen-Sets (GSs) bei S. suis-infizierten HIBCPP Zellen, sowie 28 GS für 
PCPEC und 21 bei den CPs von Schweinen, die an einer Meningitis erkrankt waren, identifiziert. Bei 
diesen signifikanten GSs gab es eine Überlappung von 8 GSs zwischen den 3 Versuchsansätzen. Der 
größte Anteil der signifikanten GSs spielt eine Rolle bei Zellsignaltransduktionwegen (zum Beispiel 
TNFα durch NFκB) und Zellsignalwegen (zum Beispiel Hypoxie), aber auch bei der Immunabwehr 
(zum Beispiel Entzündungsreaktion) und Zellentwicklung (zum Beispiel Epithel-Mesenchym 
Übergang). Zusätzlich zu den in den infizierten Proben angereicherten GSs wurde auch analysiert, 
welche biologischen Prozesse während einer S. suis Infektion unterdrückt wurden. Hier wurden GSs, 
die bei der Zellvermehrung und beim Zellmetabolismus eine Rolle spielen, identifiziert. Letztlich 
wurde die RNA-seq Methode mittels einer quantitativen PCR validiert. 
In einer weiteren Vergleichsanalyse wurden zusätzlich anhand der CP Proben aus den in vivo 
Tierversuchen die konventionelle RNA-seq Methode mit der „Massive Analysis of cDNA Ends“ 
(MACE) Sequenziermethode verglichen. Eine Übereinstimmung von ungefähr 50 % der mithilfe der 
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beiden Methoden ermittelten signifikanten DEGs wurde gefunden, und bei der GSEA wurde für beide 
Methoden eine Anreicherung der identischen 17 signifikanten GSs aus beiden Sequenziermethoden 
beobachtet. 
Durch diese Arbeit wurde aufgedeckt, dass viele zelluläre Antworten im humanen und porzinen CP 
vergleichbar sind, vor allem bei den zellulären Prozessen der Immunabwehr. Jedoch müssen in der 
Zukunft ausführlichere nachverfolgende Untersuchungen durchgeführt werden, um spezifische 
Abläufe am CP bei einer S. suis Infektion aufzuklären. 
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1. Introduction  
1.1. Streptococcus suis (S. suis) 
1.1.1. Characterization 
S. suis is a Gram-positive, opportunistic, and zoonotic pathogen. As a Gram-positive bacterium, it is 
surrounded by a thick polysaccharide capsule (CPS). The CPS is used to divide S. suis into different 
serotypes (STs) (Smith et al., 1999). Currently, 35 different S. suis STs have been characterized based 
on the antigen presence on the bacterial CPS (Dutkiewicz et al., 2017). Furthermore, these various 
STs are further divided into different sequence types based on the Multilocus Sequence Typing 
method, which compares the nucleotide sequence of selected house-keeping genes and therefore 
can also determine the evolutionary relationship (Goyette-Desjardins et al., 2014; King et al., 2002). 
616 sequence types have been identified for S. suis, with approximately half of them being allocated 
to specific STs (Haas and Grenier, 2018). Furthermore, different sequence types were found to be 
associated with disease to a different degree. For example, sequence type 1 was strongly associated 
with meningitis and sepsis, and is most often isolated in cases of disease in Europe, whereas 
sequence types 27 and 87 are less likely to be associated with disease (Goyette-Desjardins et al., 
2014; King et al., 2002). 
Additionally, the predominance of specific S. suis STs tends to vary depending on the geographic 
location. The predominant STs isolated from diseased pigs in Europe are 2, 9, and 7, whereas in Asia 
these include STs 2, 3, and 4 (Haas and Grenier, 2018). Worldwide though, ST 2 is most frequently 
isolated in disease incidences (Haas and Grenier, 2018). 
Although vaccine development is of high importance and a few products exist on the market for 
specific S. suis ST2 and ST9 strains, due to the high antigen variance of the S. suis CPS, development 
of a single universal vaccine has remained a challenge (Baums et al., 2009; Haas and Grenier, 2018). 
However, continuous research to understand the role of potential virulence-associated and virulence 
factors of S. suis remains a main focus for vaccine development (Segura, 2015). 
 
1.1.2. Virulence factors and virulence-associated factors 
Virulence factors are required for a pathogen to successfully aid in establishing an infection in the 
host. Approximately 200 virulence factors have been described in recent years, which contribute to 
S. suis establishing disease in the host (Dutkiewicz et al., 2018; Segura et al., 2017). The majority of 
Introduction 
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the described factors are considered being associated with disease development, whereas the 
bacterial CPS is the only “true” virulence factor required to establish disease (Smith et al., 1999). 
The polysaccharide bacterial CPS is considered the only essential virulence factor for S. suis, since in 
vivo porcine experiments demonstrated that CPS deletion resulted in complete loss of pathogenicity 
(Smith et al., 1999). Studies have shown that the CPS protects S. suis from immune recognition in the 
blood by masking its surface antigens, therefore preventing the up-take by phagocytic immune cells 
(Fittipaldi et al., 2012). However, the absence of the CPS allows for better adhesion, e.g. to epithelial 
cells, suggesting that S. suis can regulate the CPS expression depending on the niche it is colonizing 
(Fittipaldi et al., 2012). 
Besides the CPS, the most important virulence factors which are found in the majority of virulent 
S. suis STs include suilysin (SLY), extracellular factor (EF), and muramidase-released protein (MRP), 
therefore making them candidates for a universal S. suis vaccine development (Haas and Grenier, 
2018). The factor SLY is a known pore-forming toxin, thereby inducing host cell lysis and aiding S. suis 
during invasion (Gottschalk et al., 1995). Furthermore, EF is a secreted protein and MRP is a protein 
found anchored to the bacterial cell wall, both of which were found associated with S. suis-induced 
disease (Vecht et al., 1991). 
The presence of these numerous virulence-associated factors supports, but is not essential, for the 
successful S. suis pathogenesis in the porcine or human host. 
 
1.1.3. Pathogenesis in swine 
By being the natural host, pigs are often found colonized with S. suis. S. suis usually asymptomatically 
colonizes pigs tonsils, nasal cavities, intestinal tract, and genital tract (Wertheim et al., 2009). During 
birth, the offspring are exposed to, and colonized by, the mother’s vaginal flora, and protected by the 
maternal antibodies from birth and during weaning (Cloutier et al., 2003; Dutkiewicz et al., 2017). 
S. suis disease primarily affects young piglets (4 to 10 weeks of age), often in the post-weaning phase 
when maternal antibodies decline (Rieckmann et al., 2018). However, with advancing age following 
weaning, growing pigs showed an increase of antibody production, concurrent with reduced bacterial 
survival in blood-bactericidal assays (Rieckmann et al., 2018). Furthermore, aerosol transmission 
between experimentally colonized and S. suis-free piglets was also demonstrated (Berthelot-Herault 
et al., 2001). 
The most common clinical manifestations observed in the field include sepsis and meningitis, but 
endocarditis, arthritis, pneumonia, and peritonitis are also reported (Dutkiewicz et al., 2017). Much 
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research is dedicated to understanding the pathogenic mechanisms which elicit disease, in order to 
develop vaccines, improve treatment options with rising antibiotic resistance, and reduce economic 
losses (Haas and Grenier, 2018). Animal suffering is not only an ethical down-side of this pathogen, 
but from the human industrious aspect, S. suis also affects the pork industry and can lead to major 
economic losses. For example, in the United States alone, a loss of US$ 300 million in the pork 
industry was estimated (Staats et al., 1997). 
Since S. suis is a known zoonotic pathogen, it does not only affect pigs, but it can also have a 
detrimental impact on humans. 
 
1.1.4. Pathogenesis in humans 
The first human-associated S. suis meningitis and septicemia cases were described in 1968 in the 
Netherlands (Perch et al., 1968). Over the past 20 years, the number of S. suis afflicted humans has 
increased, and between the years of 2002 and 2013, 1,642 S. suis infections in humans were 
reported (Dutkiewicz et al., 2017; Goyette-Desjardins et al., 2014). Furthermore, one minor and one 
major outbreak have occurred in 1998 in Jiangsu, China (Hu et al., 2000) and during the summer of 
2005 in Sichuan, China (Yu et al., 2006), respectively. The morbidity during these outbreaks was 25 
and 215 cases, with a mortality rate of 56 % and 18 % in Jiangsu and Sichuan, respectively, and these 
human cases were concurrent to outbreaks in the pig populations, which affected 80,000 animals 
(Du et al., 2017; Dutkiewicz et al., 2017). 
The primary risk factor for disease development in humans has been associated with working in the 
swine industry as a butcher or abattoir worker, and S. suis infection in humans is therefore 
considered an occupation-associated disease (Rayanakorn et al., 2018). Furthermore, disease 
development has also been linked to the consumption of undercooked or raw pork products and 
blood, which are part of cultural dishes in countries like Thailand, Vietnam, and China (e.g. Hong 
Kong) (Rayanakorn et al., 2018). This, together with the fact that Asia has a major swine-rearing 
industry for producing the majority of the global pork products for consumption, provides an 
explanation as to why S. suis is one of the leading causes for adult bacterial meningitis in 
southeastern Asian countries (Dutkiewicz et al., 2017; Pappas, 2013). For example, Ho Dang Trung 
and colleagues found that S. suis was the number one leading cause for CNS infection in Vietnam (Ho 
Dang Trung et al., 2012). However, Asian countries are not the only ones affected. In Europe, 
approximately 71 % of the reported S. suis cases came from The Netherlands, The United Kingdom, 
Spain, and France, which are countries also home to major swine husbandry (Dutkiewicz et al., 2017). 
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Approximately 75 % of human S. suis infections have been attributed to ST2, with the second most 
common being ST14, making up 2 % (Goyette-Desjardins et al., 2014). As also seen in pigs, the most 
common and severe clinical manifestations include meningitis, sepsis, and streptococcal toxic shock 
syndrome, while endocarditis, arthritis, and spondylodiscitis have also been reported (Huong et al., 
2014; Tang et al., 2006).  
The recovery of S. suis-induced meningitis is often accompanied by long-term impairments, such as 
vestibular dysfunction, visual impairment, or complete or partial auditory loss, with the latter being 
the most common implication from S. suis infection (Huong et al., 2014). In a retrospective meta-
analysis study focusing on S. suis meningitis in humans, it was found that 53 % of survivors suffered 
from hearing loss (van Samkar et al., 2015). These long-term sequelae are not only a hindrance for 
the patient, but can also have an economic impact. For example, a study carried out in Vietnam, 
where S. suis is the leading cause for bacterial meningitis, found that individuals suffering from 
hearing loss or other vestibular dysfunction, following the recovery of S. suis meningitis, either were 
unlikely to continue in their line of work or had a 2.6 times higher risk of being unemployed (Huong 
et al., 2019). 
 
1.2.  The central nervous system (CNS) 
Two major barriers are described in separating our CNS from the rest of our body. These barriers are 
known as the blood-brain barrier (BBB) and the blood-cerebrospinal fluid barrier (BCSFB). During his 
exploration for the human soul in the early 16th century, Leonardo da Vinci was the first to illustrate 
the ventricular system (Del Maestro, 1998), which is known today as the site of the BCSFB. Later, 
during the turn of the 20th century, observations made by Ehrlich and Goldmann provided the first 
evidence that the CNS is compartmentalized from the rest of the body (Ehrlich, 1885; Goldmann, 
1913). This was demonstrated by the injection of dye into the vascular system, thereby staining all 
organs with the exception of the brain, and vice versa following the dye injected into the 
cerebrospinal fluid (CSF) (Ehrlich, 1885; Goldmann, 1913). These barrier interfaces are in place in 
order to regulate metabolite influx and waste efflux, thereby maintaining a strict homeostatic and 
sterile environment. 
 
1.2.1. The blood-brain barrier (BBB) 
The main property of the BBB is constituted by tightly connected endothelial cells lining the 
capillaries of the vascular system in the brain, thereby making up the largest barrier between the 
blood and CNS (Abbott et al., 2010). The tight connection between the endothelial cells is created by 
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the presence of the tight junction proteins, namely zonula occludens 1, 2, and 3 (ZO1-3), as well as 
adherens junctions, such as cadherin proteins (Wolburg and Lippoldt, 2002). Additional cells found in 
close association with the BBB endothelial cells are pericytes and astrocytes, which provide further 
main support in the BBB maintenance and function (Abbott et al., 2006). Pericytes are most closely 
associated with BBB endothelial cells, and together they are found within the basal lamina (Abbott et 
al., 2006). This basal membrane structure is surrounded by the endfeet of astrocytes, which are 
located in an extracellular matrix space where additional cell types, such as microglial immune cells 
and nerve terminals are found, which further provide support to the BBB (Abbott et al., 2006). In 
addition to the physical barrier property, the BBB is described to be equipped with specialized 
adenosine triphosphate (ATP)-binding cassette (ABC) transporters, as well as transcytosis 
mechanisms for the influx of macromolecules to support the in- and efflux between the blood and 
CNS, thereby creating a chemical and metabolic barrier (Abbott et al., 2010). 
 
1.2.2. The blood-cerebrospinal fluid barrier (BCSFB) at the choroid plexus (CP) 
The second vascular barrier is the BCSFB. The BSCFB is located in the four brain ventricles at the 
choroid plexus (CP) structure, which forms an interface between the vascular system and the 
cerebrospinal fluid (CSF) (Wolburg and Paulus, 2010). The main difference of the BCSFB to the BBB is 
that the barrier at the BCSFB is constituted by the tight junctions connecting the CP epithelial cells 
and the endothelial cells exhibit fenestration (Wolburg and Paulus, 2010). 
In the ventricular system, a total of four BCSFB sites exist, which can be located at the two CP present 
in each of the lateral ventricles of the two brain hemispheres, and one CP in each of the third and 
fourth ventricle of the CNS (Figure 1 A) (Liddelow, 2015). Figure 1 B depicts the overall cell 
arrangement found at the CP, making up an interface of the BCSFB, which is the second largest, 
highly-vascularized, barrier to the CNS. The main barrier property at the CP results from the polarized 
epithelial cells, which are connected via tight junctions and tight junction-associated proteins, such 
as ZO1 and occludin (Figure 1 B) (Wolburg et al., 2001). These tightly connected epithelial cells rest 
on a basement membrane with an underlying stroma (Figure 1 B). Fenestrated endothelial cells are 
found lining the vasculature and allow for the passage of water, nutrients, and immune cells from the 
blood to the CNS (Figure 1 B) (Wolburg and Paulus, 2010). 
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Figure 1. The choroid plexus (CP) localization and cellular arrangement. The red-labelled marks are 
indicative of the two CP located in the lateral ventricles of the left and right brain hemispheres, as 
well as the CP in the 3rd and the 4th ventricles (A). The CP epithelial cells are tightly connected and 
form the barrier to the CNS, and fenestrated CP endothelial cells allow immune cells to migrate 
into the stroma, but also water and nutrient exchange from the blood to the CNS (B). Image A was 
modified from Servier Medical Art, licensed under a Creative Commons Attribution 3.0 Unported 
License (http://smart.servier.com/). Image B was modified from Lauer et al. (2018). 
The BCSFB barrier does not only present a physical barrier to keep the CNS a sterile environment 
from potential pathogens or other blood-borne threats to the CNS, but has also been described to 
act as a chemical barrier (Ghersi-Egea et al., 2018; Liddelow, 2015). The epithelial cells of the CP are 
known to be equipped with an array of efflux transmembrane transporters, for e.g. family members 
of ABC transporters, and metabolizing enzymes in order to aid in the removal of neurotoxic 
substances (Ghersi-Egea et al., 2018). Furthermore, a neuroprotective role is enabled via other 
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passive and active transporters, for e.g. members of the solute carrier family, for the movement of 
substrates across the barrier, thereby preventing the free diffusion from the bloodstream (Liddelow, 
2015). However, this chemical specificity makes drug-delivery into the CNS challenging and is, 
therefore, a subject of pharmaceutical research (Strazielle and Ghersi-Egea, 2016). 
The CP is not only an essential physical and biochemical barrier to the CNS, but also has the 
important function of producing the majority of the CSF in our CNS, which, amongst other things, 
acts as a shock-absorber to prevent harm to the brain (Liddelow, 2015). A physiological feature which 
allows for optimal CSF secretion is the apically located microvilli of the CP epithelial cells, which form 
a brush border, thereby increasing the surface area (Ghersi-Egea et al., 2018). Through the flux of 
sodium, chloride, and bicarbonate across the cell membrane, an osmotic gradient is created, which 
results in the sodium / potassium - ATPase and carbonic anhydrase enzyme activity. Via the 
enzymatic activities, water from the vascular system is then subsequently driven through aquaporin-
1 channels into the CNS, thereby generating the CSF (Ghersi-Egea et al., 2018; Liddelow, 2015). It is 
estimated that the CP produces approximately 500 ml CSF per day, thereby replacing the CSF three 
to five times daily (Ransohoff and Engelhardt, 2012). 
The CP has an important function in maintaining the BCSFB and producing the CSF for the 
homeostasis of the CNS. However, due to its location at the interface between the blood and CNS, 
barrier disruption caused by, for e.g., inflammation has been implicated with debilitating diseases, 
such as multiple sclerosis (Vercellino et al., 2008). Furthermore, the CP has also been implicated in 
cancer metastasis to the CNS, schizophrenia, as well as an invasion route of pathogenic 
microorganisms (Kim et al., 2016; Lauer et al., 2018; Schwerk et al., 2015; Vandenhaute et al., 2015). 
 
1.2.3. The arachnoid barrier 
Finally, a third, non-vascular, arachnoid barrier is described. The brain and spinal cord are fully 
surrounded by the meninges membranes depicted in Figure 2, which is comprised by the dura mater, 
arachnoid mater, and pia mater (Ransohoff and Engelhardt, 2012; Weller et al., 2018). The dura 
mater is found directly underneath the skull bone, followed by the arachnoid mater, which forms the 
outer layer of the subarachnoid space (SAS). The bottom layer of the SAS is composed of the pia 
mater, which surrounds the cerebral cortex - the gray matter of the brain (Weller et al., 2018). The 
SAS is the location of CSF circulation, but also the site where blood vessels run through with 
perpendicular arteries reaching into the cerebral cortex (Weller et al., 2018). Parts of the arachnoid 
membrane protrude outward through the dura, creating villi which allow for the reabsorption of CSF 
into the vascular system (Ransohoff and Engelhardt, 2012). 
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Figure 2. The meninges in the CNS. The meninges are comprised by the dura, arachnoid, and pia 
matter, which lie between the skull bone and the gray matter (cerebral cortex) of the brain. This 
image was modified from Servier Medical Art, licensed under a Creative Commons Attribution 3.0 
Unported License (http://smart.servier.com/). 
The CNS barriers are essential in maintaining a homeostatic environment via selective influx and 
efflux mechanisms, but also by providing a physical barrier. The physical and biochemical barriers are 
not only in place to prevent entry of blood-borne microorganisms or neurotoxic substances, but 
strictly regulate immune cell activity, too. 
 
1.3.  Infection of the CNS 
Although the CNS is compartmentalized from the rest of the body, it is not immune to infection. 
Different types of inflammation can occur due to infection with a pathogenic agent. These are 
divided into meningitis, encephalitis, or meningoencephalitis (Dando et al., 2014). During meningitis, 
the meninges membranes (Figure 2) covering the brain and spinal cord becomes inflamed, and 
clinically presents itself with neck stiffness, fever, headache, and a change in the mental state (Dando 
et al., 2014). During encephalitis, the brain parenchyma (gray and white matter) is affected and 
inflamed, with symptoms similar to meningitis, including the possible presentation with seizures 
(Dando et al., 2014). Lastly, meningoencephalitis is when not just the brain, nor just the meningitis, 
but both are inflamed, often resulting in a lethal outcome, especially when induced by amoeba 
(Dando et al., 2014). 
Many different pathogens, which are classified into viral, bacterial, fungal, and parasitic classes, are 
capable of inducing meningitis. The most common cause of meningitis are viral pathogenic agents, 
which can provoke aseptic meningitis, but are also a frequent cause of encephalitis (Glaser et al., 
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2006; Wright et al., 2019). The optimal therapy of viral meningitis is prevention via vaccination; 
however, viral meningitis normally results in a positive prognosis for a full recovery with supportive 
care provided in a hospital (Wright et al., 2019). Fungal and parasite-induced meningitis tend to 
occur at a much lower rate, with clinical manifestation commonly linked to the immune status of the 
patient, but are often associated with a high mortality rate or long-term sequelae (Goralska et al., 
2018; Graeff-Teixeira et al., 2009). The second most common cause of infection of the CNS are 
bacterial agents, which, unlike viral pathogens, tend to cause more detrimental outcomes in terms of 
recovery, and are not uncommon to result in death despite the availability of antibacterial treatment 
agents (Doran et al., 2016). 
 
1.3.1. Bacterial meningitis 
Meningitis caused by bacterial microorganisms tends to be more severe than viral meningitis, and 
can lead to death if no prompt treatment actions are taken. The age group plays an important factor 
for an individual to develop bacterial meningitis, and includes newborn, infants, adolescents, and 
elderly people (Dando et al., 2014). Studies examining the long-term sequelae of children who 
suffered from bacterial meningitis found that the most common long-term ailments included a low 
intelligence quotient, seizures, auditory impairment, and problems with their fine motor skills 
(Chandran et al., 2011; Grimwood et al., 1995). However, in addition to age, an individual’s immune 
status is also considered an important factor in susceptibility (Dando et al., 2014). 
In theory, most microorganisms infecting humans are capable of causing meningitis. However, the 
most common bacterial agents include Neisseria meningitidis, Streptococcus pneumoniae, Listeria 
monocytogenes, Haemophilus influenzae type b, Streptococcus agalactiae, and Escherichia coli K1 
strains (Kim, 2010; van Ettekoven et al., 2017). Furthermore, the neglected zoonotic pathogen 
Streptococcus suis (S. suis) has been one of the leading causes of adult bacterial meningitis in recent 
years, especially in southeast Asian countries (Dutkiewicz et al., 2017). 
Although vaccines for the most common bacterial meningitis-causative agents exist and are 
effectively applied in the western world, incidences still occur which require a speedy diagnosis and 
adequate treatment plans for the best outcome. The use of antibiotics in combination with the 
application of corticosteroids, but only for infections with selected bacteria, have been suggested for 
the treatment during bacterial meningitis (van Ettekoven et al., 2017). Compared to western 
countries, incidences are much higher in non-industrial countries such as along the “meningitis belt” 
in Africa, where seasonal epidemics of meningitis occur and mortality is high (Agier et al., 2017). 
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In order for bacteria to induce meningitis in the host, a series of steps must occur. Bacterial 
meningitis isolates are commonly found as part of the mucosal membrane of the nasopharynx 
(Doran et al., 2016). In a next step, the pathogen must penetrate the tissue in order to reach the 
bloodstream. Here, the successful meningitis-inducing microorganisms are known to possess an 
array of virulence factors and defense mechanisms, which allows them to evade or overcome the 
recognition by the immune system (Doran et al., 2016). Once the pathogen reaches either the BBB or 
BCSFB, it must adhere to the endothelial (BBB) or epithelial (BCSFB) cells before it can breach the 
barriers to the CNS. Three main pathogen invasion mechanisms have been described, which involve 
the traversing of the BBB or BCSFB via transcellular (through the cell) or paracellular (between 
adjacent cells) mechanisms, but also a “Trojan horse” mechanism has been characterized, which 
commonly utilizes phagocytic immune cells traveling to the site of infection (Doran et al., 2016; Kim, 
2008; Schwerk et al., 2015). 
During bacterial invasion and replication, damage to the host’s cells occurs in many different ways. 
However, while fighting the infection, a badly orchestrated immune response as well as factors 
released by the host can also cause cellular damage to the host’s own cells, which can have long-
term consequences for recovery or can result in death. 
 
1.3.2. The host response during bacterial CNS infection  
Upon the successful establishment of infection, a tug-of-war between the host defense and invading 
pathogens occurs. As mentioned above, evolved human pathogens are equipped with an array of 
virulence factors to help them survive against the host’s primary defense mechanisms, which occur 
via the innate immune response (Ransohoff and Engelhardt, 2012). 
Various immune cells are found residing in the CNS, such as microglia cells in the brain parenchyma 
and Kolmer’s epiplexus cells associated with the apical microvilli surface of the CP at the BCSFB, 
which are both a type of phagocytic cell (Ransohoff and Engelhardt, 2012). Furthermore, dendritic 
cells and macrophages are found patrolling the stroma of the BCSFB (Ransohoff and Engelhardt, 
2012). However, immune cells found circulating in the blood stream are also known to patrol the 
CNS, despite the physical barriers present at the BBB and BCSFB (Engelhardt et al., 2017). The CNS 
has even been described as an “immune privileged” site, since a much lower number of immune cells 
are found to be monitoring this environment in comparison to circulating immune cells in the 
bloodstream (Engelhardt et al., 2017; Meeker et al., 2012). In a healthy state, the composition of 
immune cells found in the CNS consists of approximately 1 white blood cell per µl of CSF, which gives 
a ratio of immune cells in the CNS to the blood of approximately 1 to 2,500 for T and B cells and 1 to 
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2,000 for monocytes (Meeker et al., 2012). However, during infection, the immune cell profile was 
found to vary depending on the causative agent. For example, viral meningitis is associated with a 
higher number of T cells in the CNS, whereas bacterial meningitis is associated with a higher 
presence of neutrophils (Egelund et al., 2017; Meeker et al., 2012). 
In addition to the host’s immune cells, epithelial cells, for example, have been shown to contribute to 
the immune response by releasing inflammatory signaling molecules, e.g. cytokines, to recruit 
immune cells to the site of infection for effective clearance, or other components, e.g. matrix 
metalloprotease 9, which aid in the degradation of pathogen-released factors (Grandgirard et al., 
2013; Lauer et al., 2018). These factors, however, not only have the function of clearing the 
pathogen, but in some instances can result in damage to the host itself. A study investigating the 
early inflammatory response via cytokine presence in the CSF of patients suffering from meningitis 
found that the presence of, e.g., interleukins 1 beta and 6 (IL1β and IL6), as well as tumor necrosis 
factor alpha (TNFα) was significantly enriched in patients who died or suffered long-term sequelae 
(Grandgirard et al., 2013). 
Furthermore, tissues infected with bacterial agents were found to be in a hypoxic state (Schaffer and 
Taylor, 2015). Hypoxia describes the limited presence of oxygen molecules in a given environment, 
and results in the dimerization of, most commonly, the transcription factor hypoxia-inducible factor 
(HIF), which transcribes genes regulating anoxic metabolism and increased vascularization (i.e. 
angiogenesis) in order to promote cell survival in the hypoxic tissue (Taylor and Colgan, 2017). 
However, hypoxia can also modulate the host’s immune cell function and response (Taylor and 
Colgan, 2017). A pathological hypoxic environment can have different sources, which include the 
replication of cancer cells, immune cells consuming oxygen in a microenvironment due to increased 
immune cell presence or as a defense mechanism during infection, and bacterial replication and 
metabolism (Schaffer and Taylor, 2015; Taylor and Colgan, 2017). Furthermore, hypoxia has been 
linked to the breakdown of the BBB (Al Ahmad et al., 2012). 
 
1.3.3. The BCSFB and S. suis 
It has been demonstrated that pathogens can overcome the barriers to the CNS. Since the BBB 
provides the largest interface between the blood and CNS, the main research focus is dedicated to 
this area. However, the BCSFB was also demonstrated to play an important role for pathogen 
invasion into the CNS (Lauer et al., 2018; Schwerk et al., 2015). Importantly, substantial evidence 
exists between the interplay of the BSCFB and the zoonotic pathogen S. suis, hinting at the utilization 
of the BCSFB as a main route to the CNS. One common observation is that S. suis infections are 
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associated with lesions at the CP, which was first observed in natural and experimentally in vivo 
infected pigs described by Sanford, as well as Williams and Blakemore (Sanford, 1987; Williams and 
Blakemore, 1990). Consequently, an increase of in vivo and in vitro research has been dedicated to 
investigating S. suis virulence. 
Many in vitro models of the BCSFB exist from a variety of organisms. For example, cultivated human 
papilloma (HIBCPP) (Ishiwata et al., 2005), primary porcine (PCPEC) (Haselbach et al., 2001), immortal 
porcine (PCP-R) (Schroten et al., 2012), immortal rat (Z310) (Zheng and Zhao, 2002), and primary rat 
(Tsutsumi et al., 1989) CP epithelial cells are used. Furthermore, many in vivo models used for 
studying S. suis pathology exist, including pigs, mice, and adult and larval zebrafish (Segura et al., 
2017). However, the porcine in vivo model is the most essential, given that pigs are the natural host 
organisms of S. suis, and experimental induction in vivo has been well established with piglets (Seele 
et al., 2018; Segura et al., 2017). 
Additionally, S. suis investigations utilizing in vitro BCSFB models with human and porcine CP 
epithelial cells have been conducted (Schwerk et al., 2012; Tenenbaum et al., 2009). These in vitro 
BCSFB models allow for the cell cultivation in a standard model, which cultivates the polar CP 
epithelial cells with the apical surface facing upwards (in vivo reflecting the CSF compartment), and 
an inverted culture, where the CP epithelial cells are cultivated with the basolateral cell side facing 
upwards (in vivo reflecting the blood compartment) (Tenenbaum et al., 2009). 
By employing PCPEC and HIBCPP cells, it was observed that S. suis can invade the CP epithelial cells 
and traverse the BCSFB in vitro when applied to the basolateral cell side (Schwerk et al., 2012; 
Tenenbaum et al., 2009). Furthermore, from the aspect of the host response, it was observed that 
the primary PCPEC contribute to inflammatory response in vitro via cytokine expression (Schwerk et 
al., 2011). In a further study, the in vitro BCSFB composed of PCPEC was used in order to investigate 
and characterize the transmigration of granulocytes following the infection of S. suis (Wewer et al., 
2011). In an advanced set-up of the human in vitro human BCSFB model, which also applied 
granulocytes, the formation of neutrophil extracellular traps (NETs) was observed following the 
infection with S. suis of HIBCPP cells from the basolateral cell side (de Buhr et al., 2017). 
Despite growing evidence of the important role the BCSFB plays as an entry gate for, e.g., pathogens 
into the CNS, the CP remains to be an understudied area of research. 
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1.4.  Transcriptome studies via Next-Generation Sequencing (NGS) 
For nearly two decades, the Sanger-sequencing method, also known as the first generation 
sequencing, provided break-through scientific advancements, such as sequencing the human 
genome (International Human Genome Sequencing, 2004; Sanger et al., 1977). However, this 
method of DNA-sequencing was time consuming and costly, and advancements to this method did 
not provide much improvement (Metzker, 2005). NGS technology has become increasingly popular 
over the past decade, and encompasses the expedited high through- and output of data acquired 
with the help of informatics, in order to apply it in a biological setting (Metzker, 2010). 
NGS can be applied in a variety of ways, including for the single-cell analysis, where the 
transcriptome of a single cell is analyzed, or dual sequencing, which, in the case of studying host-
pathogen interaction, examines the transcriptome of both organisms simultaneously (Saliba et al., 
2017). Additionally, various forms of RNA-sequencing (RNA-seq) exist which allow for the 
investigation of not only the polyadenylated (poly(A)) mRNA, but also include non-coding RNA (e.g. 
micro RNA and long non-coding RNA), total RNA, and pre-mRNA (Hrdlickova et al., 2017; Kukurba and 
Montgomery, 2015). 
 
1.4.1. RNA-seq 
RNA-seq, which uses NGS technology, has become a popular method to evaluate the global 
transcriptional response of a defined cell sample exposed to different stimuli, and over the past years 
has become the preferred method for transcriptome studies. Due to its numerous advantages, it has 
quickly become the preferential method over microarray analysis for studying the transcriptional 
response in a cell (Wilhelm and Landry, 2009). The major advantage is that RNA-seq quantifies 
transcripts, without the requirement of prior knowledge of a gene sequence (Kukurba and 
Montgomery, 2015). Furthermore, uncharacterized genes can be identified though RNA-seq, as well 
as alternatively spliced or rare transcripts (Metzker, 2010). 
However, a few drawbacks to this advanced method exist. Factors can be the costs for maintaining 
the technology, having the capacity to store the large amounts of generated data, but also 
sequencing experiments with complex aims (Wilhelm and Landry, 2009). As an example for the 
latter, in order to identify and determine a reliable number of alternatively spliced transcripts, a 
higher number of transcripts out of the sample have to be sequenced (termed “high sequence 
depth”) (Kukurba and Montgomery, 2015). Furthermore, the assembly and reliable analysis of the 
generated data can present a challenge, with many software programs available in order to 
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normalize and compute sequencing-generated data, which can sometimes lead to differential results 
(Martin and Wang, 2011; Soneson and Delorenzi, 2013). 
The RNA-seq work-flow encompasses a series of basic steps. Following the RNA isolation from the 
biological sample, the transcripts have to be prepared to a library, which consists of fragmented 
transcripts, since the sequencing machine is limited in capacity to produce long reads (Hrdlickova et 
al., 2017). The transcripts in the library are ligated with adapter regions on both ends, which contain 
predefined sequences for barcoding the samples and sequences complementary to the flow cell 
utilized for sequencing (Hrdlickova et al., 2017). Figure 3 depicts the sequence of events via the 
Illumina sequencing method, following the preparation of the RNA-seq library. The samples are 
applied to a flow cell (Figure 3 C), where transcript clusters are generated through bridge 
amplification (Figure 3 A) (Metzker, 2010). Once the clusters are generated, the flow cell is flooded 
with fluorescent-labelled nucleotides (Fig. 3 B), which allows the computer to generate the transcript 
sequence based of the different emitting colors, which are uniquely assigned to the specific 
nucleotides (Figure 3 C) (Metzker, 2010). 
 
Figure 3. Illumina’s sequencing method. In an initial step, the prepared RNA-seq library consisting 
of the fragmented transcripts containing adapter regions are applied to the flow cell for bridge 
amplification (A). Following the bridge amplification and cluster formation, the flow cell is flooded 
with fluorescent-labelled nucleotides (B). Following the binding of the compliment nucleotide, the 
computer tracks the sequence of each cluster on the flow cell based on the fluorescent color being 
emitted at a defined wavelength (C). This image was modified from Metzker (2010) and Whiteford 
et al. (2009). 
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Furthermore, samples can be sequenced via single- or paired-end reads. In the single-end sequencing 
mode, the transcript is sequenced only from a single direction, and this mode has the advantage of 
being cheaper, but still works well for thoroughly annotated organisms (Conesa et al., 2016). The 
paired-end sequencing mode sequences the transcript from both directions, which aids in the 
confidence of a sequenced read being aligned to the correct transcript, especially when working with 
an organism whose transcriptome has not been well annotated (Conesa et al., 2016; Wang et al., 
2009). 
An additional aspect to take into consideration when undertaking a transcriptome study is the 
sequencing depth. The depth of sequencing reflects the amount of transcripts in a sample, which are 
covered and detected during sequencing (Tarazona et al., 2011). Normally, the sequencing depth is 
dependent on the experimental aim, where more complex aims are encouraged to generate a higher 
number of sequence reads, i.e. deeper sequencing (Conesa et al., 2016). For example, in order to 
evaluate alternatively spliced transcripts or wanting to generate data on rare expressed transcripts, 
the samples must be sequenced deeper (Conesa et al., 2016). However, there is no uniform 
consensus for an appropriate number of reads required for an adequate biological interpretation of 
the given experimental set-up (Conesa et al., 2016; Tarazona et al., 2011). 
 
1.4.2. Massive Analysis of cDNA Ends (MACE)  
Conventional RNA-seq sequences randomly fragmented transcripts (Figure 4). However, various 
sequencing techniques exist, one of which is a newly developed sequencing method named MACE. 
Unlike in the conventional RNA-seq method, MACE sequences transcripts specifically from the 3’ 
transcript end (Figure 4) (Rotter et al., 2017). 
 
 
Figure 4. Conventional RNA-seq versus MACE sequencing. A higher sequencing depth can be 
achieved with the MACE sequencing method, due to each sequenced read accounting for a single 
transcript in the analyzed sample, whereas conventional RNA-seq results in possibly more than one 
sequenced read of a single transcript. This image was modified from Rotter et al. (2017). 
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The MACE sequencing method brings many advantages with it. The main advantage in comparison to 
the conventional RNA-seq method is that the investigated sample set can be sequenced at a deeper 
level without increased costs or number of reads, due to each read accounting for a single transcript 
(Rotter et al., 2017). Figure 4 depicts the distribution of reads along a transcript from conventional 
generated RNA-seq and MACE. During conventional RNA-seq, the transcripts are randomly 
fragmented and sequenced, which can result in different fragments from a single transcript flowing 
into the final data quantification, and may result in an overrepresentation of longer transcripts 
(Rotter et al., 2017). During MACE library preparation the transcripts are also fragmented. However, 
only the fragments from the 3’ transcript end are used as input for sequencing, which results in each 
sequence read accounting for a single transcript in the sample, thereby eliminating the bias of longer 
versus shorter transcript expression in a sample (Rotter et al., 2017). Furthermore, MACE is 
advantageous for studies investigating single nucleotide polymorphisms (SNPs), since SNPs are found 
to primarily occur in the untranslated region at the 3’ end of a transcript, which is covered by MACE 
(Rotter et al., 2017). 
 
1.5.  Aim of this study 
Since the CP at the BCSFB was previously observed to be utilized by S. suis to gain entry into the CNS, 
the aim of this study was to evaluate the transcriptional response of human and porcine CP epithelial 
cells. Furthermore, the response of in vitro infected porcine CP cells was compared to the CP from 
pigs infected with S. suis ST2 in vivo, which were suffering from meningitis. Especially gaining insight 
into the in vivo aspect is of high interest and value, since the CP transcriptome of pigs suffering from 
meningitis has never been investigated. From this study, new cellular mechanisms should be 
elucidated, which take place during the pathogenesis of infection, and will allow further insight into 
the host’s cellular processes and, specifically, the contribution of the CP during a potentially fatal 
S. suis infection of the CNS. For the transcriptome analysis, NGS technology was applied in order to 
sequence mRNA transcripts from the host cells. 
Additionally, two sequencing methods which utilize NGS technology were compared to each other. 
The CP tissue samples obtained from the porcine in vivo infection experiments were subject to 
sequencing via the conventional RNA-seq method, as well as the MACE sequencing method, both of 
which were carried out with the Illumina system. Although the same sample analysis should 
theoretically produce the same results, different sequencing techniques could have the potential of 
introducing variation, therefore making it subject to investigation as part of this work. 
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2. Materials 
2.1. Streptococcus suis (S. suis) 
2.1.1. S. suis strains 
S. suis ST2, strain 10, wild type (“H4”) and a S. suis ST2, strain 10, capsule-deficient mutant (“H5”) 
used in this study were kindly provided by Dr. Maren Seitz from the Institute of Microbiology at the 
University for Veterinary Medicine Hannover, Germany. These strains were previously characterized 
in an in vivo porcine model, where the H5 strain was characterized to be avirulent (Smith et al., 
1999). 
2.1.2. S. suis cultivation and preservation medium 
S. suis H4 and H5 were cultivated in liquid Todd Hewitt Broth (THB; Oxoid, Wesel, Germany) in order 
to prepare bacteria stocks for long-term storage and infection experiments. Columbia agar plates 
with sheep blood (Oxoid, Wesel, Germany) were used as solid medium for bacterial cultivation and 
determining the colony forming units (CFU). The medium for long-term preservation at -80 °C was 
composed of bacteria suspended in DMEM/F-12 (1x) medium (containing L-Glutamine, 15 mM 
HEPES, without phenol red; Gibco/Life Technologies™, Paisley, UK) with an optical density at 600 nm 
(OD600) of 0.65, containing 20 % glycerol (Sigma-Aldrich, Steinheim, Germany). 
 
2.2. Host cells and in vivo experiments 
2.2.1. Human papilloma choroid plexus epithelial (HIBCPP) cells 
In this study, HIBCPP cells were used as a human in vitro BCSFB model. These cells were originally 
isolated from a 29-year-old woman diagnosed with a malignant choroid plexus papilloma, and 
characterized as a cell line by Ishiwata and colleagues (Ishiwata et al., 2005). They have been 
described by Schwerk and colleagues to be a suitable in vitro BCSFB model due to their nature of 
forming tight junctions, which in turn resulted in low permeability towards macromolecules and a 
high transepithelial electrical resistance (TEER) (Schwerk et al., 2012). Furthermore, in concordance 
of their nature to maintain a homeostatic niche in the CNS, HIBCPP cells have been characterized to 
possess transporter proteins essential for xenobiotic restriction (Bernd et al., 2015). Additionally, 
HIBCPP cells exhibit cellular polarity, with the presence of microvilli on the apical cell side (Schwerk 
et al., 2012). This cellular polarity is a further essential point when utilizing HIBCPP cells for in vitro 
investigations, since the cultivation in a standard model allows for the investigation of cellular 
responses from the apical epithelial cell side, which in vivo would reflect the CSF compartment. In 
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contrast, an inverted BCSFB model utilizing HIBCPP cells has been established, which allows for the in 
vitro investigation of these cells when applying the substance or subject of interest to the epithelial’s 
basolateral surface, which in vivo would reflect the blood side of the barrier (Dinner et al., 2016; 
Schwerk et al., 2012). 
2.2.2. Primary porcine choroid plexus epithelial cells (PCPEC) 
The isolation and characterization of primary PCPEC was first described by Gath and colleagues and 
Haselbach and colleagues (Gath et al., 1997; Haselbach et al., 2001). These primary cells were 
characterized to have maintained their ability to form tight junctions, exhibited phenotypic 
polarization with the presence of microvilli on their apical surface, and displayed the ability to 
secrete fluid from the basolateral to the apical side when they were cultivated ex vivo (Gath et al., 
1997; Haselbach et al., 2001). These characteristics have made PCPEC ideal for in vitro investigations 
involving the BCSFB. Tenenbaum and colleagues later applied the primary PCPEC in the inverted cell 
culture BCSFB model, which allows for in vitro cellular investigations from the epithelia’s basolateral 
cell side (Tenenbaum et al., 2009). 
For each cell batch utilized for an infection experiment in this present work, the CP of freshly 
slaughtered pigs was collected at the meat-processing center in Mannheim 
(Fleischversorgungszentrum GmbH Mannheim). 
2.2.3. Porcine in vivo experiments 
The CP tissue samples used for the transcriptome analysis were collected from two independent in 
vivo porcine infection experiments. Both experiments were carried out in collaboration with the 
research group of Prof. Christoph G. Baums, head of the Institute for Bacteriology and Mycology at 
the Veterinary Faculty of the University of Leipzig. Additionally, the same pig breed (German 
Landrace Pig from the Bundes Hybrid Zucht Programm (BHZP) GmbH, Dahlenburg-Ellringen, 
Germany, Line 01), which were approximately 8 weeks old, was used in both animal experiments. 
The in vivo porcine infection experiment, from which our “meningitis-free” samples were obtained, 
was carried out at the Institute for Bacteriology and Mycology at the Veterinary Faculty of the 
University of Leipzig. The animals from which the samples were obtained were part of a published 
study performed by Rieckmann and colleagues (Rieckmann et al., 2018). 
The in vivo porcine infection experiment, from which our “meningitis” samples were obtained, was 
carried out at an animal experiment facility at the Veterinary University of Hannover. The animals 
from which the samples were obtained were part of the published study carried out by Rungelrath 
and colleagues (Rungelrath et al., 2018). 
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2.3. Cell media, their composition and constituents required for cell culture 
maintenance 
All incubation and cell maintenance steps took place in a humidified incubator (Thermo Fisher 
Scientific, Dreieich, Germany) at 37 °C and 5 % CO2, unless otherwise noted. 
2.3.1. HIBCPP cells 
HIBCPP cells were cultivated on ThinCertTM cell culture filter membranes, with a 3 µm pore diameter, 
in the inverted BCSFB model and maintained as previously described by Schwerk and colleagues 
(Schwerk et al., 2012). Table 1 summarizes the cell medium composition required for HIBCPP cell 
cultivation, infection experiments, and long-term storage. 
In addition, Trypsin-EDTA (0.25 %; Gibco/Life Technologies, Paisley, Germany) was used to detach 
cells from the cell culture flask and trypan blue solution (Sigma-Aldrich, Steinheim, Germany) was 
used diluted at a ratio of 1:10 with the HIBCPP cell suspension, in order to determine cell density. 
Table 1. HIBCPP cell medium required for cell cultivation and long-term storage. 
10 % HIBCPP cell cultivation medium 
composition 
Final 
concentration 
Manufacturer 
DMEM/F-12 (1x) with L-Glutamine, 
15 mM HEPES, and phenol red 
Fetal calf serum (FCS) 
Penicillin/Streptomycin (5000 U ml-1) 
 
Human recombinant insulin solution 
(10 mg ml-1) 
 
 
10 % (v/v) 
100 U/ml/ 
100 µg/ml 
0.05 % (v/v) 
Gibco/Life Technologies™, Paisley, UK 
 
Gibco/Life Technologies™, Paisley, UK 
Gibco/Life Technologies™, Paisley, UK 
 
Sigma-Aldrich, Steinheim, Germany 
1 % HIBCPP infection medium 
composition 
  
DMEM/F-12 (1x) with L-Glutamine, 
15 mM HEPES, without phenol red 
FCS 
Human recombinant insulin solution  
 
 
1 % (v/v) 
0.05 % (v/v) 
Gibco/Life Technologies™, Paisley, UK 
 
Gibco/Life Technologies™, Paisley, UK 
Sigma-Aldrich, Steinheim, Germany 
Long-term storage medium composition   
HIBCPP cells suspended in 10 % HIBCPP 
cell culture medium 
FCS 
DMSO (dimethylsulfoxide) 
70 % (v/v) 
 
20 % (v/v) 
10 % (v/v) 
See above 
 
Gibco/Life Technologies™, Paisley, UK 
Sigma-Aldrich, Steinheim, Germany 
 
2.3.2. Primary PCPEC 
Primary PCPEC were cultivated on ThinCertTM cell culture filter membranes, with a 3 µm pore 
diameter, in the inverted BCSFB model and were cultivated and maintained as previously described 
(Tenenbaum et al., 2009).                    
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Mouse laminin (50 µg ml-1; Becton, Dickinson & Co., Franklin Lakes, NJ, USA), which is an important 
glycoprotein part of the basement membrane, was used to facilitate epithelial adherence to the cell 
culture filter membrane. 
Table 2 summarizes the media and individual medium components required for the primary PCPEC 
isolation and maintenance. 
Table 2. Media composition for the cultivation of primary porcine choroid plexus epithelial cells. 
 Final 
concentration 
Manufacturer 
1. For meat-processing center  
HBSS with Ca2+ and Mg2+ 
HEPES Buffer (1 M) 
Penicillin-Streptomycin (P/S; 5000 U ml-1) 
 
2 % (v/v) 
2.4 % (v/v) 
Gibco/Life Technologies™, Paisley, UK 
Lonza, Basel, Switzerland 
Gibco/Life Technologies™, Paisley, UK 
2. For meat-processing center  
DMEM/F-12 (1x) with L-Glutamine, 
15 mM HEPES, and phenol red 
P/S 
 
 
2 % (v/v) 
Gibco/Life Technologies™, Paisley, UK 
 
Gibco/Life Technologies™, Paisley, UK 
3. For washing the CP after collection (“wash medium”)  
HBSS without Ca2+ and Mg2+ 
HEPES Buffer (1 M) 
P/S 
 
2 % (v/v) 
2.4 % (v/v) 
Gibco/Life Technologies™, Paisley, UK 
Lonza, Basel, Switzerland 
Gibco/Life Technologies™, Paisley, UK 
4. Medium for trypsin treatment (“trypsin medium”)  
HBSS without Ca2+ and Mg2+ 
P/S 
Trypsin 
 
2.4 % (v/v) 
0.2 % (w/v) 
Gibco/Life Technologies™, Paisley, UK 
Gibco/Life Technologies™, Paisley, UK 
Belger Biochemie, Kleinmachnow, 
Germany 
5. Medium for seeding cells (“AraC medium”)  
DMEM (1x) with GlutaMAX™ with 4.5 g L-1 
D-Glucose, pyruvate, and phenol red 
Fetal calf serum (FCS) 
P/S 
Human recombinant insulin solution 
Cytosine Arabinoside (AraC; 40 mg) 
 
 
10 % (v/v) 
2 % (v/v) 
0.05 % (v/v) 
20 µM 
Gibco/Life Technologies™, Paisley, UK 
 
Gibco/Life Technologies™, Paisley, UK 
Gibco/Life Technologies™, Paisley, UK 
Sigma-Aldrich, Steinheim, Germany 
Cell Pharm GmbH, Hannover, 
Germany 
6. Cell-cultivation medium without AraC (“AraC-free medium”) 
As described for “5. AraC medium”, but without AraC  
7. Serum-free medium (“SFM – with P/S”) 
DMEM (1x) with GlutaMAX™ with 4.5 g/L 
D-Glucose and without phenol red 
P/S 
HEPES Buffer (1 M) 
L-Glutamine (200 mM) 
Sodium Pyruvate (100 mM) 
Human recombinant insulin solution 
 
 
2 % (v/v) 
2.4 % (v/v) 
2 % (v/v) 
1.2 % (v/v) 
0.05 % (v/v) 
Gibco/Life Technologies™, Paisley, UK 
 
Gibco/Life Technologies™, Paisley, UK 
Lonza, Basel, Switzerland 
Invitrogen, Carlsbad, CA, USA 
Invitrogen, Carlsbad, CA, USA 
Sigma-Aldrich, Steinheim, Germany 
8. Serum-free medium for infection experiment (“PCPEC infection medium”) 
As described for “7. SFM – with P/S”, but without P/S  
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2.4. Oligonucleotide primers and DNA Size Ladder 
The oligonucleotide primers were designed with the help of Primer3 software (Rozen and Skaletsky, 
2000), were synthesized by Sigma-Aldrich (Steinheim, Germany), and delivered in lypophilic form. 
The oligonucleotide primers were reconstituted with double-distilled H2O (Gibco/Life Technologies™, 
Paisley, UK), to a concentration of 100 pmol µl-1, as recommended by the manufacturer. 
Furthermore, the primers were designed to overlap the exon-exon regions of a gene, therefore 
yielding PCR products of mature mRNA transcripts. 
For evaluating the reverse transcriptase polymerase chain reaction (RT-PCR) products during the 
agarose gel electrophoresis, the GeneRuler 100 bp DNA Ladder (Thermo Fisher Scientific, Dreieich, 
Germany) was run along with the samples as an amplicon size indicator. 
Table 3 summarizes the oligonucleotides used to perform the semi-quantitative RT-PCR. 
Table 3. Oligonucleotide primers used for the RT-PCR. 
Gene Oligonucleotide primer for RT-PCR Annealing 
Temp. (°C) 
Amplicon 
size (bp) 
Reference 
Human 
gapdh 
 
nfkbiz 
 
il8 
 
tnf-α 
 
cxcl1 
 
cxcl2 
Forward 5’-TGTTGCCATCAATGACCCCTT-3’ 
Reverse 5’-CTCCACGACGTACTCAGCG-3’ 
Forward 5’-CAGTTCAAGTTAGCTGGCTGA-3’ 
Reverse 5’-TCTGTGGAGAATACTGGTACAGG-3’ 
Forward 5’-CAAGAGCCAGGAAGAAACCA-3’ 
Reverse 5’-GTCCACTCTCAATCACTCTCAG-3’ 
Forward 5’-GAGCACTGAAAGCATGATCC-3’ 
Reverse 5’-CGAGAAGATGATCTGACTGCC-3’ 
Forward 5’-CTCTTCCGCTCCTCTCACAG-3’ 
Reverse 5’-GGGGACTTCACGTTCACACT-3’ 
Forward 5’-CTCAAGAATGGGCAGAAAGC-3’ 
Reverse 5’-AAACACATTAGGCGCAATCC-3’ 
60 
 
60 
 
60 
 
60 
 
60 
 
60 
202 
 
177 
 
225 
 
234 
 
239 
 
213 
Borkowski et 
al. (2014) 
Borkowski et 
al. (2014) 
Borkowski et 
al. (2014) 
Borkowski et 
al. (2014) 
van Sorge et 
al. (2008) 
van Sorge et 
al. (2008) 
Porcine 
gapdh 
 
il8 
 
il1β 
 
cxcl2 
Forward 5’-CAGCCTCAAGATCATCAGCA-3’ 
Reverse 5’-TCCAGGGGCTCTTACTCCTT-3’ 
Forward 5‘-GATGCCAACACAACTTCAATCA-3’ 
Reverse 5‘-GCCAAAACAGGATTTCCAGC-3’ 
Forward 5‘-ATGCCAACGTGCAGTCTATG-3’ 
Reverse 5‘-GAAGACGGGCTTTTGTTCTG-3’ 
Forward 5‘-ACTGCTCTTGTTTAGCATCTTCTC-3’ 
Reverse 5‘-TGACCAAACGGAAGTCATAGC-3’ 
55 
 
60 
 
55 
 
55 
594 
 
221 
 
400 
 
109 
Tenenbaum 
et al. (2008) 
This study 
 
This study 
 
This study 
Bacteria – S. suis 
ORF 
E&F of 
capsule 
Forward 5’-ATTGGAGATATGAGTCTAGTCGGTA-3’ 
Reverse 5’-CATGACCGTCTGGGTTTACG-3’ 
   60 695 This study & 
Lakkitjaroen 
et al. (2011) 
bp, base pairs; cxcl, (C-X-C motif) ligand; gapdh, glyceraldehyde-3-phosphate dehydrogenase; il, 
interleukin; nfkbiz, NF-kappa-B inhibitor zeta; ORF, open reading frame; tnf-α, tumor necrosis factor 
alpha 
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Table 4 summarizes the oligonucleotides utilized for the quantitative PCR (qPCR) in order to verify 
single genes from the RNA-seq data. 
The human oligonucleotide primers used for the qPCR, which encode for the genes gapdh, tnfα, il8, 
and cxcl2, and the porcine oligonucleotide primers used for the qPCR, which encode for the genes il8 
and cxcl2, were the same primers as described in Table 3. 
Table 4. Oligonucleotide primers used for the qPCR. 
Gene Oligonucleotide primer for qPCR Annealing 
Temp. (°C) 
Amplicon 
size (bp) 
Reference 
Human     
il1β 
 
zc3h12a 
 
tcim 
 
nfkbia 
 
hif1α 
 
vegfa 
 
mxi1 
 
dusp2 
 
Forward 5’-AGCTACGAATCTCCGACCAC-3’ 
Reverse 5’-CGTTATCCCATGTGTCGAAGAA-3’ 
Forward 5’-GGCAGTGAACTGGTTTCTGGA-3’ 
Reverse 5’-GATCCCGTCAGACTCGTAGG-3’ 
Forward 5’-AGAAGAGCCTGGACAGATGT-3’ 
Reverse 5’-TTTTCTCTCCCTGTCCTCCC-3’ 
Forward 5’-CTCCGAGACTTTCGAGGAAATAC-3’ 
Reverse 5’-GCCATTGTAGTTGGTAGCCTTCA-3’ 
Forward 5’-GAACCCATTCCTCACCCATC-3’ 
Reverse 5’-GCATCCTGTACTGTCCTGTG-3’ 
Forward 5’-TCTTCAAGCCATCCTGTGTG-3’ 
Reverse 5’-CCCTTTCCCTTTCCTCGAAC-3’ 
Forward 5’-CTCTCTTCCTCACAGTCCCA-3’ 
Reverse 5’-CAGGGGTAAGGTCTCCAAGA-3’ 
Forward 5’-ATCTTGCCCTACCTGTTCCT-3’ 
Reverse 5’-GCTGTTCTTCACCCAGTCAA-3’ 
60 °C 
 
60 °C 
 
58 °C 
 
60 °C 
 
58 °C 
 
58 °C 
 
58 °C 
 
58 °C 
 
186 
 
232 
 
175 
 
135 
 
250 
 
235 
 
194 
 
222 
This study 
 
Borkowski et 
al. (2014) 
This study 
 
This study 
 
This study 
 
This study 
 
This study 
 
This study 
Porcine     
gapdh 
 
tnfα 
 
il1β 
 
zc3h12a 
 
tcim 
 
nfkbia 
 
hif1α 
 
vegfa 
 
mxi1 
 
dusp2 
Forward 5’-TGGTGCTACGTATGTTGTGG-3’ 
Reverse 5’-ATTGCTGACGATCTTGAGGG-3’ 
Forward 5’-ACGTTTTCCTCACTCACACC-3’ 
Reverse 5’-TCGATCATCCTTCTCCAGCT-3’ 
Forward 5’-GAGTGCAAACTCCAGGACAA-3’ 
Reverse 5’-GGTGGGCGTGTTATCTTTCA-3’ 
Forward 5’-CTGTAGGATTGGTTCTGGCC-3’ 
Reverse 5’-CGAGAGAAAGGAGGGTTTGG-3’ 
Forward 5’-CCGATCAACTTCACGTCTGT-3’ 
Reverse 5’-CTGCAATTCTTCTCCAGCCT-3’ 
Forward 5’-TGTCGCTCTTGTTGAAGTGT-3’ 
Reverse 5’-TCTGTGAACTCTGACTCCGT-3’ 
Forward 5’-TGTAATGCTCCCCTCATCCA-3’ 
Reverse 5’-GGCTGATCTTGAATCTGGGG-3’ 
Forward 5’-CGAGTACATCTTCAAGCCGT-3’ 
Reverse 5’- CATCTCTCCTATGTGCTGGC-3’ 
Forward 5’- GCAGAGTATTGGGAGTGACG-3’ 
Reverse 5’-GAGACTGCAACATGAACCCA-3’ 
Forward 5’-CAGATGGTGGAGATCAGTGC-3’ 
Reverse 5’-CTGCCCCATGAAACTGAAGT-3’ 
58 °C 
 
58 °C 
 
58 °C 
 
58 °C 
 
58 °C 
 
58 °C 
 
58 °C 
 
58 °C 
 
58 °C 
 
58 °C 
177 
 
176 
 
218 
 
156 
 
181 
 
193 
 
198 
 
154 
 
155 
 
228 
This study 
 
This study 
 
This study 
 
This study 
 
This study 
 
This study 
 
This study 
 
This study 
 
This study 
 
This study 
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dusp2, dual specificity phosphatase 2; hif1α, hypoxia-inducible factor 1 alpaha; mxi, MAX interactor 
1; nfkbia, NFαB inhibitor alpha; tcim, transcriptional and immune response regulator; vegfα, vascular 
endothelial growth factor alpha; zc3h12a, zinc finger CCCH-type containing 12A 
 
2.5.  RNA-seq 
RNA-seq was carried out in collaboration in the Biochip Laboratory of PD Dr. Ludger Klein-Hitpass, at 
the University Hospital in Essen, Germany. 
In order to prepare the RNA library for conventional RNA-seq of the HIBCPP cells, the Ovation Human 
FFPE RNA-Seq Multiplex System Kit (NuGen, Illumina, San Diego, CA, USA) was used. For the PCPEC 
and the porcine CP tissue from the in vivo infection experiments, the Universal Plus mRNA-Seq kit 
(NuGen, Illumina, San Diego, CA, USA) was used for the RNA library preparation. Furthermore, a 
second RNA library was prepared using the RNA from the CP tissue samples obtained from the in vivo 
porcine infection experiments with the MACE Library Preparation Kit (6x) for Mi-Seq (Illumina), Single 
End Sequencing, (GenXPro, Frankfurt am Main, Germany). The latter RNA library was prepared in 
order to explore an alternative RNA-seq method called MACE. 
The sequencing of the pooled HIBCPP cell sample set library was performed using HiSeq 2500 flow 
cell system (Illumina®, San Diego, CA, USA) in the high-output and paired-end mode. The sequencing 
of the pooled RNA libraries of the PCPEC samples and the in vivo CP samples was carried out on the 
HiSeq 2500 flow cell system (Illumina®, San Diego, CA, USA) in the rapid-run and paired-end mode. 
Lastly, the RNA library, also generated from the in vivo CP samples, for MACE was sequenced using 
the MiSeq v3 flow cell system (Illumina®, San Diego, CA, USA) in the single-end mode. 
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2.6.  Laboratory Equipment 
The following laboratory equipment was utilized to carry out the work in this thesis. 
Description and Model Manufacturer 
Agilent 2100 Bioanalyzer 
Analog Vortex Mixer 
Autoclave 5075 ELV 
Cell culture/CO2 incubator Hera Cell 240 
Centrifuge – Micro 200R with 242A Rotor 
Centrifuge – Rotana 460R with Rotor 5624 
Centrifuge – Picofuge® II Microfuge 
Clean Bench Hera Save 
Geldocumentation Biovision-3026WL/26MX 
Hemocytometer (Neubauer Chamber); 0.1 mm 
depth; 0.0025 mm2 
HiSeq 2500 Sequencing System 
Light microscope Axiovert 40C 
Magnetic Stand – 96 
Micro pestle 
MiSeq Benchtop Sequencer 
Multiwell plate Reader Infinite M200 
Pipetboy Comfort 
Pipette Reference (10 µl / 2.5 µl) 
Pipette Research (1000 / 200 / 100 / 20 µl) 
Qubit® 2.0 Fluorometer 
S220 Focused-ultrasonicator with Adaptive 
Focused Acoustics® 
Spectrophotometer NanoDrop® ND1000 
Spectrophotometer WPA Biowave Co 8000 
Thermocycler 2720 
Thermomixer compact 
Voltohmmeter Millicell® -ERS 
Voltohmmeter-Electrode MERSSTX 01 
Waterbath SW22 
Agilent Technologies, Waldbronn, Germany 
VWR, Darmstadt, Germany 
Systec, Linden, Germany 
Thermo Fisher Scientific, Dreieich, Germany 
Hettich, Kirchlengern, Germany 
Hettich, Kirchlengern, Germany 
Stratagene, San Diego, CA, USA 
Thermo Fisher Scientific, Dreieich, Germany 
Vilber Lourmat, Eberhardzell, Germany 
NeoLab, Heidelberg, Germany 
 
Illumina®, San Diego, CA, USA 
Zeiss, Oberkochen, Germany 
Thermo Fisher Scientific, Dreieich, Germany 
Eppendorf, Hamburg, Germany 
Illumina®, San Diego, CA, USA 
Tecan, Männedorf, Germany 
IBS Integra Biosciences, Zizers, Switzerland 
Eppendorf, Hamburg, Germany 
Eppendorf, Hamburg, Germany 
Thermo Fisher Scientific, Dreieich, Germany 
Covaris®, Woburn, MA, USA 
 
Peqlab, Erlangen, Germany 
Biochrom, Berlin, Germany 
Applied Biosystems, Waltham, MA, USA 
Eppendorf, Hamburg, Germany 
Millipore, Billerica, MA, USA 
Millipore, Billerica, MA, USA 
Julabo, Seelbach, Germany 
 
Materials 
36 
 
2.7.  Chemicals and Buffers 
The following chemicals and buffers (and their composition) were used in this study. For the 
preparation buffers, media, and agarose gels, water from the MilliQ® ultrapure water filtering system 
was used (Millipore; Billerica, MA, USA). 
Description Composition Manufacturer 
Dimethylsulfoxide (DMSO) 
TAE Buffer (1x) 
 
 
RLT Lysis Buffer 
 
Agarose NEEO Ultra 
Quality 
Ethidium Bromide 
Ethanol (absolute 99.9 %) 
 
Dulbecco’s phosphate 
buffered solution (DPBS) 
with Ca2+ and Mg2+ 
DPBS without Ca2+ & Mg2+ 
 
40 mM Tris 
20 mM Acetic acid 
1 mM EDTA pH 0.3 
RLT-Lysis Buffer 
10 mM ß-mercaptoethanol 
Sigma-Aldrich, Steinheim, Germany 
Carl Roth, Karlsruhe, Germany 
Merck, Darmstadt, Germany 
Carl Roth, Karlsruhe, Germany 
Qiagen, Hilden, Germany 
Sigma-Aldrich, Steinheim, Germany 
Carl Roth, Karlsruhe, Germany 
 
AppliChem, Darmstadt, Germany 
Mallinckrodt, Baker, Devender, 
Netherlands 
Gibco/Life Technologies, Paisley, UK 
 
 
Gibco/Life Technologies, Paisley, UK 
 
 
 
 
 
 
 
 
 
Materials 
37 
 
2.8.  Consumables 
The following consumables were used to carry out this project. 
Description Manufacturer 
Mx3000P Optical Strip Caps 
Mx3000P Strip Tubes 
Agilent Bioanalyzer HS DNA chip 
Agilent Bioanalyzer RNA Nano chip 
qPCR 96-well non-skirted plate 
Agencourt AMPure XP SPRI Beads 
Serological Pipette (5 ml/10 ml/25 ml) 
Covaris microTUBE 
Safe-lock Centrifuge Tubes (0.5 ml/1.5 ml/2ml) 
96-well plate, black and uncoated 
Cryo.sTM, cryogenic vial with screw cap, PP, 1 ml 
Conical Tubes (15 ml / 50 ml) 
Cuvette 
ThinCertTM Cell Culture Filter Membrane for 24-
well plates; 3 µm pore diameter, 2 x 106 pores 
Tissue Culture flask, 75 cm2, 250 ml, PS, red filter 
6-well Cell Culture Plate 
12-well Cell culture Plate 
24-well Cell Culture Plate 
TipOne® (100 µl / 200 µl / 1000 µl XL) Graduated 
Filter Tip (sterile) 
TipOne® 10 µl XL Graduated Filter Tip Max. Vol. 
20 µl (sterile) 
TipOne® RPT (100 µl / 200 µl / 1000 µl XL) 
Graduated Filter Tip (sterile) 
TipOne® RPT 10 µl XL Graduated Filter Tip Max. 
Vol. 20 µl (sterile) 
Agilent Technologies, Waldbronn, Germany 
Agilent Technologies, Waldbronn, Germany 
Agilent Technologies, Waldbronn, Germany 
Agilent Technologies, Waldbronn, Germany 
Agilent Technologies, Waldbronn, Germany 
Beckman Coulter Life Sciences, Brea, CA, USA 
Becton, Dickinson & Co., Franklin Lakes, NJ, USA 
Covaris®, Woburn, MA, USA 
Eppendorf, Hamburg, Germany 
Nunc, Roskilde, Denmark 
Greiner Bio-One, Frickenhausen, Germany 
Greiner Bio-One, Frickenhausen, Germany 
Greiner Bio-One, Frickenhausen, Germany 
Greiner Bio-One, Frickenhausen, Germany 
 
Greiner Bio-One, Frickenhausen, Germany 
Starlab, Hamburg, Germany 
Starlab, Hamburg, Germany 
Starlab, Hamburg, Germany 
Starlab, Hamburg, Germany 
 
Starlab, Hamburg, Germany 
 
Starlab, Hamburg, Germany 
 
Starlab, Hamburg, Germany 
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2.9.  Kits 
The following kits were used to carry out parts of this project. 
Kit Manufacturer 
AffinityScript QPCR cDNA Synthesis Kit 
Brilliant II SYBR® Green QPCR Master Mix 
MACE Library Preparation Kit (6x) for Mi-Seq 
(Illumina), Single End Sequencing 
LIVE/DEAD Viability/Cytotoxicity Kit for mammalian 
cells 
NEBNext® Library Quant Kit for Illumina® 
Ovation Human FFPE RNA-Seq Multiplex System Kit 
Universal Plus mRNA-Seq 
QIAShredder 
QIAquick PCR Purification kit, up to 10 µg PCR 
products; 100 bp to 10 kbp 
RNase-free DNase Set 
RNeasy Micro Kit 
RNeasy Mini Kit 
Taq DNA Polymerase Kit (1000 U) 
QubitTM double stranded DNA high sensitivity assay 
Agilent Technologies, Waldbronn, Germany 
Agilent Technologies, Waldbronn, Germany 
GenXPro, Frankfurt am Main, Germany 
 
Molecular Probes, Eugene, Oregon, USA 
 
New England Biolabs Inc., Ipswich, MA, USA 
NuGen, Illumina, San Diego, CA, USA 
NuGen, Illumina, San Diego, CA, USA 
Qiagen, Hilden, Germany 
Qiagen, Hilden, Germany 
 
Qiagen, Hilden, Germany 
Qiagen, Hilden, Germany 
Qiagen, Hilden, Germany 
Qiagen, Hilden, Germany 
Thermo Fisher Scientific, Dreieich, Germany 
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2.10. Software 
The following software programs were utilized in order to acquire data presented in this study. 
Differing versions of the Molecular Signature Database (MSigDB) were used due to the extended 
time frame in between sequencing analysis of the different samples. 
Software Developer 
MXPro 
Trimmomatic-0.30 
Spliced Transcripts Alignment to a Reference 
(STAR) RNA aligner 
InkScape version 0.92 
CASAVA 1.8.2 
Illumina® Sequencing Analysis Viewer (SAV) 
Partek Genomics Suite 
Integrative Genomics Viewer  (IGV) 
Primer3 
StrandNGS 
i-control™ 
Vision-Capt 
Zeiss ZEN Imaging Software 
Gene Set Enrichment Analysis (GSEA) V 2.0.14 
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3. Methods 
3.1.  S. suis 
3.1.1. Bacteria cultivation and preparation for in vitro infection experiments 
In order to cultivate bacteria for the infection experiments, an aliquot of the S. suis strain long-term 
storage stock (from – 80°C) was added to 10 ml Todd Hewitt Broth (THB) in a 15 ml conical tube. The 
lid of the test tube was kept loose and the test tube was placed at an angle in the water bath, where 
the bacteria were incubated at 37 °C for 6 h, where the bacteria were grown to mid-log phase. 
Following the incubation, the bacterial culture was washed twice. First, the bacterial cell suspension 
was centrifuged at 2680 x g for 10 min. The supernatant was discarded and the bacteria pellet was 
re-suspend in 10 ml on the respective HIBCPP cell or PCPEC infection medium (see Table 1 and Table 
2). The centrifugation step was repeated and the supernatant was discarded before the bacterial 
pellet was re-suspended in 1 ml medium used during the infection experiment (see above). A 1:10 
dilution of the bacteria suspension was made, and the OD600, using a photometer, was determined. 
The bacterial cell suspension was then adjusted to an OD600 of 0.65, which resulted in approximately 
2x108 CFU ml-1. Again, the bacterial cell density was adjusted in the respective HIBCPP cell or PCPEC 
infection medium. The bacterial cell suspension adjusted to an OD600 of 0.65 will be referred to as the 
inoculum. 
In order to determine the bacterial CFU, which was used for infection of host cells in vitro, as well as 
the CSF throughout the infection time points, the inoculum and an amount, which equaled a 
multiplicity of infection (MOI) 10, was serial diluted up to 106, and 10 µl of the last 3 dilutions were 
plated in duplicate onto Colombia sheep blood agar plates. The sheep blood agar plates were 
incubated inverted in a humidified incubator at 37 °C and 5 % CO2 overnight, and the CFU were 
counted the following day. 
  
3.1.2. Strain-confirmation PCR 
The bacteria primers listed in Table 3 were used in order to confirm the strain containing the open 
reading frames (ORFs) E and F in the S. suis wildtype (H4) and to assure the absence of the bacterial 
capsule (H5). 
S. suis was prepared as described above (section 3.1.1) by being cultivated in THB, washed twice with 
DPBS (with Ca2+ and Mg2+), and the OD600 was adjusted to 0.65. The bacterial inoculum was incubated 
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at 99°C for 10 min in order to lyse the bacterial cell membranes and to release the genomic content 
into the suspension. 
The composition of the PCR reaction mixture is summarized in Table 7 and the PCR program is 
described in Table 8 was set. The cDNA synthesis step was not performed preceding the PCR, since 
the bacterial cell lysis released its DNA. 
Figure 5 depicts the positive confirmation of the presence of the bacterial cell wall in the S. suis ST2 
wildtype (H4) strain. The PCR product is indicative of the presence of the bacterial ORFs E and F, 
which is expressed by the gene cpsE and cpsF. Smith and colleagues previously described that the 
ORFs E and F are essential in order for the proper formation of the bacterial capsule (Smith et al., 
1999). In contrast, the absence of a PCR product for the non-encapsulated H5 S. suis ST2 strain 
confirms the deletion of ORFs E and F. 
 
 
Figure 5. S. suis ST2 strain 10 bacterial capsule verification via PCR. A size marker ranging from 100 
to 1000 base pairs (bp) is indicated on the left. The band at approximately 700 bp for the H4 strain 
is indicative for the genes encoding for the bacterial cell well formation. The absence of a product 
band for the H5 strain confirms the absence of the bacterial capsule on a transcriptome level. The 
PCR products were run on a 1.5 % agarose gel at 120 V for 40 min and the image was captured 
using the VisionCapt software. 
 
3.1.3. Long term storage 
The S. suis strains were cultivated and washed twice with DPBS (with Ca2+ and Mg2+) as described 
above (3.1.1). Subsequently to the second DPBS wash, the OD600 of the bacterial cell suspension was 
adjusted to 0.65 in DMEM/F-12 medium containing 20 % glycerol. The bacterial suspension was 
aliquoted into cryo tubes and stored at -80 °C. 
Methods 
42 
 
3.2. Cell culture 
3.2.1. HIBCPP cell cultivation 
3.2.1.1. Splitting and seeding the cells onto ThinCertTM cell culture filter 
membranes 
To split the HIBCPP cells from a T75 cell culture flask, the cells were rinsed twice with 10 ml DPBS 
(without Ca2+ and Mg2+) in order to remove free Ca2+ and Mg2+ ions, which can prevent the proper 
enzymatic activity of 0.25 % Trypsin-EDTA, which was subsequently added. The cells were incubated 
with trypsin-EDTA for up to 20 min at 37 °C in order to detach them from the cell culture flask. To 
stop the trypsin digestion, 1 volume of the 10 % HIBCPP cell medium was added. 
The cell suspension was transferred to a 50 ml conical tube and a 1:2 dilution was made with trypan 
blue in order to count the cells. Trypan blue is an azo dye, which is taken up by dead or dying cells 
and thereby stains them blue due to their permeable membranes; living cells remain unstained. The 
diluted cell suspension was counted while the HIBCPP cell suspension was centrifuged at 55 x g for 
10 min at room temperature. Following the centrifugation, the supernatant was discarded and the 
cell density was adjusted to 1 x 106 cells ml-1. 
The cells were cultivated as previously described by Schwerk and colleagues in the inverted cell 
culture method of the human in vitro BCSFB model (Schwerk et al., 2012), with some modifications. 
For this, 24-well cell culture membrane filters, with a pore diameter of 3 µm, were placed inverted 
into a 12-well cell culture plate, thereby exposing the basolateral filter side upwards. Pre-warmed 
10 % FCS HIBCPP cell culture medium was used to fill the well along with the inverted apical filter 
side, before the HIBCPP cell suspension was applied to the basolateral side of the filter membrane. A 
maximum of 100,000 cells were seeded per cell culture filter insert, which, when confluent, resulted 
in approximately 400,000 cells per filter. As a general rule, for HIBCPP with a lower cell passage 
number, fewer cells were seeded onto the filter membrane. HIBCPP cells up to passage 38 were used 
for experiments, since these exhibited the most continuity based on previous experiences in the 
laboratory. 
One day after the cells were seeded onto the basolateral cell culture filter membrane side, the filter 
membranes were flipped, and placed hanging into a 24-well cell culture plate. The cells were 
supplied with 10 % FCS HIBCPP cell culture medium – 1 ml medium on the apical cell side (well) and 
500 µl on the basolateral cell side (inside the filter compartment). Cell culture medium was 
exchanged every second day. 
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Approximately three to four days post-seeding, the barrier-forming property (TEER) of the HIBCPP 
cells was monitored via a voltohmmeter (section 3.3.1.1.1). Once the HIBCPP cells reached a TEER of 
at least 70 Ω x cm2, they were transferred to 1 % HIBCPP cell medium. The exposure to serum-
starvation induced the formation of a higher TEER usually by the following day, a phenomenon 
previously observed during the cultivation of PCPEC (Gath et al., 1997). It has been suggested, that 
FCS inhibits proper tight junction formation, but also an improved cell polarity in vitro, likely due to 
serum-containing growth factors (Chang et al., 1997; Hakvoort et al., 1998). Confluent HIBCPP cell 
filters with a TEER of at least 240 Ω x cm2 and a maximum of 740 Ω x cm2 were used in the infection 
experiments. 
 
3.2.1.2. Long-term storage 
The HIBCPP cells were treated with trypsin and washed twice as described above (3.2.1.1). 
Subsequently to the final wash, the HIBCPP cells were suspended in medium composed of 70 % of 
the 10 % FCS HIBCPP cell medium (Table 1), 20 % (v/v) FCS, and 10 % (v/v) DMSO. 
The cells were slowly cooled in increments by starting with placing them on ice, storage at – 20 °C for 
a few hours, then being placed in – 80 °C overnight, followed by the transfer into liquid nitrogen the 
following day. 
 
3.2.2. PCPEC: collection, isolation, and maintenance  
The day before the CP were collected at the meat-processing center of Mannheim 
(Fleischversorgungszentrum Mannheim GmbH), the basolateral side of the 24-well ThinCertTM cell 
culture filter membranes (3 µm pore diameter; pore density of 2 x 106 pores cm-1) was coated with 
5 µg cm2 -1 mouse laminin (50 µg/ml stock; Becton, Dickinson & Co., Franklin Lakes, NJ, USA). The 
laminin-coated filters were left to dry overnight. 
All the cell culture media and their components, utilized for the CP collection, primary CP epithelial 
cell selection, and cell cultivation, are summarized in Table 2. 
The following day, the CP was collected from the lateral ventricle from freshly slaughtered pigs at the 
meat-processing center. Upon the removal from the carcass, the CP was immediately placed into 
medium 1 “for the meat-processing center”. Before leaving the facility, the collected CP were 
transferred to medium 2 “for the meat-processing center” (Table 2). 
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The collected CP were subsequently processed in an aseptic setting under laboratory conditions. In 
the first step, the CP tissue was transferred to pre-warmed “wash medium” in a petri dish. In order to 
remove excess blood and wash the CP, the thin end of the CP was held with sterile tweezers while 
the thick end of the CP was cut off with dissection scissors. Subsequently, the CP was pulled across 
the edge of the petri dish. This process was repeated until the CP had a light pink-white appearance.  
In order to remove the CP epithelial cells from the CP tissue strands, the “trypsin medium” was 
freshly prepared. 11 washed and bled-out CP strands were added to the trypsin medium and 
incubated for 45 min at 4 °C. This was followed by a 17 min incubation step in a 37 °C water bath 
with slight agitation. In order to stop the trypsin digestion, one volume of pre-warmed FCS was 
added to the 20 ml CP-trypsin solution. The CP strands were further agitated using a serological 
pipette, in order to remove remaining CP epithelial cells from the stroma, and subsequently 
discarded.  
The cell suspension was transferred to a 50 ml conical tube and centrifuged for 10 min at 55 x g at 
room temperature. Following centrifugation, the supernatant was removed, including the red blood 
cells, layered on top of the white cell pellet. The pellet was suspended in a total of 10 ml “AraC 
medium”, before 100 µl of the cell suspension was applied to the laminin pre-coated basolateral 
ThinCertTM cell culture filter membrane side, which contained pre-warmed AraC medium on the 
apical side. 
In addition to seeding the cells onto the cell culture filter membranes, PCPEC were also seeded in a 6-
well cell culture plate, in duplicate, in order to monitor cell adherence and potential fibroblast 
contamination. For this, 1 ml of the PCPEC cell suspension was added to 2 ml AraC medium. These 
cells were supplied with the same cell medium as the cells cultivated on the cell culture filter 
membranes, and were discarded once the PCPEC developed a TEER high enough to be used in 
infection experiments. 
One day after the cells were seeded, the filters were washed once by flipping and hanging the cell 
culture filter membranes into a 24-well cell culture plate containing pre-warmed DPBS (containing 
Ca2+ and Mg2+) in order to remove non-adherent cells. The AraC medium from the 12-well cell culture 
plate, in which the PCPEC were seeded in the day before, was transferred to a new 24-well cell 
culture plate, to which the filters were transferred to after the DPBS wash. 
The PCPEC were left undisturbed until day 4 post-seeding. After 4 days in AraC medium, the cell 
medium was changed every 2 days using “AraC-free” medium. Starting 6 days post-seeding, the TEER 
development was monitored with a voltohmmeter (section 3.3.1.1.1). Once the TEER reached 
approximately 100 Ω x cm2, the cells were transferred to SFM – with P/S. 
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Once a TEER of approximately 170 Ω x cm2 was reached, the cells were cultivated in SFM – without 
P/S. A confluent primary PCPEC layer on the 24-well cell culture filter membrane consisted of 
approximately 60,000 cells. 
 
3.3.  Sample generation: infection experiments 
Transcriptome analysis was carried out on samples obtained from three different sources. The first 
sample set was generated by infecting immortal HIBCPP cells in the established human in vitro model 
of the BCSFB. The second sample set was generated by infecting ex vivo cultivated primary PCPEC 
cells in a porcine in vitro BCSFB model. The third sample set was obtained by isolating the CP from 
piglets, which were experimentally infected in vivo. These piglets were diagnosed as suffering from 
meningitis or were diagnosed as meningitis-free. 
 
3.3.1. In vitro infection experiments 
HIBCPP cells and PCPEC were infected in vitro with S. suis ST2, strain 10, wildtype (H4) and a non-
encapsulated mutant strain (H5) once the TEER values reached at least 250 Ω x cm2. The infection 
was performed with a MOI of 10, meaning 10 bacterial cells were added per 1 host cell. Therefore, 
4 x 106 and 6 x 105 bacterial cells were added to the confluent HIBCPP cells and PCPEC, respectively.  
The HIBCPP cells were infected up to 10 h, with time points being in 2 h increments. The primary 
PCPEC were infected up to 6 h, again, with time increments being in 2 h. Throughout the infection 
time points, multiple parameters were measured and examined to evaluate the barrier intactness. 
 
3.3.1.1. Barrier Integrity of the in vitro BCSFB models 
One main characteristic of CP epithelial cells is the formation of tight junctions, thereby producing a 
barrier. The ability of HIBCPP cells and primary PCPEC to form tight junctions in vitro has previously 
been demonstrated, which makes these cells ideal as an in vitro BCSFB model (Schwerk et al., 2012; 
Tenenbaum et al., 2009). 
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3.3.1.1.1.  Transepithelial Electrical Resistance (TEER) 
In order to evaluate the barrier development and barrier integrity of HIBCPP cells and PCPEC, the 
TEER was measured by utilizing a voltohmmeter coupled with a chopstick STX01 electrode (Millipore, 
Schwalbach, Germany). Before each TEER measurement, the electrode was incubated in 80 % 
ethanol for 10 min. Subsequently, the residual ethanol traces were rinsed off of the electrode and 
calibrated in the cell culture medium in which the host cells were in. In order to measure the TEER, 
the longer arm of the chopstick electrode was placed into the well, whereas the shorter arm was 
placed inside the compartment of the cell culture membrane filter insert. The resulting measurement 
was presented in units of resistance Ohm (Ω). 
In order to calculate the resistance across the cell culture filter membrane area (Ω x cm2), the 
measured Ω, from which the blank value was subtracted (cell culture membrane filter not containing 
any cells) was multiplied by the surface area of the 24-well cell culture filter membrane 
(approximately 0.336 cm2). 
For the in vitro infection experiments of HIBCPP cells and PCPEC, the TEER was measured before 
starting the infection and following the infection time point, in order to monitor the barrier 
intactness of the epithelial cells.  
 
3.3.1.1.2. Inulin-flux 
In order to monitor the paracellular permeability of the confluent CP epithelial cell layer throughout 
the infection intervals, fluorescein isothiocyanate (FITC)-inulin solution was utilized. FITC-inulin is a 
flurecein-labelled sugar molecule, with a molecular weight ranging from 2000 to 5000. By utilizing 
the Tecan Infinite M200 multiwell reader, FITC-inulin was excited at 490 nm and a fluorescence 
measurement was obtained at 520 nm. 
At the start of each in vitro infection experiment, 10 µl of a 50 µg ml-1 FITC-inulin stock solution was 
added to the filter compartment of each filter (basolateral cell side), in order to evaluate paracellular 
permeability from the basolateral to the apical cell side. 
Following the infection time point, the medium in the 24-well (apical CP epithelial cell side) was 
removed, and 200 µl was added per well in duplicate of a black 96-well plate per condition, and 
measured at 490 nm excitation and 520 nm emission. Based on a standard curve, which was run in 
parallel during each infection experiment, the percentage of the FITC-inulin flux was calculated. 
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3.3.1.2. Cell viability – live/dead assay 
Following the infection time point, the filters were washed once with phenol red- and serum-free 
DMEM/F-12 cell medium, referred to as “SFM”, before being placed into a fluorescent dye mixture, 
provided in the Live/Dead Viability/Cytotoxicity kit for mammalian cells, composed of ethidium 
homodimer (2 mM stock) and calceine green (4 mM stock) diluted 1:500 and 1:8000, respectively, in 
SFM. The cells were incubated in a humidified incubator at 37 °C and 5 % CO2 for 15 min. Following 
the incubation, the filters were washed three times in SFM, and were subsequently placed into a new 
well containing SFM. The filters were analyzed using the fluorescence microscope with the 10x 
objective in conjunction with the ZEN software and representative pictures were captured. Cells 
which emitted green (excitation 490 nm and emission 515 nm) are indicative of viable cells, whereas 
red-emitting (excitation 535 nm and emission 617 nm) cells are identified as dead. 
 
3.3.2. In vivo porcine infection experiments 
3.3.2.1. Animal ethics statement 
In vivo piglet infection experiments, and the subsequent necropsy, were carried out by veterinarians, 
in compliance with the principles outlined in the European Convention for the Protection of 
Vertebrate Animals Used for Experimental and Other Scientific Purposes, as well as the German 
Animal Protection Law (Tierschutzgesetz). The CP tissue samples analyzed in this study originated 
from two different in vivo infection studies. The CP tissue samples from the meningitis-free animals 
were part of a study, which was approved by the Landesdirektion Sachsen, with the permit number 
TVV26/15, which includes approval through the registered committee for animals experiments 
(Rieckmann et al., 2018). The experiment analyzing the CP from animals suffering from meningitis 
were approved by the Committee on Animal Experiments of the Lower Saxonian State Office for 
Consumer Protection and Food Safety under the permit number 33.12-42,502-04-16/2305A 
(Rungelrath et al., 2018). 
 
3.3.2.2. Experimental set-up and CP collection 
In the study, from which the CP tissue samples were collected from the meningitis-free animals, 8-
week old male piglets were intravenously infected with a bacterial density of 2 x 108 CFU ml-1 S. suis 
ST7 (Rieckmann et al., 2018). 
In the study, from which the CP tissue samples from piglets suffering from meningitis were taken, 
sedated, 8-week old male piglets, which were same breed as the meningitis-free pigs, were infected 
via intranasal application with a bacterial density of 1.5 x 109 CFU ml-1 S. suis ST2 following a 
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treatment with 1 % acetic acid of the mucosal surface of the nasal cavity (Baums et al., 2006; 
Rungelrath et al., 2018). In a previous investigation of the piglet model used to study in vivo 
experimentally induced S. suis infections, Pallares and colleagues found that an experimental set-up, 
which included the pre-treatment of the mucosal nasopharynx area with acetic acid prior to 
intranasal infection, resulted in effective disease induction, which reflected disease observations 
made in the field (Pallares et al., 2003). 
In both experiments, the animals were monitored and examined every 8 h post-infection for the 
onset of disease and were given a clinical score, based on their body temperature, food uptake, and 
overall behavior (alertness, breathing pattern, mobility). An animal was considered morbid if it 
presented with a fever of at least 40.2 °C. If a high fever persisted (at least 40.5 °C), along with apathy 
and/or anorexia over a 36 h time period, the piglet was euthanized for predefined animal welfare 
reasons. Additionally, if the piglet presented severe symptoms, such as body tremors, convulsions, or 
polyarthritis, the animal was subject for immediate euthanasia. 
Onset of severe disease usually occurred 3 to 5 days post-infection. Once a predefined humane 
endpoint was reached, the animal was sedated and subsequently euthanized via the intravenous 
administration of T61® (200 mg ml-1 embutramide, 50 mg ml-1 mebezonium, and 5 mg ml-1 tetracain; 
Intervet, Merck, Sharp & Dohme).  
Immediately following the euthanasia of each animal, a necropsy was performed, which has been 
previously described by Baums and colleagues (Baums et al., 2006). Additionally, the brain was 
promptly removed and cut between the two brain hemispheres in order to gain access to the lateral 
ventricles. One of the two CP from the lateral ventricles was removed, briefly rinsed in sterile DPBS, 
and flash-frozen in liquid nitrogen for subsequent RNA isolation and transcriptome analysis. 
When working with RNA, time in fixating the samples is of the essence to maintain RNA integrity for 
reliable downstream analyses (Kukurba and Montgomery, 2015). Due to RNase enzymatic activities, 
mRNA turnover is a strictly regulated process in living cells. However, once death sets in, RNA 
degradation is not part of normal cellular function and could skew the transcriptome profile at a 
given physiological state (Gallego Romero et al., 2014; Kukurba and Montgomery, 2015). In order to 
aim at the most accurate snap-shot of the transcriptome profile being investigated, the time 
between the death of the animal and freezing the CP was kept to a minimum and averaged 
approximately 20 min. 
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3.4.  Molecular techniques  
3.4.1. RNA isolation 
For isolating RNA from the infection experiments, the RNeasy technology from Qiagen was used. In 
this method of RNA isolation, a buffer is utilized in order to inactivate RNase activity. Ethanol is 
employed to enhance RNA-binding to a silica-based membrane of a spin column, and a series of the 
manufacturer’s buffers are provided in the RNA isolation kits in order to wash away any 
contaminants resulting from the cell lysis process in order to obtain pure RNA post-isolation. 
The RNeasy Mini Kit was used for total RNA isolation from HIBCPP cells and the CP tissue from the in 
vivo porcine experiments. For the HIBCPP cell infection experiments, the filters were briefly rinsed 
with DPBS (with Ca2+ and Mg2+), before the filter was placed inverted into a 12-well cell culture plate. 
150 µl of the RLT cell lysis buffer (section 2.7) was applied to the cells, and using a pipette, the cells 
were gently scratched off while applying the lysis buffer. The cell lysate was collected in a 1.5 ml 
centrifuge tube and at a later point further processed following the Qiagen RNeasy Mini kit protocol 
“purification of total RNA from animal cells using spin technology”. Additionally, one cell culture 
transmembrane filter containing a confluent layer of approximately 400,000 cells was used for RNA 
isolation. 
For the CP tissue collected from the in vivo porcine infection experiments, 30 mg of the fresh-frozen 
tissue was suspended in 600 µl RLT cell lysis buffer (section 2.7) and a micro pestle was used to 
homogenize the tissue. To further process the samples, the homogenized tissue suspension was 
applied to a QiaShredder before the total RNA was isolated according to the manufacturer’s protocol 
“purification of total RNA from animal tissues”. 
RNA was isolated from PCPEC using the RNeasy Micro Kit, due to the low starting material 
requirement defined by the manufacturer. As with the HIBCPP cell samples, 150 µl of the RLT cell 
lysis buffer (section 2.7) was used per filter for the RNA isolation and four cell culture membranes 
containing a confluent layer of PCPEC, with approximately 60,000 cells, were pooled. The 
manufacturer’s protocol “purification of total RNA from animal and human cells” was followed. 
All isolated RNA samples underwent an on-column DNase I treatment, which was integrated during 
the RNA isolation protocols (15 min incubation at room temperature), as described by the 
manufacturer. Following the isolation, RNA samples were eluted in RNase-free H2O and stored at -
80 °C. The RNA concentration was determined with the spectrophotometer NanoDrop. 
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3.4.2. cDNA synthesis 
In order to perform the RT-PCR or qPCR with RNA isolated from the infection experiments, 0.5 µg 
RNA from HIBCPP and the in vivo experiments was reverse transcribed to generate the 
complementary strand to the isolated RNA transcripts called copy DNA (cDNA). For PCPEC, due to the 
low RNA yield following the isolation, 0.125 µg RNA was reverse transcribed to generate cDNA. Table 
5 summarizes the individual components for 1 cDNA synthesis reaction mixture for a total volume of 
20 µl, as was described in the AffinityScript QPCR cDNA Synthesis Kit. 
Table 5. Composition for 1 cDNA synthesis reaction mixture. 
10 µl 
3 µl 
1 µl 
X* µl 
X** µl 
First Strand Master Mix 
Random Primers 
AffinityScript Reverse Transciptase/RNase Block Enzyme Mixture 
RNA 
RNase-free H2O 
*  amount equal to 0.125 µg PCPEC RNA or 0.5 µg HIBCPP and CP tissue RNA 
** amount to equal the total volume of the reaction to 20 µl 
 
Table 6 summarizes the program used for the cDNA synthesis. The cDNA was synthesized with the 
help of the Thermocycler 2720. 
Table 6. cDNA synthesis program used with the thermocycler 2720. 
cDNA synthesis step Program temperature Program length 
primer annealing 
cDNA synthesis 
cDNA synthesis termination 
25 °C 
42 °C 
95 °C 
5 min 
15 min 
5 min 
 
All cDNA samples were prepared according to manufacturer’s instructions and the subsequent 
resulting cDNA was stored at -20 °C. 
 
3.4.3. Semi-quantitative RT-PCR and gel electrophoresis 
Following the double-strand cDNA synthesis, a semi-quantitative RT-PCR was performed in order to 
evaluate the expression of specific genes. The PCR allows for the exponential amplification, enabled 
by thermal cycling, which facilitates DNA melting and enzyme-driven replication of a desired region 
or gene of interest with the use of oligonucleotide primers. In this study, the expression of mature 
mRNA transcripts, which do not include intron regions, was investigated. 
In this study, the gene expression was evaluated semi-quantitatively in order to compare and detect 
changes in expression levels before amplification resulted in a fully saturated band on the gel 
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electrophoresis. In order to achieve this, the thermocycler was paused after either the 26th, 28th, or 
32nd cycle of amplification, depending on the evaluated sample, and the remainder of the sample 
was amplified for four more cycles. 
With the use of Qiagen’s Taq DNA Polymerase kit, the reaction mixture was prepared as described in 
Table 7. 
Table 7. The composition for one PCR reaction mixture, with the total volume of 25 µl. 
Compositions for 1 PCR Reaction Mixture 
2.5 µl 
1 µl 
1 µl 
0.125 µl 
0.5 µl 
19.88 µl 
CoralLoad PCR Buffer, 10x 
dNTP mixture, 10 mM of each nucleotide 
Forward and Reverse Oligonucleotide Primer mixture, 1:10 diluted 
Taq polymerase, 250 units 
cDNA 
distilled H2O 
 
Table 8 was the program setting of the Thermocycler 2720 in order to perform the RT-PCR reaction. 
Table 8. PCR program for the RT-PCR reaction. 
PCR step Temperature (°C) Time Number of Cycles 
Initial denaturing 
Denaturation 
Annealing 
Extension 
Final Extension 
Hold 
94 
94 
58-60* 
72 
72 
8 
2 min 
30 sec 
30 sec 
1 min 
7 min 
∞ 
1 
30** 
30** 
30** 
1 
*Annealing temperature was dependent on primer. See Table 3 for exact annealing temperature. 
**Number of cycles varied on the PCR type and samples used. See figure legends for specification. 
 
The PCR products were run on a 1.5 % agarose-ethidium bromide gel in 1 x TAE buffer and 120 V for 
approximately 40 min. Images were captured using the gel documentation system in conjunction 
with the VisionCapt software. 
 
3.4.4. qPCR 
Quantitative PCR (qPCR) allows for the numerical assessment of gene expression either via absolute 
or relative quantification. The qPCR detection format in this study applied the use of SYBR® Green I 
Dye. SYBR® green is a fluorescent dye, which binds to the minor groove of the double-stranded DNA 
generated during amplification. Once SYBR green is bound, a maximum excitation at 497 nm and 
maximum emission at 520 nm can be used to detect product amplification.   
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Additionally, a reference dye is included during the qPCR reaction which acts as a baseline since its 
fluorescence does not change, and can therefore be used to normalize any non-PCR related 
fluorescence variations which may arise. It can be detected with an excitation at 584 nm and 
emission at 612 nm. 
To quantitatively evaluate the expression of selected genes, the Brilliant II SYBR® Green QPCR Master 
Mix kit was used to prepare the reaction mixture for the qPCR, which is summarized in Table 9. 
Table 9. The composition of one qPCR reaction mixture. 
Compositions for 1 qPCR Reaction Mixture 
12.5 µl 
0.375 µl 
6.925 µl 
0.5 µl 
5 µl 
2 x Brilliant II SYBR Green Master Mix 
30 nM diluted reference dye (ROX) 
distilled H2O 
cDNA 
forward and reverse oligonucleotide primer mixture with a final concentration of 
250 nM 
 
The qPCR was run using the Stratagene Mx3005P system with the MX software using the 1 plateau 
pre-melt / RT segment and normal 2-step amplification setting, as described in Table 10. A third 
segment was included to determine the dissociation curve and to ensure amplification of only the 
amplicon product of interest, since SYBR green binds to all available double stranded DNA, including 
primer dimers. To generate the dissociation/melting curve, the sample is initially heated to 95 °C in 
order to melt the DNA, then cooled to 55 °C, followed by a temperature ramp up to 95 °C. During the 
temperature ramp-up, the increasing fluorescence measurements are collected, resulting in a peak. 
A drop can be observed when the double-stranded DNA melts, thereby releasing the intercalated 
SYBR green molecules. Based on the resulting dissociation/melting curve, an interpretation to the 
amplified product and number of amplicons can be made. 
Table 10. The MxPro software setting for the qPCR. 
PCR step Temperature (°C) Time Number of Cycles 
Segment 1: 
Initial denaturing 
 
95 
 
10 min 
 
1 
Segment 2: 
Denaturation 
Combined Annealing and Extension 
 
95 
58 
 
30 sec 
1 min 
 
40 
40 
Segment 3:  
Dissociation/Melting curve 
 
 
95 
55 
95 
 
1 min 
30 sec 
30 sec 
 
1 
1 
1 
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During the qPCR run, the threshold cycle (CT) was determined, which was used to calculate the fold-
change between phenotype A versus phenotype B (infected versus uninfected). The CT ensures that 
the gene of interest is being expressed in the exponential phase during the PCR amplification step, 
and is inversely correlated to the number of amplicons in the sample (Schmittgen and Livak, 2008). 
The gene fold-change was calculated based on the method for relative quantification called the 2-ΔΔCt 
method (Livak and Schmittgen, 2001). The formula which is applied in order to determine the 2-ΔΔCt is 
as follows: 
2−∆∆𝐶𝑇 =
𝐶𝑇 𝑔𝑒𝑛𝑒 𝑜𝑓 𝑖𝑛𝑡𝑒𝑟𝑒𝑠𝑡 − 𝐶𝑇 𝑖𝑛𝑡𝑒𝑟𝑛𝑎𝑙 𝑐𝑜𝑛𝑡𝑟𝑜𝑙 𝑜𝑓 𝑝ℎ𝑒𝑛𝑜𝑡𝑦𝑝𝑒 𝐴
𝐶𝑇 𝑔𝑒𝑛𝑒 𝑜𝑓 𝑖𝑛𝑡𝑒𝑟𝑒𝑡𝑠𝑡 − 𝐶𝑇 𝑖𝑛𝑡𝑒𝑟𝑛𝑎𝑙 𝑐𝑜𝑛𝑡𝑟𝑜𝑙 𝑜𝑓 𝑝ℎ𝑒𝑛𝑜𝑡𝑦𝑝𝑒 𝐵
 
The house-keeping gene (internal control) gapdh was used to calculate the fold-change 2-ΔΔCt of the 
gene of interest between the infected versus uninfected phenotypes. 
Furthermore, the significance of the gene fold change from infected samples in comparison to 
uninfected samples was calculated using the unpaired student’s t-test. A result was considered 
significant if p ≤ 0.05. 
  
3.5. Conventional RNA-seq and MACE sequencing – an external collaboration 
A conventional RNA-seq was carried out in collaboration with PD Dr. Ludger Klein-Hitpass at the 
Institute for Cell Biology at the University Hospital Essen with all samples obtained during the 
infection experiments (section 3.3). 
In addition to the conventional RNA-seq, a sequencing method called MACE was perform. The MACE-
sequencing method was carried out on the samples, which were obtained from the in vivo porcine 
infection experiments. 
 
3.5.1. RNA integrity 
Before the RNA libraries were prepared for sequencing, the RNA integrity was evaluated using the 
Agilent 2100 Bioanalyzer System in combination with the Agilent Bioanalyzer RNA Nano Chip. The 
Agilent 2100 Bioanalyzer system utilizes an automated electrophoresis solution in order to score the 
ratio between the 18S and 28S ribosomal RNA (rRNA) subunits. A score ranging from 1 – 10 is given 
based on the ratio, and this score is termed the “RNA Integrity Number” (RIN). A RIN of 10 is given to 
non-degraded RNA, with a 2-to-1 ratio between the 28S and 18S rRNA, and, therefore, the best RNA 
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quality. RNA used in NGS studies should have a RIN of at least 6 in order to retrieve reliable data 
(Kukurba and Montgomery, 2015). 
 
3.5.2. Library preparation and library sequencing 
For this study, different RNA-seq library preparation kits were utilized and the preparation was 
carried out in strict accordance to the manufacturer’s protocols for the respective kits. The RNA-seq 
library preparation involves a sequence of the same steps, which include poly(A) mRNA selection, 
RNA fragmentation, cDNA synthesis, blunt end repair, adaptor ligation, strand selection, and the final 
library amplification via PCR. However, the sequence of these steps may vary depending on the 
sequencing design or sample input. Since the main aim of this study was to investigate the 
transcriptional response during infection, the RNA-seq library preparation focused on selecting the 
poly(A) mRNA transcripts and depleting the samples of rRNA in order to achieve a proper coverage of 
the changing transcriptome to gain a better insight into the biological processes. The rRNA 
transcripts make up approximately 80 to 90 % of the total RNA profile, and do not provide much 
biologically relevant information when investigating the global transcriptional profile of infected and 
uninfected samples (O'Neil et al., 2013). The main difference for the use of two different library 
preparation kits in this study was the rRNA elimination step. 
The Ovation® Human FFPE RNA-Seq Library system was utilized for the library preparation of 100 ng 
total RNA from the HIBCPP cells for conventional RNA-seq. In the initial step of this library 
preparation method, the total isolated RNA was reverse transcribed with random priming. The rRNA 
depletion step was performed later during the library preparation with the help of AnyDeplete 
Technology, which is also known as Insert-Dependent Adaptor Cleavage (InDA-C), and was part of the 
library preparation kit protocol. AnyDeplete technology involves the use of a library of 
oligonucleotide primers which anneal to the known human rRNA (12S, 16S, 18S, and 28S) sequences. 
Following the annealing, the sequences are extended and then cleaved with an unknown reagent, 
provided in the manufacturer’s kit, in order to eliminate sequencing of these transcripts. 
The Universal Plus mRNA-Seq library kit was used for the preparation of 100 ng total RNA from the 
porcine samples sequenced via conventional RNA-seq. The main reason for the use of this kit to 
prepare the porcine samples was the unavailability of a porcine AnyDeplete oligonucleotide library. 
With this kit, the poly(A) mRNA transcripts are selected with polydT Beads at the beginning of the 
library preparation, therefore eliminating the need for further rRNA elimination. 
A third library preparation kit was utilized in order to prepare 500 ng total RNA from the in vivo 
samples for the alternative MACE sequencing method. This method of library preparation consisted 
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of the cDNA synthesis, a step which directly involved the selection of poly(A) mRNA transcripts, 
purification, fragmentation, end repair, adaptor ligation, and a library amplification via PCR. The 
rRNA was depleted via poly(A) mRNA selection, in a first step of the library preparation. 
Further steps of the library preparation include the fragmentation of the transcripts. The desired 
fragment length is dependent on the instrument used for sequencing, since length can have an 
influence during the cluster generation on the flow cell (Head et al., 2014). The Covaris S220 
Focused-ultrasonicator, with the Covaris microTUBE, set to 10 % duration, 200 cycles per burst, and 
140 sec was used to generate fragment sizes of approximately 250 bp long. Fragment lengths were 
analyzed on the Agilent 2100 Bioanalyzer System using the Agilent Bioanalyzer HS DNA chip. 
Bead-purification steps were carried out with the help of Agencourt AMPure XP SPRI beads in order 
to remove adapter or primer dimers throughout the various cDNA synthesis, adaptor ligation, or PCR 
amplification steps.  
The Qubit system was used in combination with the double stranded DNA high sensitivity assay kit in 
order to determine the DNA concentration of the prepared libraries before these were pooled.  
Adaptor ligation introduces specific 8 bp long barcode sequence to each of the individual biological 
replicates of infected and uninfected samples. With the use of the barcodes, one library pool 
containing all the biological replicates for each phenotype (infected and uninfected) was generated 
for sequencing. The library pool was quantified utilizing the NEBNext® Library Quant kit, which is a 
SYBR Green based qPCR method essential in order to achieve the optimal cluster density on the 
sequencing flow cell required for an optimal sequencing output. 
The final prepared transcript for sequencing is depicted in Figure 6. It includes adapters which 
recognize the corresponding sequence on the sequencing flow cell. Adapters are located on both 
ends of the transcript (library insert), due to the bridge amplification step for cluster generation 
preceding the sequencing. Additionally, a barcode sequence is included in the adapter region to 
allow pooling of different samples into a single lane of the flow cell. Furthermore, the final library 
structure also includes a “read primer” for the cluster generation on the flow cell preceding 
sequencing. 
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Figure 6. The general library structure following the RNA-seq library preparation. The library 
structure consists of two adapter regions, which contain a barcode sequence, primers for cluster 
generation on the flow cell, and the corresponding flow cell sequence for attachment. The 
sequence of interest is the “library insert”. This image was modified from the Illumina RNA-seq 
library preparation instruction manual. 
The pooled libraries were sequenced using Illumina’s HiSeq 2500 or MiSeq flow cell system in the 
paired-end mode for the epithelial cells (HIBCPP cells and PCPEC) and the CP samples obtained in 
vivo, and single-end mode for the samples obtained in vivo sequenced via MACE. For details, please 
refer to section 2.5. 
 
3.5.3. Bioinformatic data processing post-sequencing 
In order to analyze the sequenced fragments, also termed “reads”, in terms of differential gene 
expression and utilizing transcriptome analysis platforms, the data had to be bioinformatically 
processed. The data processing for all sequenced samples included the trimming of the adapter 
sequences, alignment and quantification of the fragments post-sequencing. 
The first step was to remove the adapter sequences in order to ensure accuracy during further 
downstream processing and preventing the loss of valid sequence data. This was carried out with the 
help of the Trimmomatic-0.30 software tool, which was designed to identify full and partial adapter 
sequences from single- and paired-end Illumina NGS data (Bolger et al., 2014). 
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The trimmed sequences were subject to alignment by utilizing the RNA aligner STAR software (Dobin 
et al., 2013). The sequences generated from the HIBCPP cells were aligned to the human genome 19 
and the sequences generated from the porcine samples (PCPEC and CP from the in vivo infection 
experiments) were aligned to the Sus scrofa genome 11.1. The aligned sequences of the HIBCPP cell 
and PCPEC samples were imported into the StrandNGS software and filtered on quality metrics, 
which included the removal of reads that had more than one match, an alignment score of below 95, 
mapping quality below 40, and lengths less than 20. This additional filtering step was not carried out 
on the sequences aligned from the in vivo experiment. Instead, these sequences were subject to 
Universal Molecular Identifiers filtering, which resulted in less than 5 % of reads removed. These 
aligned and filtered reads can be imported to the Integrative Genomics Viewer, which allows 
visualization of the NGS datasets (Robinson et al., 2011).  
Lastly, for the quantification of the RNA sequences, the aligned and filtered reads were imported to 
the Partek Genomics Suite (PartekGS) software. This software reports the reads per kilobase of exon 
model per million reads (RPKM), which is a scaling method applied in order to normalize the RNA 
abundancies (Mortazavi et al., 2008). The formula employed in order to calculate the RPKM is as 
follows: 
𝑅𝑃𝐾𝑀 =
𝑟𝑎𝑤 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑟𝑒𝑎𝑑𝑠
𝑒𝑥𝑜𝑛 𝑙𝑒𝑛𝑔𝑡ℎ
 𝑥 
1,000,000
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑚𝑎𝑝𝑝𝑒𝑑 𝑟𝑒𝑎𝑑𝑠 𝑖𝑛 𝑠𝑎𝑚𝑝𝑙𝑒
 
The RPKM normalizes the transcript length in relation to the total number of reads of the transcript 
in the sequencing measurement. 
In order to evaluate the differential gene expression and to utilize data analysis platforms for 
downstream analysis, the resulting RPKM values and/or the raw reads were used to generate the 
Differentially Expressed Genes (DEGs) list and to perform a Gene Set Enrichment Analysis (GSEA). 
 
3.5.4. RNA-Seq statistical data analysis: DEGs and GSEA 
In order to evaluate the differential expression of individual genes, DEGs were identified using the 
PartekGS software implementing the one-way analysis of variance (ANOVA) test. A step-up method 
to correct for multiple testing was applied to generate corrected p-values, but due to the low 
number of replicates, the correction for multiple testing eliminated many potential true-positive 
targets. For this reason, the identification of DEGs was based on uncorrected p-values. The resulting 
p-values were exported and further manual filtering steps were carried out in Excel from Microsoft 
Office. Filters, which were applied in order to generate the final DEG list, included at least 10 (for the 
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PCPEC and in vivo samples) or 20 (for the HIBCPP cell samples) raw reads of the transcript in the 
biological triplicates of one class (uninfected versus infected) and an uncorrected p-value of ≤ 0.05. 
Additionally, a more stringent list was created which only displayed a list of significant DEGs with a 
corrected (step-up method) p-value ≤ 0.05. The genes resulting in the final DEG list with an 
uncorrected and corrected p-value ≤ 0.05 were taken into consideration. 
A second statistical analysis was applied using the RPKM values, by utilizing the GSEA software, which 
allows the user to interpret the data on a biological relevant gene set level, and not on individual 
genes, when comparing different biological states (Mootha et al., 2003; Subramanian et al., 2005). 
The GSEA makes use of the Molecular Signature Database (MSigDB), which contains approximately 
18,000 gene sets (GSs), categorized into eight major groups (Liberzon et al., 2015; Liberzon et al., 
2011; Subramanian et al., 2005). The GSEA was run with the standard settings in the gene set 
permutation mode, set to 1000 permutations. In order to select potential interesting candidates, GSs 
which presented a false discovery rate (FDR) q-value ≤ 0.25 were considered to be of interest, along 
with a normalized enrichment score (NES) of approximately ± 2. 
 
3.5.5. Accession numbers 
The data generated during RNA-seq was deposited in the Sequence Read Archive (SRA) on the 
National Center for Biotechnology Information (NCBI) platform. The BioProject accession number for 
the HIBCPP cell data is PRJNA533919. The BioProject accession number for the PCPEC data is 
PRJNA533792. The BioProject accession numbers for the data acquired from the in CP tissue which 
was isolated following the in vivo infection experiments can and sequenced via conventional RNA-seq 
and MACE are PRJNA534398 and PRJNA534382, respectively. 
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4. Results 
4.1.  In vitro infected HIBCPP cells show an inflammatory response 6 h post-
infection from the basolateral cell side with S. suis ST2 
An infection with the zoonotic pathogen S. suis ST2, whose natural host is the pig, is known to result 
in the same clinical manifestations, such as septicemia and meningitis, in humans. Its interaction with 
the immortal HIBCPP cells line in the in vitro BCSFB model was previously investigated. Observations 
showed that S. suis ST2 and the non-encapsulated mutant display strong invasion rates into the 
HIBCPP cells when applied to the basolateral host cell side (Schwerk et al., 2012). To date, no 
transcriptome analysis has been performed with HIBCPP cells infected from the basolateral cell side 
in vitro with S. suis. Therefore, the first aim of this thesis was to determine the time point of the 
strongest transcriptional inflammatory response when the HIBCPP cells were infected from the 
basolateral cell side, which in vivo would demonstrate the blood side. 
The in vitro infection study parameters, which were collected included the epithelial barrier integrity 
via TEER measurement and the determination of the FITC-inulin flux across the barrier. Additionally, 
a live/dead assay was performed in order to assess cell viability throughout infection time points. 
Lastly, the cells were fixed and lysed following each infection time point, and the RNA was isolated in 
order to evaluate the expression of inflammatory genes for each time point. HIBCPP cells were 
infected for a total of up to 10 h with a bacterial MOI of 10, and samples were collected in an 
increment of 2 h. Due to the HIBCPP cells exhibiting the strongest inflammatory response 6 h post-
infection (data not shown), the data for this time point will be presented. 
Figure 7 A depicts the TEER values of HIBCPP cells before the infection (0 h) and infected with S. suis 
ST2 for 6 h, either with the wildtype (H4) or the non-encapsulated mutant (H5). The TEER remained 
stable, with only a slight decrease after the 6 h infection time point. Before the infection experiment, 
the TEER values displayed an average of 475 Ω x cm2 (± 130), 510 Ω x cm2 (± 106), and 508 Ω x cm2 (± 
136) for uninfected, H4 infected, and H5 infected, respectively. Following the 6 h infection time 
point, the TEER showed a slight decrease for all conditions, with the average TEERs being 415 Ω x cm2 
(± 95) for uninfected HIBCPP cells, 460 Ω x cm2 (± 109) for H4 infected cells, and 382 Ω x cm2 (± 128) 
for H5 infected cells. 
Additionally, Figure 7 B depicts that the average FITC-inulin flux remained very low after 6 h of 
infection, with values of below 1.7 % (± 1.9), 0.7 % (± 0.8), and 1.6 % (± 1.4) for uninfected, H4 
infected, and H5 infected cells, respectively. By relying on an educated guess, a value was 
determined based on previous experiences in our laboratory, which accepts a 1 % FITC-inulin flux per 
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hour of infection. These low FITC-inulin flux values therefore reflect an intact barrier 6 h post-
infection. 
 
Figure 7. The HIBCPP barrier integrity remained intact 6 h post-infection with S. suis ST2. The 
average TEER (Ω x cm2) and standard deviation values of the measurements before (0 h) and after 
(6 h) the infection time period of the HIBCPP cells is presented (A). The average percentage with 
the standard deviation of the FITC-inulin flux following the 6 h infection time point is presented in 
a box-plot (B). The HIBCPP cell infection experiments were carried out at least three times and in 
triplicates for each condition. 
Analysis of cell viability, via the live/dead assay, after the 6 h infection time point is depicted in Figure 
8. The majority of the HIBCPP cells remained viable (indicated in green), with very few dead cells 
(indicated in red) present for uninfected, S. suis H4 and S. suis H5 infected cells (Figure 8). 
 
Figure 8. The live/dead assay of HIBCPP cells infected with S. suis ST2 H4 and H5 strains for 6 h 
reveals a majority of viable cells. A representative image for each condition was chosen, and the 
live/dead assay was performed in duplicate. The images were captured with the 10x magnification 
using a fluorescent microscope, and the white bar in the bottom right corner represents 50 µm. 
Lastly, Figure 9 depicts the analysis of inflammatory genes via a semi-quantitative RT-PCR, 
demonstrating that HIBCPP cells exhibit a strong inflammatory response 6 h post-infection with 
S. suis ST2. When comparing the uninfected cells to HIBCPP cells infected with the H4 and H5 S. suis 
ST2 strains, the expression levels indicated by the band intensity increased for genes encoding for 
the cytokines and chemokines TNFα, IL8, CXCL1, CXCL2, as well as for IκBζ, which encodes for a 
regulator of the transcription factor NFκB, while the expression of the house-keeping gene encoding 
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for GAPDH remained coherently expressed. For the uninfected cells, it appears that a basal level of 
expression exists for the evaluate genes. However, when comparing the band intensities, it is 
apparent that a stronger expression occurs during infection. Furthermore, the S. suis ST2 H5 strain 
appears to clearly induce a stronger response in all of the evaluated inflammatory genes, especially 
when comparing the band intensities after 26 cycles to those of the S. suis ST2 H4 infected cells, since 
some 30 cycle amplicons appeared to have reached saturation. Following the 6 h time point, the 
inflammatory response diminished (data not shown). 
 
 
Figure 9. Semi-quantitative RT-PCR of 6 h in vitro infected HIBCPP cells reveals a strong 
inflammatory response on the transcriptome level. The gene expression of the genes indicated on 
the left hand side were semi-quantitatively assessed after 26 and 30 PCR cycles (indicated at the 
top) of uninfected HIBCPP cells in comparison to HIBCPP cells infected for 6 h with S. suis ST2 
strains H4 and H5. A representative image is depicted. The samples were run on a 1.5 % agarose-
ethidium bromide gel and the image was captured using the Vision-Capt software. 
 
Due to the strong transcriptional response following the 6 h infection period (Figure 9), during which 
the CP epithelial barrier was maintained, as was demonstrated by a high TEER and a low flux of FITC-
inulin (Figure 7), as well as a viable cell population (Figure 8), these cell samples were selected for the 
global transcriptome analysis via RNA-seq. The S. suis ST2 H5 infections were included in the 
preliminary analysis, since this mutant had previously shown to induce gene regulation with some 
variation in CP epithelial cells in comparison to the S. suis H4 wildtype (Schwerk et al. (2011) and 
unpublished data). However, these samples were excluded from further analysis due to the higher 
relevance of S. suis ST2 wildtype causing infection in the field. 
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4.2.  Primary PCPEC show a strong inflammatory response 6 h post - in vitro 
infection from the basolateral cell side with S. suis ST2 
As a zoonotic pathogen, not only is the interaction of S. suis ST2 with human cells is of interest, but 
also understanding the pathogenesis during the interactions with cells of its natural host is of high 
importance. A few in vitro studies have previously been conducted, in order to study the interaction 
of S. suis ST2 with primary PCEPC. It was demonstrated, that S. suis ST2 can effectively invade host 
cells, when applied to the basolateral epithelial cell side, and translocate to the apical cell side 
(Tenenbaum et al., 2009). It was further found to induce apoptosis and necrosis when PCPEC were 
infected from the apical cell side (Tenenbaum et al., 2006). Furthermore, PCPEC cells were observed 
to contribute to the inflammatory response by producing cytokines and chemokines (Schwerk et al., 
2011). However, in the latter experimental set-up, PCPEC were infected from the apical cell side, 
which in vivo reflects the CSF compartment. So far, no transcriptional response had been 
investigated, when PCPEC were infected from the basolateral cell side. The aim of this experiment 
was to investigate the time point at which PCPEC exhibited the strongest inflammatory response at 
the transcriptional level, when infected from the basolateral side with S. suis ST2 at a MOI of 10. 
In this study, PCPEC were infected in vitro up to 6 h from the basolateral cell side with S. suis ST2 H4 
and the non-encapsulated H5 strains. As was done with the HIBCPP cells, different experimental 
parameters were evaluated every 2 h, including the cell barrier integrity via TEER measurement and 
the passage of the fluorescent-labelled macromolecule, FITC-inulin, since it had previously been 
described that S. suis ST2 infecting PCPEC from the apical cell side induced a barrier break-down 
(Tenenbaum et al., 2005). Additionally a live/dead assay was performed to examine cell viability 
throughout the infection period. Lastly, the RNA was isolated and a semi-quantitative RT-PCR was 
performed as a pre-assessment for determining the time point of the strongest inflammation, and 
the RNA was subsequently subject for RNA-seq. These experiments were carried out at least three 
times and were performed in quadruplicates for each condition. Due to the PCPEC exhibiting the 
strongest inflammatory response 6 h post-infection (data not shown), the data for this time point will 
be presented. 
The PCPEC barrier displayed an intact barrier, with the average TEER before of 277 Ω x cm2 (± 44), 
289 Ω x cm2 (± 17), and 277 Ω x cm2 (± 37) for uninfected, H4 infected, and H5 infected primary 
PCPEC, respectively, before the start of infection (Figure 10 A). The barrier property of the epithelial 
cells remained intact throughout the 6 h infection period, with the average TEER values being 275 Ω x 
cm2 (± 67) for uninfected cells, 274 Ω x cm2 (± 32) for H4 infected cells, and 297 Ω x cm2 (± 76) for H5 
infected PCPEC. 
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Additionally, the FITC-inulin flux through the barrier remained very low 6 h post-infection, with the 
average percentages depicted in Figure 10 B as being 2.2 (± 1.9) for uninfected cells, 1.9 (± 1.3) for H4 
infected cells, and 1.1 (± 0.9) for H5 infected cells. By relying on an educated guess, a value was 
determined based on previous experiences in our laboratory, which accepts a 1 % FITC-inulin flux per 
h of infection. Since the TEER values remained stable and the flux of the FITC-inulin remained below 
6 %, it was deduced that the in vitro barrier remained intact throughout the 6 h infection time 
period. 
 
Figure 10. The PCPEC in vitro barrier remained intact 6 hours post-infection with S. suis ST2. The 
average TEER (Ω x cm2) before (0 h) and after a 6 h infection time point remained stable (A). The 
average FITC-inulin flux remained below 6 % following the infection time point, indicating a low 
permeability for macromolecules through the in vitro barrier property, and is presented in a box-
plot (B). The PCPEC infection experiment was carried out at least three times, for each condition 
performed in quadruplicate. 
The live/dead assay revealed that the majority of cells remained viable (green cells), with a minority 
being dead (red), following the 6 h period (Figure 11). However, in comparison to the live/dead assay 
of the HIBCPP cells which displayed a green layer of cells (Figure 8), the presence of black spots was 
observed. This may be due to PCPEC forming a true monolayer of epithelial cells, whereas HIBCPP 
cells have been observed to form papilloma-like multi-cell layers (Ishiwata et al., 2005). 
 
Figure 11. The live/dead assay of uninfected primary PCPEC and PCPEC infected with S. suis ST2 H4 
and H5 strains for 6 h reveals a majority of viable cells. A representative image for each condition 
was chosen and the live/dead assay was performed in duplicate. The images were capture with the 
10x magnification using a fluorescent microscope, and the white bar in the bottom right corner 
represents 50 µm. 
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Lastly, following the RNA isolation, the expression levels of the inflammatory response genes were 
evaluated, with a representative image depicted in Figure 12. The inflammatory response genes 
selected for evaluation were previously shown to be regulated by CP epithelial cells during infection 
experiments in our laboratory (Schwerk et al., 2011). As was observed with the HIBCPP cells, the 
PCPEC also displayed strong expression levels of inflammatory cytokines 6 h post-infection with 
S. suis ST2. Again, basal levels of expression were observed for genes encoding for IL8 and CXCL2 in 
the uninfected PCPEC. However, no expression could be detected for IL1β in uninfected cells. The 
expression of the house-keeping gene GAPDH showed a coherent expression level. 
 
 
Figure 12. Semi-quantitative RT-PCR of infected PCPEC displays an inflammatory response 6 h post-
infection with S. suis ST2. The gene expression of the genes indicated on the left hand side were 
semi-quantitatively assessed after 26 and 30 PCR cycles (indicated at the top) of uninfected PCPEC 
in comparison to 6 h infected PCPEC with S. suis ST2 strains H4 and H5. A representative image is 
depicted. The samples were run on a 1.5 % agarose-ethidium bromide gel and the image was 
captured with the Visio-Capt software. 
 
Since the primary PCPEC demonstrated the strongest inflammatory response on a transcriptional 
level 6 h post-infection, along with an intact barrier and a viable cell population, these samples were 
selected for the global transcriptome analysis via RNA-seq. As was the case with the HIBCPP cells, the 
PCPEC infected with S. suis H5 strain were only included in the preliminary analysis due to their 
previous implication of inducing a strong inflammatory response, but were excluded from the 
sequencing analysis due to the higher relevance of S. suis ST2 wildtype causing infection in the field. 
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4.3.  The CP of in vivo infected piglets suffering from meningitis exhibited an 
inflammatory response 
Previous observations made by Sanford and colleagues, and later by Williams and Blakemore, from 
naturally and experimentally infected pigs, first implicated the CP during S. suis – induced meningitis 
(Sanford, 1987; Williams and Blakemore, 1990). Lesions were observed at the CP in animals suffering 
from meningitis. In association with these lesions was the loss of the microvilli of the apical CP 
epithelial cell side, a reduction of CP-associated epiplexus macrophages, as well as an increased 
presence of immune cells and fibrinous exudate in the ventricles (Sanford, 1987; Williams and 
Blakemore, 1990). To date, no global transcriptome analysis has been performed of the CP during 
S. suis-induced bacterial meningitis. In collaboration with the group of Prof. Baums, at the Institute 
for Bacteriology and Mycology, Faculty of Veterinary Medicine, University of Leipzig, S. suis ST2 in 
vivo infection experiments with 8-week old piglets were carried out. 
The meningitis-free animals were part of a study, which included being experimentally infected with 
S. suis ST7 (Rieckmann et al., 2018). These animals exhibited minor symptoms post-infection, 
including fever, which cleared within 48 h. For the remaining 14 days of the experiment, the animals 
did not show any symptoms of disease. Following the conclusion of the experiment, the animals 
were euthanized and a necropsy was performed subsequently to euthanasia. Part of the necropsy 
consisted of CSF collection and preserving the organs, known to be colonized by S. suis, in formalin 
for histopathological evaluation by the veterinary pathologist at the Institute for Veterinary 
Pathology, Faculty of Veterinary Medicine, University of Leipzig. No bacterial growth occurred from 
the collected CSF and the veterinary pathologists confirmed the absence of histopathological 
abnormalities, for the three animals included in this study, at the brain and the CP. These results are 
summarized in Table 11. 
The CP tissues from the animals suffering from meningitis were part of a study, which included being 
experimentally infected with the wildtype S. suis ST2 strain 10 (Rungelrath et al., 2018). The onset of 
clinical symptoms occurred approximately 3 to 5 days post-infection, and included high fever, body 
tremors, convulsions, and ataxia. The onset of these symptoms resulted in the humane endpoint, 
and the animals were euthanized. Again, part of the necropsy consisted of CSF collection and 
preserving the organs, known to be colonized by S. suis, in formalin for histopathological evaluation 
by the veterinary pathologist at the Department of Pathology, University of Veterinary Medicine 
Hannover. The CSF of all animals showed a high amount of bacterial CFUs per ml of CSF, which were 
confirmed via PCR to be S. suis ST2 (data not shown). Additionally, all of the piglets which exhibited 
symptoms of meningitis were also confirmed post-mortem, via histopathological evaluation of the 
brain and CP, to be suffering from meningitis. These results are summarized in Table 11. 
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Table 11. Summary of the symptoms post-infection with S. suis ST2: bacterial CFU in the CSF and 
the histopathological findings of the CP from the in vivo infected piglets used in this study. 
Meningitis-free animals 
Animal Number Symptoms post-infection Bacterial 
CFU per 
ml of CSF 
Histopathological findings 
17 Day 1: 40.7 °C fever 
Day 2: no fever 
None No indication of infection of the 
brain or CP 
 
24 
Day 1: 41.1 °C then 40.4 °C fever 
Day 2: 40.7 °C fever, which 
cleared by the end of the day 
 
None 
No indication of infection of the 
brain or CP 
 
43 
Day 1: 41.1 °C then 41.3 °C 
Day 2: 41.3 °C, which cleared by 
the end of the day 
 
None 
No indication of infection of the 
brain or CP 
Animals suffering from meningitis 
 
4 
42.1 °C fever, ataxia, kyphosis, 
body tremors, abdominally 
reinforced breathing 
 
3.33 x 107 
Moderate multifocal fibro-
purulent meningitis and moderate 
multifocal plexus chorioiditis 
 
5 
41 °C fever, ataxia, body 
tremors, convulsions 
 
5.43 x 107 
High grade multifocal fibro-
purulent meningitis and moderate 
multifocal plexus chorioiditis 
 
34 
41.7 °C fever, body tremors, 
abdominal reinforced breathing, 
nystagmus, opisthotonus 
 
3.03 x 107 
Moderate multifocal fibro-
purulent meningitis (no comment 
on the state of the CP) 
 
Before the brain was preserved in formalin, one CP was removed from one lateral ventricle and flash 
frozen in liquid nitrogen. Following the RNA isolation, a semi-quantitative RT-PCR was performed in 
order to confirm an inflammatory response at the CP of in vivo S. suis ST2 infected piglets. The same 
inflammatory genes encoding for the cytokines and chemokines, IL1β, IL8, and CXCL2, used to 
evaluate the PCPEC, were also used for this sample set. As depicted in Figure 13, the CP isolated from 
piglets suffering from meningitis shows a clear inflammatory response by the increased expression 
(enhanced signal when referencing the GAPDH signal) of the genes encoding IL1β and IL8, as 
compared to the meningitis-free piglets. The signal for the CXCL2 expression, in contrast, was only 
enhanced for some piglets suffering from meningitis. Again, as was observed in the semi-quantitative 
RT-PCR performed with the PCPEC (Figure 12), a basal level of expression was present for IL8 and 
CXCL2 in all three piglets. However, IL1β was found to be basally expressed in two out of the three 
meningitis-free piglets. GAPDH was used as a house-keeping gene, which displayed a non-coherent 
expression likely due to either the heterogeneous cell population found in the CP tissue or lower RNA 
integrities compared to RNA from the in vitro infection experiments (Figure 14). 
Results 
67 
 
 
Figure 13. The choroid plexus of S. suis ST2 in vivo infected piglets shows an inflammatory response 
in comparison to piglets not suffering from meningitis. The samples were run on a 1.5 % agarose-
ethidium bromide gel and the image was captured using the Vision-Capt software. 
 
Following the confirmation of an inflammatory response at the CP of pigs suffering from meningitis in 
comparison to meningitis-free animals, the samples from these six animals were selected for further 
global transcriptome analysis via RNA-seq. 
 
4.4.  RNA-sequencing quality controls and sequencing alignment analysis 
Preceding the RNA-seq analysis, two quality controls were performed to ensure reliable input for a 
proper downstream analysis. The first quality control consisted of evaluating the RNA integrity. 
Following the confirmation of high quality RNA as input, the RNA-seq library was prepared and a 
second quality control of the library was performed to ensure the correct fragment sizes and 
determine the concentration. 
Following the RNA-seq, the quantity and the transcript alignment of the reads to the reference 
genome were analyzed. 
For each sample set (HIBCPP cells, PCPEC, CP from in vivo studies), biological triplicates for each 
condition (uninfected versus S. suis ST2 H4 infected / meningitis-free versus meningitis) were 
selected for a global transcriptome analysis via RNA-seq. 
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4.4.1. RNA samples were of high integrity for RNA-seq analysis 
The first control step, before the RNA samples were prepared for RNA-seq, was to perform a quality 
control of the RNA. For this, the RIN was determined by evaluating the ratio of the 28S and 18S rRNA. 
A score of 10 is given when the ratio of 28S to 18S rRNA is 2:1, indicating no degradation, and a score 
below 10 indicating various levels or rRNA degradation (Schroeder et al., 2006). 
A good RNA integrity is an important factor during sequencing analysis for a reliable down-stream 
analysis. Previous studies examined the correlation between RNA integrity and accurate transcript 
quantification, and it has been suggested that utilizing RNA with a RIN of at least 6 yielded the most 
reliable results in down-stream analysis for data interpretation (Gallego Romero et al., 2014; Kukurba 
and Montgomery, 2015). 
Figure 14 summarizes the electropherograms produced by the Agilent 2100 Bioanalyzer, which was 
used to evaluate the RNA integrity. Based on the surface area of each peak, the ratio between the 
28S and 18S rRNA is determined, and a score is given by the software of the Agilent 2100 
Bioanalyzer. Each biological replicate underwent this quality control preceding the RNA-seq. 
All biological replicates of the uninfected (Figure 14 A) and S. suis ST2 H4 infected (Figure 14 B) 
HIBCPP cells displayed a very high RIN, with the lowest RIN being 9.5. Additionally, all biological 
samples for uninfected (Figure 14 C) and infected (Figure 14 D) PCPEC exhibited a high RIN, with the 
lowest RINs being 8.9. These high RIN values are indicated by the two large, distinct peaks at 42 sec 
and 49 sec, indicative of the 18S and 28S rRNA, respectively. 
The RNA quality of the RNA isolated from the CP tissue isolated following the in vivo infection 
experiments generally displayed lower, but overall good, RINs. The RINs from the meningitis-free 
animals (Figure 14 E) and animals suffering from meningitis (Figure 14 F) were above 8.5, with 
exception of one sample, the CP from pig number 34 suffering from meningitis, having a RIN of 7.4. 
 
The RNA samples isolated following the infection experiments displayed good quality, and were 
therefore processed further via RNA-seq library preparation, as described in section 3.5.2. 
Subsequently to the library preparation, the library was evaluated for fragment sizes and profile on 
the Agilent 2100 Bioanalyzer, which were approximately 300 bp for the HIBCPP library and 350 bp for 
the porcine (in vitro and in vivo samples) libraries  (data not shown). 
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Figure 14. Summary of the Agilent 2100 Bioanalyzer electropherogram depicts RNA with high 
integrity used as starting material for RNA-seq. The label for each electropherogram lists the 
sample origin, phenotype, and biological replicate or animal number, along with the RIN for each 
sample. The distinct peaks at approximately 42 sec and 49 sec are indicative of the 18S and 28S 
rRNA, respectively, whereas the small peak appearing at approximately 28 sec is indicative of the 
5S rRNA subunit. The small peak appearing at approximately 22 sec is indicative of the marker. 
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4.4.2. Bioinformatic processing post-sequencing revealed efficient mapping to 
exon gene regions    
Following the sequence run, the generated reads were aligned to either the human or the porcine 
reference genome with the RNA aligner STAR (Dobin et al., 2013), which was part of the PartekGS 
software (2.10). Subsequently, the aligned reads were mapped and assigned to corresponding host 
transcripts, thereby simultaneously quantifying them. Evaluation of the alignment and mapping 
efficiency to the reference genome is an important aspect before proceeding with the data 
interpretation, in order to determine sequencing accuracy and DNA contamination (Conesa et al., 
2016). Since we want to investigate the transcriptional profile change of protein-coding genes during 
the state of S. suis ST2 infection, efficient mapping to exon regions of mRNA transcripts is necessary.  
Table 12 summarizes the output generated following the read alignment to the human or porcine 
reference genomes. No pre-defined ranges exist for acceptable values for the various parameters. 
Instead, suggestions exist based on experimental aim or set-up (Conesa et al., 2016). 
The total number of reads reflects the sequencing depth achieved for each sample. Approximately 20 
million reads were generated per sample of the HIBCPP cell sample set and for the samples 
originating from the in vivo infection experiments, and approximately 10 million reads were 
generated for the PCPEC samples. For the PCPEC, less reads were generated for the samples due to 
the sequencing mode, which was set to rapid-run, in contrast to high-output sequencing mode 
selected for HIBCPP cells. However, neither of the two sequence modes have an effect on the data 
output. 
For the HIBCPP cell samples, approximately 62 - 74 % of the aligned reads fully overlapped to an exon 
region, and up to approximately 15 % fully overlapped an intron region of the reference genome. The 
aligned reads obtained from the samples of porcine origin (in vitro and in vivo samples) displayed a 
higher full exon overlap, of approximately 80 %, and only approximately 4 % fully overlapping to an 
intron region. 
Approximately 8 % human and 5 % of porcine paired-end reads had one aligned read, which 
displayed an overlap with an exon region, but was not compatible with any transcript due to no 
compatible alignment of the second read and, therefore, did not contribute to transcript read count. 
All samples displayed a very low percentage of transcripts which partially overlapped an exon region 
(2 % or less), and approximately 10 % of reads which were located between genes. 
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Additionally, about 70 % of transcripts in the models (62,083 for human and 49,447 for pigs) had 
reads aligned to them. Lastly, the majority of reads which aligned to an intron-exon junction were 
compatible with a transcript. 
 
The alignment and mapping summary post-sequencing displayed values within acceptable ranges for 
all samples which underwent sequencing and alignment, and therefore, were statistically analyzed in 
the next step. 
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Table 12. Summary of mapped and aligned reads generated by the PartekGS software. 
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4.5.  The statistical analysis of the sequenced samples via DEG and GSEA 
Multiple data analysis tools exist today, which allow for the interpretation of the data generated 
during the high-throughput NGS analysis. The RNA-seq-generated data was statistically analyzed on 
two different levels in order to gain thorough insight, but to also gain a biological overview. The first 
evaluation included the generation of DEGs lists, which evaluate the differential gene expression of 
individual genes following different treatment conditions. The second evaluation was performed with 
the GSEA utilizing the MSigDB in order to give a biological interpretation of the samples during 
infection and uninfected states. 
 
4.5.1. DEGs 
The first aim to interpret the data was to determine the magnitude of statistically significant DEGs 
based on the number of reads detected during the alignment and mapping process by the PartekGS 
software. This software applied a one-way ANOVA test in order to generate lists of significantly DEGs 
(uncorrected p ≤ 0.05) for the samples which were infected with S. suis ST2 in relation to uninfected 
host cells or meningitis-free animals. An additional DEG list was generated with a corrected p-value, 
in order to correct for multiple testing (De and Baron, 2012). As an additional filtering step, only 
genes which displayed at least 10 raw reads of a transcript in all three biological replicates for one 
class (uninfected versus infected) were taken into consideration for the final DEG list. 
A total of 1,479 significant (p ≤ 0.05) DEGs were identified following the analysis of S. suis ST2 
infected versus uninfected HIBCPP cells. However, only a total of 63 DEGs were identified, which 
exhibited at least a 2-fold up- or down-regulation, of which 32 genes displayed an up-regulation and 
31 genes displayed a down-regulation. The results of the uncorrected p-values are presented in Table 
13, since the correction of the p-value yielded no significantly DEGs (data not shown). Table 13 
summarizes the significant DEGs for infected versus uninfected HIBCPP cells, which showed a fold 
change of at least 2 (up- and down-regulated) and had an uncorrected p-value of ≤ 0.05. 
The highest significant up-regulation observed was a 3.6 fold change for the gene encoding for 
ZFPL36L1. The strongest down-regulation was observed for the microRNA3648 with an 8-fold 
change. Interestingly, the majority of the genes only exhibited a 2- to 3-fold differential expression 
following the 6 h infection period with S. suis ST2. 
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Table 13. A total of 63 genes were significantly differentially expressed in S. suis ST2 infected 
versus uninfected HIBCPP cells. The significance and gene fold change were determined with the 
PartekGS software implementing the one-way ANOVA test. Significant DEGs with a ±2 fold change 
and an uncorrected p-value ≤ 0.05 are presented. 
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For the in vitro S. suis ST2 infected PCPEC samples, a total of 430 genes were identified as 
significantly differentially regulated with an uncorrected p-value ≤ 0.05. However, only a total of 50 
genes displayed a significant differential regulation, of which 46 genes exhibited an up-regulation of 
at least 2-fold, and 4 genes exhibited a down-regulation of at least 2-fold.  
Table 14 summarizes the significant DEGs for S. suis ST2 infected versus uninfected primary PCPEC, 
which showed a fold change of at least 2 (up- and down-regulated). 
Interestingly, the in vitro infected primary PCPEC displayed a very strong cellular response during the 
infection with S. suis ST2, with a maximum of 134-fold up-regulation for IL1β. A total of 21 genes 
exhibited an up-regulation of at least 3-fold, with the majority of these genes known to being 
involved in the inflammatory response and regulation. The differential gene fold change observed in 
S. suis ST2 infected PCPEC shows a much stronger response of the porcine epithelial cells in 
comparison to the human epithelial cells. 
In contrast, a total of only four genes encoding for VSIG4, DLGAP5, KNL1, and STRC were significantly 
differentially down-regulated during S. suis ST2 infection. The gene encoding for STRC was the 
highest significantly down-regulated gene, which exhibited a maximum down-regulation of 3-fold 
change. 
When evaluating the DEG list of genes with a corrected p-value, only one gene encoding for ACOD1 
remained significant (p = 0.025; data not shown). 
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Table 14. A total of 50 genes were significantly differentially expressed in S. suis ST2 infected 
versus uninfected PCPEC. The significance and gene fold change were determined with the 
PartekGS software implementing the one-way ANOVA test. Significant DEGs with a ±2 fold change 
and an uncorrected p-value ≤ 0.05 are presented. 
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Finally, a total of 3355 DEGs with an uncorrected p-value of ≤ 0.05 were identified in the CP of pigs 
suffering from S. suis ST2 – induced meningitis in relation to meningitis-free pigs. The DEG list of 
significant genes with an uncorrected p-value ≤ 0.05 presented 479 genes, which were at least ± 2-
fold regulated, of which 171 genes were up-regulated and 308 genes were down-regulated (data not 
shown). Due to this large size, the significant DEGs with corrected p-values are presented in Table 15. 
In total, 30 genes which were significantly differentially regulated exhibited a fold change of at least 
± 2 with a corrected p-value of ≤ 0.05. 12 of the 30 genes displayed an up-regulation and 18 genes 
displayed a down-regulation. Table 15 summarizes the significant DEGs found in the CP, from animals 
suffering from meningitis versus meningitis-free piglets which showed a fold change of at least 2 (up- 
and down-regulated) and a corrected p-value of ≤ 0.05. 
The strongest up-regulation was 11.3-fold for the gene encoding INSM1, whereas the strongest 
down-regulation was 6.3-fold for the gene encoding for TIMD4. Furthermore, of the 30 genes 
identified in Table 15, 13 genes exhibited a fold change ± 3. 
Table 15. A total of 30 genes were found to be significant Differentially Expressed Genes in the 
choroid plexus of pigs suffering from S. suis ST2 – induced meningitis versus meningitis-free pigs. 
The significance and gene fold change were determined with the PartekGS software implementing 
the one-way ANOVA test. Significant DEGs with a ±2 fold change and a corrected p-value ≤ 0.05 are 
presented. 
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When comparing the PartekGS-generated significant DEG lists with an uncorrected p-value, the CP 
isolated following the in vivo infection experiments with S. suis ST2 resulted in the highest number of 
significantly DEGs, with a total of 479 genes which exhibited a fold change of at least 2 or below -2. In 
contrast, the infected HIBCPP cells and PCPEC displayed 63 and 50, respectively, significantly DEGs 
with a fold change above 2 or below -2. Furthermore, the highest observed fold change for infected 
HIBCPP cells was 8, whereas for the infected PCPEC the highest observed fold change was 134. For 
the data resulting from the in vivo samples, a significant fold change 3 or above was observed for 5 
genes, with the highest being 11.3. Only two overlapping significant DEGs were identified in the 
infected CP epithelial cells, HIBCPP cells and PCPEC, and included transcriptional and immune 
response regulator (TCIM) and Rho family GTPase 1 (RND1). 
The DEG lists give a first indication of individual significantly differentially regulated genes during the 
state of a S. suis ST2 infection in epithelial cells or at the CP during acute meningitis in comparison to 
uninfected cells or the CP of meningitis-free animals. In order to gain further insight and understand 
the biological processes, a GSEA was performed. 
 
4.5.2. GSEA 
In addition to identifying the significance of differential expression of individual genes, we also 
performed a GSEA in order to evaluate the data in terms of biologically relevant functions. The GSEA 
was originally developed by Mootha and colleagues, and first described by Subramanian and 
colleagues, in order to give a biological interpretation of data generated during high-throughput 
analysis (Mootha et al., 2003; Subramanian et al., 2005). The GSEA makes use of the MSigDB, which 
contains annotated Gene Sets (GSs) that are divided into eight large categories, composed of genes 
sharing or being involved in a biological function (Liberzon et al., 2011; Subramanian et al., 2005). 
Through an algorithm applied by the GSEA software, individual genes, which are assigned to GSs 
based on a priori knowledge, are ranked and assigned an enrichment score based on how strong they 
distinguish between, for e.g., the state of infection compared to an uninfected state,  but also how 
often the gene is encountered (Subramanian et al., 2005). 
However, the enrichment score reflects gene enrichment within a single GS. Since different GS are 
composed of a varying amount of genes, the GS size needs to be taken into consideration in order to 
draw comparisons of the enrichment between different GSs, thereby resulting in a normalized 
enrichment score (NES). In this study, a positive NES represents GSs, which are positively enriched in 
infected epithelial cells or the CP of pigs suffering from meningitis, whereas a negative NES 
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represents enriched GSs in either uninfected host cells or the CP of meningitis-free pigs. GSs which 
exhibited a NES of ± 2 were further taken into considered during the evaluation of the data. 
Furthermore, when evaluating an enriched GS, the most important aspect to take into consideration 
is the probability of the results presenting a true or false positive, which is identified through the 
FDR. A FDR value of below or equal to 0.25 is considered significant in the GSEA, which is indicative of 
the result being statistically a true-positive in 75 % of the cases (Subramanian et al., 2005). 
In addition to attributing enriched genes to pre-defined GSs, GSEA also evaluated the individual 
genes for their enrichment and how well their expression differentiates in the two phenotypes. 
Figure 15 depicts the heat-map generated in the GSEA analysis of the top 50 genes, which were 
found to be most distinguishing between S. suis ST2 infected epithelial cells or animals suffering from 
meningitis and uninfected epithelial cells or meningitis-free animals. The dark red is indicative of 
genes, which show the strongest differentiation in a positive direction in the infected/meningitis 
phenotype, whereas dark blue represent a strong differential expression towards a negative 
direction in the uninfected/meningitis-free phenotype. 
The strongest coherent differential expression between the biological triplicates for each phenotype 
can be observed for the samples, which originated from the porcine in vivo experiments. However, 
strong coherence was observed for the majority of the biological HIBCPP cells and PCPEC replicates. 
Furthermore, the majority of the GSEA enriched genes was also identified with the PartekGS 
software, and which can be found in the presented DEG lists in section 4.5.1. 
 
Overall, the majority of the top 50 enriched genes displayed coherent differentiation in all biological 
replicates for the investigated phenotype. Interestingly, the top enriched genes determined by the 
GSEA software were also identified through the DEG analysis performed with the PartekGS software. 
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Figure 15. The GSEA generated heat-map depicts a coherent expression of the biological triplicates 
for all sample sets of the top 50 ranked genes. Dark red reflects gene enrichment of infected cells 
or animals suffering from meningitis. Dark blue reflects gene enrichment in uninfected cells or 
meningitis-free pigs. 
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4.5.2.1. The enrichment of hallmark GSs in infected human and porcine CP 
cells, and the in vivo CP response 
The hallmark GS was first described by Liberzon and colleagues, and consists of 50 GSs, which 
represent well-defined and coherent biological states (Liberzon et al., 2015). They were generated 
from GSs published in the seven major categories, and were created in order to reduce redundancy. 
Furthermore, these 50 GSs are divided into eight major biological categories of: cellular components, 
development, immune reaction, cellular metabolism, pathways, cellular proliferation, signaling, and 
DNA damage (Liberzon et al., 2015). The hallmark GS collection is usually the first step in the data 
assessment to gain an overview of significant biological functions of the sample set in order to 
explore new targets and develop new hypotheses. 
The GSEA of analyzed HIBCPP cell samples revealed that a total of 18 GSs out of the 50 hallmark GS 
collection were found to be significantly enriched in 6 h S. suis ST2 infected cells. Table 16 presents 
the significantly enriched hallmark GSs, which exhibited a FDR q-value of less than or equal to 0.25. 
The majority of the significantly enriched GSs can be categorized into cell signaling, and include TNFα 
signaling via NFκB, IL2-STAT5, GSs with up- and down-regulated genes by KRAS activation, and 
transforming growth factor beta (TGFβ) signaling. Additionally, five GSs belonging to the immune 
cellular processes were significantly enriched and include inflammatory response, interferon γ 
response, IL6-JAK/STAT3 signaling, allograft rejection, and complement system. Furthermore, the 
most significantly enriched GS was hypoxia (NES 3.24, q-value 0.000), and is categorized into the 
cellular pathways, along with apoptosis (NES 1.53, q-value 0.032). The GS epithelial-mesenchymal 
transition (EMT) was the third significantly enriched GS (NES 1.98, q-value 0.001) and belongs to the 
category of cellular development along with myogenesis (NES 1.54, q-value 0.030). Lastly, the apical 
surface GS belonging to the category of cellular component, and the P53 pathway belonging to 
cellular proliferation were also found to be significantly enriched. A summary of the significantly 
enriched GSs designated to the respective cellular processes, as well as the percentage of the 
designated enriched GSs of the total number of significant GSs, are depicted in Figure 16. 
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Table 16. GSEA of 18 hallmark GSs, which are significantly enriched in S. suis ST2 infected HIBCPP 
cells. The normalized enrichment score (NES) represents the extent of GS enrichment, taking the 
number of genes (“size”), which compose the GS, into account. The false discovery rate (FDR) is 
considered significant if q is ≤ 0.25. 
 
Table 17 summarizes the enriched GSs of the response of the infected PCPEC. A total of 28 GSs were 
found to be significantly enriched and displayed a FDR of q ≤ 0.25. The majority of enriched GSs are 
categorized into the cellular signaling and include the GSs TNFα signaling via NFκB, IL2-STAT5, Wnt/β-
catenin, early estrogen response, up- and down-regulated genes by KRAS activation, NOTCH, TGFβ, 
androgen response, and mTORC1 signaling. The category with the second most enriched GSs were 
found to belong to the immune response and include interferon α, γ, and inflammatory response, 
allograft rejection, IL6-JAK/STAT3 signaling, complement system, and coagulation. Interestingly, the 
top five enriched GSs display involvement of the immune response. The category containing the third 
most enriched GSs for the infected or meningitis phenotype was the cellular pathway and included 
hypoxia, apoptosis, unfolded protein response, and reactive oxygen species pathway. Furthermore, 
GSs categorized into cellular metabolism were also found to be enriched and included xenobiotic 
metabolism, glycolysis, and cholesterol homeostasis. The GSs angiogenesis and EMT, which are 
categorized into cellular development, were found to be enriched. Lastly, the GSs containing genes 
up-regulated in response to UV-radiation, categorized into cellular DNA damage response, and the 
P53 pathway belonging to the category of cellular proliferation, were enriched. A summary of the 
significantly enriched GSs designated to the respective cellular processes, as well as the percentage 
of the designated enriched GSs of the total number of significant GSs, are depicted in Figure 16. 
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Table 17. GSEA of 28 hallmark GSs, which are significantly enriched in infected primary PCPEC. The 
normalized enrichment score (NES) represents the extent of GS enrichment, taking the number of 
genes (“size”), which compose the GS, into account. The false discovery rate (FDR) is considered 
significant if q is ≤ 0.25. 
 
Table 18 summarizes the enriched GSs of the response of the CP in animals, which suffered from 
meningitis. In total, 21 GSs were significantly (FDR q ≤ 0.25) enriched. 
The majority of the GSs belong in the category of cellular signaling, with these GSs being TNFα 
signaling via NFκB, IL2-STAT5, TGFβ, and Wnt/β-catenin signaling, early and late estrogen response, 
as well as androgen response, and the GS containing up-regulated genes following KRAS signaling. 
The categories for immune system, cellular development, and pathways all displayed an equal 
amount of enriched GSs. The inflammatory response, IL6-JAK/STAT3 signaling, and coagulation are 
categorized as immune response. The GSs angiogenesis, myogenesis, and EMT can be categorized 
under development, and hypoxia, unfolded protein response, and reactive oxygen species pathway 
are categorized under cellular pathways. Cholesterol homeostasis is categorized into cellular 
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metabolism, Myc targets fall under the category of proliferation, and the enriched GSs of genes up- 
or down-regulated in response to UV radiation belong to the cellular DNA damage response. A 
summary of the significantly enriched GSs designated to the respective cellular processes, as well as 
the percentage of the designated enriched GSs of the total number of significant GSs, are depicted in 
Figure 16. 
 
Table 18. GSEA of the 21 hallmark GSs, which are significantly enriched in animals suffering from 
meningitis. The normalized enrichment score (NES) represents the extent of GS enrichment, taking 
the number of genes (“size”), which compose the GS, into account. The false discovery rate (FDR) is 
considered significant if q is ≤ 0.25. 
 
 
GSs which are enriched in uninfected cells or meningitis-free animals in comparison to the infected 
or diseased state were also evaluated and are summarized in Table 19. These GSs display a negative 
NES score and a FDR q ≤ 0.25. 
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Figure 16. Summary of the enriched GSs of the hallmark GSEA for S. suis ST2 infected HIBCPP cells, 
PCPEC, and pigs. These pie-charts summarize the enriched GSs from Table 16 - Table 18. The 
percentage, which is listed under the bold labels indicating the cellular process category, is based 
on the total number of significantly (FDR q ≤ 0.025) enriched GSs for the sample. The outer labels 
of the pie chart represent the significantly enriched GS for each sample which falls under the 
respective cellular process category. 
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In uninfected HIBCPP cells, the majority of enriched GSs were found to belong to the category of 
cellular proliferation and include the enrichment of the GSs, version 1 and 2, of genes regulated by 
Myc family members, genes regulated by the E2F transcription factors, and genes involved in the 
G2/M checkpoint of the cell division cycle. Furthermore, an enrichment of the GSs of unfolded 
proteins response, DNA repair, and spermatogenesis belonging to the cellular categories of 
pathways, DNA damage, and development, was observed. 
The uninfected PCPEC displayed the least amount of significant enriched GSs. The GS containing 
genes regulated by the E2F transcription factors, belonging to the cellular proliferation category 
displayed a significant enrichment. Furthermore, the GS containing genes up-regulated in pancreatic 
beta cells displayed enrichment. However, due to the small GS size and a relative high FDR, this 
enrichment may indicate a false-positive. 
The majority of enriched GSs in uninfected cells or meningitis-free pigs are involved in the immune 
response and cellular metabolism. The interferon α and γ response, as well as the allograft rejection 
GSs are categorized under immune response, whereas the metabolic processes include oxidative 
phosphorylation, as well as fatty acid and bile acid metabolism. 
Table 19. The hallmark GSs, which are enriched in uninfected cells or meningitis-free animals. The 
normalized enrichment score (NES) represents the extent of GS enrichment, taking the number of 
genes (“size”), which compose the GS, into account. The false discovery rate (FDR) is considered 
significant if q is ≤ 0.25. 
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When comparing the 18, 28, and 21 significantly enriched GSs from S. suis ST2 infected HIBCPP cells, 
PCPEC, and animals suffering from meningitis, respectively, a total of eight GSs were found to 
overlap. These eight GSs were TNFα signaling via NFκB, inflammatory response, hypoxia, IL2-STAT5 
signaling, IL6-JAK/STAT3 signaling, TGFβ signaling, EMT, and KRAS signaling. In contrast to the 
infected cell samples, samples that were either uninfected or animals that were meningitis-free had 
one GS in common, which was significantly enriched in this phenotype. This enriched GS contains 
gene targets which are involved in the cell cycle and are regulated by the E2F transcription factors. 
 
4.6.  Selected genes could be validated utilizing qPCR 
Following the sequencing analysis, the generated data was validated. The most common practice, as 
was also done for this study, is the validation with the relative quantification method via qPCR for 
selected genes, to determine the gene fold change of the gene of interest in relation to an internal 
control, such as a house-keeping gene. 
The DEG lists presented in section 4.5.1 were used in order to select candidate genes for the 
validation of the sequencing data. All fold changes were calculated via the 2-ΔΔCT method, and the 
house-keeping gene encoding for glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as 
an internal control in order to calculate the relative fold change of the gene of interest. 
Table 20 summarizes the fold change and the corresponding significance (uncorrected p-value of a 
one-way ANOVA test) of differentially regulated genes during the RNA-seq analysis, as determined by 
the PartekGS software. Additionally, Table 20 also summarizes the relative FC (2-ΔΔCT) between 
infected versus uninfected samples, along with the S.D., of the qPCR results. These genes were 
selected for subsequent qPCR validation, and the data from Table 20 will be discussed in relation to 
the data presented in Figure 17 - Figure 19. 
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Table 20. Summary of the fold changes (FCs) and uncorrected p-values of selected genes from the 
RNA-seq data and the FC of infected samples in relation to uninfected samples. The FC and p-
values of the RNA-seq data were determined by the software PartekGS. The FC for the qPCR data 
was calculated via the 2-ΔΔCT method using GAPDH as an internal control, and the relative FC was 
determine between infected versus uninfected samples with the S.D. Genes are considered 
significantly differentially regulated if the p-value ≤ 0.05. These listed genes were selected for 
subsequent qPCR validation. 
 
FC, fold change; S.D., standard deviation 
 
First, genes, which are implicated during inflammation, were selected for the verification. For this, 
genes, which were significantly upregulated on the DEG list of the infected PCPEC (Table 14), were 
selected and are summarized in Table 20. The relative fold change of the genes encoding for the 
cytokines and chemokines IL1β, IL8, C-X-C ligand 2 chemokine (CXCL2), and TNFα in all sample sets 
are summarized in Figure 17. 
The average fold change of infected cells or animals with meningitis in relation to uninfected cells or 
meningitis-free animals (± the standard deviation) for IL1β was 2.0 (± 3.4), 136.4 (± 83.0; p = 0.047), 
and 4.6 (± 15.3), for infected HIBCPP cells, PCPEC, and the CP from in vivo infection experiments, 
respectively. This is comparable to the data generated following the RNA-seq, which also displayed 
significance in PCPEC (p = 0.041; Table 20). 
The average fold change of infected cells or animals with meningitis in relation to uninfected cells or 
meningitis-free animals (± the standard deviation) for IL8 was 3.8 (± 7.3), 20.5 (± 12.8; p = 0.009), and 
7.6 (± 17.7), for infected HIBCPP cells, PCPEC, and the CP from in vivo infection experiments, 
respectively. The fold changes and significance were in accordance with the RNA-seq data, with the 
exception of the in vivo – generated samples (Table 20). The RNA-seq data of pigs suffering from 
meningitis revealed a 22-fold change of IL8 with a significance of p = 0.014 (Table 20). 
The average fold change of infected cells or animals with meningitis in relation to uninfected cells or 
meningitis-free animals (± the standard deviation) for CXCL2 was 4.7 (± 5.3), 19.4 (± 5.5; p = 0.011), 
and 13.0 (± 25.1), for infected HIBCPP cells, PCPEC, and the CP from in vivo infection experiments, 
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respectively. These results were comparable to the results obtained with the PartekGS software 
following RNA-seq, with the exception that the in vivo data displayed a significance (p = 0.005) of the 
fold change in meningitis versus meningitis-free animals, which was not achieved by the qPCR 
validation (Table 20). 
The average fold change of infected cells or animals with meningitis in relation to uninfected cells or 
meningitis-free animals (± the standard deviation) for TNFα was 12.0 (± 17.1), 19.8 (± 2.6; p = 
0.0002), and 1.2 (± 0.3), for infected HIBCPP cells, PCPEC, and the CP from in vivo infection 
experiments, respectively. With the exception of the PCPEC samples, which displayed a fold change 
of approximately 70 in the RNA-seq analysis, the qPCR data corresponded to the RNA-seq 
determined data (Table 20). 
 
Figure 17. Quantitative PCR validation for the RNA-seq data of genes expressing for cytokines and 
chemokines. The relative fold change of each gene was calculated by using the 2-ΔΔCT method using 
the gene encoding for GAPDH as an internal control. Each biological replicate is represented in the 
graphs, along with the mean and standard deviation. A significance of p ≤ 0.05 between the 
infected state versus uninfected state is indicated by an asterisk (*). 
In addition to the genes encoding for the cytokines and chemokines, genes, which are implicated in 
regulating the inflammatory response, were evaluated. At least one of the selected genes was found 
to be significantly differentially regulated in infected HIBCPP cells and PCPEC (Table 13 and Table 14), 
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as summarized in Table 20. The relative fold change of the genes encoding for NFκB inhibitor alpha 
(NFκBIA), zinc finger CCCH-type containing 12A (ZC3H12A; also known as Regnase), and TCIM in all 
sample sets are summarized in Figure 18. 
The average fold change of infected cells or animals with meningitis in relation to uninfected cells or 
meningitis-free animals (± the standard deviation) for NFκBIA was 2.6 (± 3.5), 3.5 (± 1.2; p = 0.016), 
and 1.7 (± 0.4; p = 0.023), for infected HIBCPP cells, PCPEC, and the CP from in vivo infection 
experiments, respectively. These results were congruent with the results obtained from the RNA-seq 
analysis (Table 20). 
The average fold change of infected cells or animals with meningitis in relation to uninfected cells or 
meningitis-free animals (± the standard deviation) for ZC3H12A was 3.1 (± 2.4), 2.0 (± 1.2), and 1.4 
(± 0.6), for infected HIBCPP cells, PCPEC, and the CP from in vivo infection experiments, respectively). 
These results matched the observations from the RNA-seq results, with the exception that the fold 
change observed in the PCPEC samples was significant (p = 0.004; Table 20) in comparison to the 
qPCR results, which detected no significance. 
The average fold change of infected cells or animals with meningitis in relation to uninfected cells or 
meningitis-free animals (± the standard deviation) for TCIM was 2.6 (± 4.6), 2.7 (± 0.4; p = 0.005), and 
3.1 (± 1.9), for infected HIBCPP cells, PCPEC, and the CP from in vivo infection experiments, 
respectively. These qPCR results are comparable to the RNA-seq results, with the exception that 
expression-fold change yielded significance (p = 0.025) in the HIBCPP cell sample set (Table 20). 
 
 
Figure 18. Quantitative PCR validation for the RNA-seq data of genes expressing immune response 
regulators. The relative fold change of each gene was calculated by using the 2-ΔΔCT method using 
the gene encoding for GAPDH as an internal control. Each biological replicate is represented in the 
graphs, along with the mean and standard deviation. A significance of p ≤ 0.05 between the 
infected state versus uninfected state is indicated by an asterisk (*). 
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Furthermore, based on the results generated by the GSEA (section 4.5.2), genes known to play a key 
role during hypoxia, or are known to have their expression influenced in a hypoxic environment, 
were chosen for validation. The relative fold change of the genes encoding for hypoxia-inducible 
factor 1 alpha (HIF1α), vascular endothelial growth factor a (VEGFA), MAX interactor 1 (MXI1), and 
dual specificity phosphatase 2 (DUSP2) in all sample sets are summarized in Figure 19, and the data 
generated during the RNA-seq analysis are summarized in Table 20. Additionally, MXI1 and DUSP2 
were found to be significantly differentially expressed in S. suis ST2 infected HIBCPP cells (Table 13). 
The average fold change of infected cells or animals with meningitis in relation to uninfected cells or 
meningitis-free animals (± standard deviation) observed for HIF1α was 0.8 (± 0.3), 1.0 (± 0.2), and 1.0 
(± 0.1), for infected HIBCPP cells, PCPEC, and the CP from in vivo infection experiments, respectively. 
These observations corresponded to the RNA-seq DEG data, with the exception of the in vivo 
samples, which displayed a significant differential expression (p = 0.008; Table 20). 
The average fold change of infected cells or animals with meningitis in relation to uninfected cells or 
meningitis-free animals (± standard deviation) observed for VEGFA was 1.6 (± 0.5), 1.4 (± 0.3), and 
1.4 (± 0.2; p = 0.048), for infected HIBCPP cells, PCPEC, and the CP from in vivo infection experiments, 
respectively. Again, these values were in line with the data obtained from RNA-seq, with the 
exception that the PCPEC sample set displayed significant differential fold change (0.006; Table 20). 
The average fold change of infected cells or animals with meningitis in relation to uninfected cells or 
meningitis-free animals (± standard deviation) observed for MXI1 was 2.8 (± 12.1), 1.0 (± 0.03), and 
1.1 (± 0.1), for infected HIBCPP cells, PCPEC, and the CP from in vivo infection experiments, 
respectively. With the exception of the PCPEC samples set, which displayed a significant differential 
expression (p = 0.008; Table 20) following the RNA-seq data analysis, the qPCR matched the RNA-seq 
data. 
The average fold change of infected cells or animals with meningitis in relation to uninfected cells or 
meningitis-free animals (± standard deviation) observed for DUSP2 was - 4.2 (± 2.2), 1.3 (± 1.5), and 
9.7 (± 1.9; p = 0.005), for infected HIBCPP cells, PCPEC, and the CP from in vivo infection experiments, 
respectively. From the RNA-seq data analysis, the gene encoding DUSP2 displayed a significant 
(p = 0.015) 2.6 down-regulation in the infected HIBCPP cell sample set (Table 20), which 
corresponded approximately to the data generated via qPCR, where an approximate 4-fold down-
regulation was observed, although this was not significant in infected cells in comparison to 
uninfected HIBCPP cells. Furthermore, RNA-seq revealed a significant (p = 0.016) 5.2-fold up-
regulation in S. suis ST2 infected PCPEC (Table 20), which yielded no significance in the qPCR 
validation. Congruence was observed for the sample set obtained from the in vivo experiments. 
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Figure 19. Quantitative PCR validation for the RNA-seq data of genes regulated during a hypoxic 
physiological state correlate to the RNA-seq data. The relative fold change of each gene was 
calculated by using the 2-ΔΔCT method using the gene encoding for GAPDH as an internal control. 
Each biological replicate is represented in the graphs, along with the mean and standard deviation. 
A significance of p ≤ 0.05 between the infected state versus uninfected state is indicated by an 
asterisk (*). 
 
Overall, the gene fold change determined following the RNA-seq data analysis could be validated 
with the qPCR method, and the significances determined following the qPCR analysis largely 
corresponded to the significant fold change determined with the PartekGS software. Genes encoding 
for the cytokines and chemokines displayed a higher fold change in the PCPEC and in samples from 
the porcine in vivo infection experiments, an observation also made from the DEG lists (section 
4.5.1). 
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4.7.  Comparing two sequencing methods: conventional RNA-seq versus MACE 
In addition to the conventional Illumina’s RNA-seq technology, many different sequencing methods 
exist, since each method has its own strengths and weaknesses. An alternative and relative new 
method was developed by GenXPro and is called MACE (Rotter et al., 2017). This sequencing method, 
which sequences only the 3` end of the transcript, brings advantages with it, in comparison to the 
conventional RNA-seq method. For example, with MACE it is possible to sequence the sample at a 
deeper level since each read is representative of one transcript in the sample, whereas conventional 
RNA-seq could have multiple reads from the same transcript, since sequencing is performed on the 
entirety of randomly fragmented transcripts (Rotter et al., 2017). 
In this study, a comparative analysis of samples sequenced via the conventional and the MACE 
sequencing methods was performed. The samples utilized for this evaluation were obtained from the 
porcine in vivo S. suis infection experiments (section 3.3.2). 
 
4.7.1. A high concordance of significantly DEGs was observed when comparing 
conventional RNA-seq and MACE data 
The first step in the data analysis post-sequencing was to generate and evaluate a list of significant 
DEGs. Following the DEG analysis, 2,263 and 1,919 DEGs with an uncorrected p ≤ 0.05, and which 
showed at least 10 raw reads in one class for all biological replicates for the conventional RNA-seq 
and MACE, respectively, were identified. Of these significant DEGs, 1,102 concordant genes were 
identified following both sequencing methods. 
Figure 20 depicts a positive correlation of concordant DEGs identified in pigs suffering from 
meningitis versus meningitis-free pigs following the conventional RNA-seq analysis (x-axis) and MACE 
analysis (y-axis). 
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Figure 20. 1,102 concordant DEGs from the conventional RNA-sequencing and MACE generated 
data. Genes with an uncorrected p-value of below or equal to 0.05 and at least 10 raw reads in all 
biological replicates of one class (meningitis versus meningitis-free) are presented. 
In addition to comparing the differential gene expression of individual genes, a GSEA was carried out 
in order to evaluate the enrichment of hallmark GSs following the MACE sequencing method. 
 
4.7.2. GSEA analysis yielded similar hallmark GS enrichment 
A GSEA, as described in section 4.5.2, was carried out with the data generated from the MACE 
sequencing. In total, 21 significant GSs were identified (Table 21), which is the same quantity 
identified following the conventional RNA-seq (Table 18). 
The majority of the GSs belong in the category of cellular signaling, with these GSs being TNFα 
signaling via NFκB, IL2-STAT5, TGFβ, Wnt/β-catenin, and MTORC1 signaling, early estrogen response, 
as well as the GS containing up-regulated genes following KRAS signaling. The category containing 
the second most enriched GS was for the immune system and included inflammatory response, IL6-
JAK/STAT3 signaling, allograft rejection, coagulation, and complement. The category with the third 
most enriched GSs included reactive oxygen species pathway, hypoxia, unfolded protein response, 
and apoptosis, which are categorized under cellular pathways. The GSs myogenesis, angiogenesis, 
and EMT can be categorized under development, and the enriched GSs of genes up- or down-
regulated in response to UV radiation belong to the cellular DNA damage response. 
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The GSEA of the MACE data revealed four different enriched GSs (apoptosis, allograft rejection, 
MTORC1 signaling, and complement) in comparison to the samples sequenced via the conventional 
sequencing method, which displayed enrichment for androgen response, Myc targets, cholesterol 
homeostasis, and late estrogen response. 
 
Table 21. GSEA of the MACE sequenced samples reveals 21 hallmark GSs, which are significantly 
enriched in animals suffering from meningitis. The normalized enrichment score (NES) represents 
the extent of GS enrichment, taking the number of genes (“size”) into account. The false discovery 
rate (FDR) is considered significant if q is ≤ 0.25. 
 
 
Only four GSs were identified as being significantly enriched at the CP of meningitis-free pigs 
following the MACE analysis. These included interferon α (NES -2.25, q = 0.000) and γ (NES -1.71, q = 
0.006) response, belonging to the category of immune response. Additionally, the metabolism 
categorized GSs, oxidative phosphorylation (NES -1.89, q = 0.000) and bile acid metabolism (NES -
1.40, q = 0.183), were also found to be significantly enriched. These four GSs were also identified as 
being significantly enriched in the same samples which underwent conventional RNA-seq. 
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5. Discussion 
S. suis, as a zoonotic opportunistic pathogen, is capable of causing disease in its natural host, the pig, 
as well as in humans by predominantly presenting itself clinically as meningitis (Dutkiewicz et al., 
2017). In vivo and in vitro evidence exists, which demonstrate and implicate the CP at the BCSFB, in 
acting as an entry gate for this pathogen into the CNS (Schwerk et al., 2012; Tenenbaum et al., 2009; 
Williams and Blakemore, 1990). In this study, the global transcriptome response of in vitro S. suis 
infected human papilloma (HIBCPP) and primary porcine CP epithelial cells (PCPEC), as well as the CP 
tissue of in vivo infected piglets, which developed S. suis-induced meningitis, was evaluated via RNA-
seq. Subsequent to sequencing, the generated data was evaluated on the differential expression of 
individual genes and was also biologically interpreted by evaluating the enrichment of GSs via the 
GSEA between the infected versus uninfected phenotypes. The data produced by the RNA-seq 
method via the Illumina sequencing technology was then validated with the qPCR method. For this, 
genes were selected based on the generated DEG list and on key genes playing a role in significantly 
enriched GSs (e.g. hypoxia). The gene fold change determined via qPCR analysis revealed a high 
congruence with the fold change calculated by the RNA-seq data analysis software. 
 
5.1. The DEG analysis of S. suis ST2 infected CP cells of pigs and humans 
5.1.1. The implications of individual differentially regulated genes at the CP 
involved in inflammation and hypoxia 
5.1.1.1. Primary PCPEC 
A previous transcriptome investigation, utilizing microarray technology, of apically S. suis ST2 
infected PCPEC, which in vivo would reflect the state of infection following bacterial translocation 
into the CNS, revealed that the CP epithelial cells contributed to the inflammatory response in vitro 
(Schwerk et al., 2011). For the 6 h basolateral infected PCPEC in this current study, which in vivo 
would reflect the state before bacteria enter the CNS, it was observed that infection with S. suis ST2 
induced a strong response in the primary porcine cells, with the majority of the identified significant 
DEGs being involved in inflammation as well. Part of the inflammatory response is the upregulation 
of cytokines and chemokines, which in this present study included IL1β, TNF, IL1α, CCL3L1, CXCL8, 
AMCF-II, CXCL2, CCL2, CCL11, CCL5, and IL6, many of which were also identified in the study by 
Schwerk and colleagues of apically infected PCPEC (Schwerk et al., 2011). IL1β was found to be the 
strongest up-regulated gene, with a 134-fold change 6 h post-infection, and is known to be involved 
in many physiological functions, among others, being a potent inducer of inflammatory signaling 
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expressed by many different cell types, including the CNS (Hewett et al., 2012). In previous studies 
evaluating the S. suis-dependent cytokine production, IL1β, along with other key inflammatory 
cytokines, such as IL6 and IL8, was found to be produced by porcine monocytes and 
polymorphonuclear lymphocytes in a whole-blood system in response to infection, as well as in 
human THP-1 monocytes (Segura et al., 2002; Segura et al., 2006). Furthermore, utilizing a murine in 
vivo S. suis infection model, the transcription of IL1β, TNF, and CCL2 in the brain during cerebral 
inflammation was demonstrated via in situ hybridization (Dominguez-Punaro et al., 2007). In addition 
to the cytokine and chemokine upregulation observed in this present work, the inflammatory 
response regulators SLAMF7, RELB, NFKBIZ, NFKBIA, and ZC3H12A were identified, further 
underlining the strong inflammatory response elicited by PCPEC during to infection. 
 
5.1.1.2. HIBCPP cells 
The transcriptome of HIBCPP cells was previously investigated following the in vitro infection with 
N. meningitidis from the basolateral cell side (Borkowski et al., 2014). In the experimental set-up 
from Borkowski and colleagues, the HIBCPP cells demonstrated a strong inflammatory response, 
which included the production of cytokines and chemokines. Previous studies involving infection of 
other human cells with S. suis, such as a human brain endothelial cell line (HBMEC) or human 
immune cells (e.g. THP-1 monocytes and dendritic cells), mainly focused their research on the 
inflammatory response of host cells, too, or on bacterial survival and interaction with host cells 
(Charland et al., 2000; Liu et al., 2011b; Meijerink et al., 2012; Segura et al., 2002). Interestingly, in 
this present study, whereas PCPEC displayed a strong inflammatory response to infection, genes 
attributed to hypoxia were found to play a more important role during infection in HIBCPP cells. The 
significant DEGs identified in basolaterally infected HIBCPP cells involved in hypoxia included 
ZFP36L1, MXI1, KLHL24, PNRC1, CDKN1C, and DUSP2. 
In addition to the hypoxic response, it was also interesting to observe the significant differential 
regulation of various RNA types, which are known to have a regulatory function and are non-protein 
coding. These regulatory RNAs included the anti-sense (AS) RNAs HLA-F, LIFR, PRKAR2A, ZEB1, and 
long intergenic non-coding RNAs (LINC) 887, 1431, 2482, as well as microRNAs (MIRs) 22HG and 
3648, which are associated with viral inflammation and cancer and cellular proliferation, respectively 
(Rashid et al., 2017; Razooky et al., 2017; Zhang et al., 2018). This suggests that non-coding RNAs play 
a role in human CP epithelial cells during infection. 
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5.1.1.3. CP of in vivo infected pigs 
Finally, for the first time the transcriptome of cells found at the CP of pigs was investigated. For this 
sample set, it is important to take into consideration that the CP tissue obtained from the in vivo 
infected pigs consists of a heterogeneous cell population, such as CP epithelial, endothelial cells, and 
immune cells located at or recruited to the BCSFB (Strazielle and Ghersi-Egea, 2000). Therefore, due 
to the tissue heterogeneity, the results of the CP tissues samples cannot directly be compared to that 
of the in vitro infection experiments with homogenous epithelial cell populations, such as the PCPEC 
and HIBCPP cells. However, this data is rich in information, which helps to understand the CP tissue-
specific response during S. suis infection. Previous studies carried out utilizing in vivo porcine S. suis 
infection models investigated the transcriptome of different organs (brain, lung, monocytes, spleen), 
but not specifically the CP (Li et al., 2010; Liu et al., 2011a). These studies evaluated the 
transcriptome at pre-defined time points (24 hours and 3 days post-infection) of 4 to 5-week old 
piglets, as compared to this present study, where the response of 8-week old pigs was analyzed 
which developed acute meningitis, finding differentially regulated genes to be predominantly 
associated with the host’s inflammatory response. 
Although gene transcription and regulation is of high interest, genes have to be translated to 
biologically active proteins in order to perform their functions in the cell. Liu and colleagues were the 
first to investigate the protein profile of the CSF in piglets suffering from meningoencephalitis. They 
found enriched up-regulated proteins were extracellular, participated in protein metabolism, and 
displayed cysteine-type peptidase activity. Down-regulated proteins were also identified as belonging 
to exosomes of cellular components, energy pathways in biological processes, and proteins 
possessing catalytic activity (Liu et al., 2018). Proteomic investigation has also been performed of 
S. suis in vivo in its natural host during disease, giving insight into virulence contribution. However, 
dual RNA-seq methods exist, which can evaluate the host and pathogen’s transcriptional response 
simultaneously and should therefore be taken into consideration in the future when investigating 
specific niches (Saliba et al., 2017; Yu et al., 2018). 
Interestingly, the final in vivo DEG list obtained in this present study contained many more gene 
targets than the lists generated following the analysis for the HIBCPP cell and PCPEC samples, likely 
due to the cell heterogeneity found in vivo. For example, from the generated DEG list generated 
post-sequencing of the CP tissue it can be deduced, based on the DEG lists generated from the 
homogenous epithelial cell culture, which genes are found not expressed by the human CP (CRNN 
and FLRT1), or likely do not originate from CP epithelial cells (TIMD4). For the future, one could 
investigate individual cells or single cell types out of the in vivo environment by making use of 
advanced techniques, such as laser-capture microdissection in combination with single-cell RNA-seq 
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(Kukurba and Montgomery, 2015). An in situ hybridization method could also be applied in order to 
evaluate the transcript origin in the heterogeneous tissue. 
Additionally, the samples obtained from the in vivo infection experiments were subject to an 
alternative sequencing method called MACE, which performs deep-sequencing by sequencing only 
the 3’-end of a transcript (Rotter et al., 2017). For the approximately 2,000 significantly (p ≤ 0.05) 
DEGs identified in both the conventional RNA-seq method and the MACE sequencing method, an 
overlap of approximately 50 % was observed. It should be considered, that the varying degree of the 
library preparation and a difference in the sequencing depth (only the 3’-transcript end versus 
random fragments of a transcript) of the MACE and conventional RNA-seq approaches could 
potentially introduce sequencing biases, which account for a variation in the quantification, and 
thereby affect the evaluation of differential expression (Alberti et al., 2014; Fang and Cui, 2011). Only 
a few comparative RNA-seq methods have previously been performed and found a higher 
concordance (80-99 %) of genes identified between the different sequencing methods (Harris et al., 
2010; Tian et al., 2010). However, in these studies, RNA profiles from a specific RNA population 
(micro RNA) from non-pathological tissue or homogenous cell population were investigated, whereas 
in this present work, the global transcriptome profile of a heterogeneous cell population in a 
pathological state was investigated, which is known to affect the estimations of transcript 
abundances (Kukurba and Montgomery, 2015). Cell homogeneity was previously discussed to result 
in more accurate quantification (Kukurba and Montgomery, 2015). Taking these details into 
consideration, 50 % gene concordance between the two different sequencing methods employed in 
this thesis could be viewed as a promising result, and MACE could be applied to future studies with 
homogenous cell populations as cheaper sequencing alternative. 
 
5.1.2. The DEG comparison between S. suis ST2 infected CP cells displayed limited 
gene overlap 
Despite S. suis most commonly presenting itself clinically the same way in both the natural host and 
humans, a differing transcriptional response was identified between the three samples in terms of 
gene fold change intensity and the biological functions attributed to the genes. When evaluating and 
comparing the PartekGS-generated DEGs between the analyzed sample sets, the upregulation of only 
two genes was found to overlap in the human and porcine in vitro infected epithelial samples during 
infection. These two genes were identified as TCIM and RND1. TCIM, which is also well known under 
the aliases TC1 and C8orf4, is a gene regulator often found in association with poor survival outcome 
during cancer, due to its involvement in regulating the Wnt/β-catenin pathway (Kim et al., 2009). 
Furthermore, TCIM was found to be upregulated by the pro-inflammatory cytokines TNFα and IL1β 
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(Kim et al., 2006), but in return also influences the up-regulation of inflammatory cytokines and the 
adhesion molecules ICAM1 and VCAM1 (Kim et al., 2009). The latter is known to be expressed by CP 
epithelial cells and has been implicated in being manipulated by bacterial pathogens in order to aid in 
invasion of the CNS (Al-Obaidi and Desa, 2018; Steffen et al., 1996). In a study performed by Kim and 
colleagues, TCIM was described as a novel inflammatory regulator in endothelial cells, since it was 
found to be regulated by, and conversely also regulating, and thereby enhancing, the transcription 
factor NFκB (Kim et al., 2009). To date, there has been no clear implication of TCIM during infection 
of the CNS. However, its upregulation has been observed for malignant cancers in the CNS (Wang et 
al., 2017). RND1 functions in the actin cytoskeletal arrangement and cellular adhesion, and has been 
implicated in viral infections, e.g. Nipah virus, which is known to affect the CNS (Glennon et al., 2015; 
Nobes et al., 1998). Interestingly, both TCIM and RND1 were previously found to be up-regulated 
during an in vitro N. meningitidis infection experimental set-up with HIBCPP cells (Borkowski et al., 
2014). 
The lack of genes overlapping in the identified DEGs may be due to various reasons. It could be 
speculated that the cell line background, i.e. whether the cells originated from papilloma cells or are 
primary cells cultivated ex vivo, plays a role since immortalization may have an impact on how a cell 
responds to a defined stressor. Furthermore, due to the swine being the natural host organism of 
S. suis, another theory could be that porcine cells may be more evolutionary attuned to responding 
to this pathogen than human cells. Along these lines, this may explain why N. meningitidis, which is 
known for its host specificity towards humans, elicited a strong inflammatory response in the HIBCPP 
cells in vitro (Borkowski et al., 2014; Hill et al., 2010). With the advancement of transcriptome studies 
being able to perform sequencing of RNA with low integrity, the CP of patients, whom succumbed to 
S. suis-induced meningitis, could potentially be evaluated post-mortem in future studies. 
Furthermore, the utilization of 3D cell culture models, such as brain organoids, which are currently 
used to study infection with Zika virus, could be optimized, since these have been shown to develop 
a CP-like structure (Renner et al., 2017). 
 
5.2. The GSEA of S. suis ST2 infected CP cells of pigs and humans 
Although the DEG analysis was able to determine individual genes regulated during infection with 
S. suis, the identification of biological pathways, in which multiple differentially expressed genes are 
connected to a common or networked performance, is of high interest in understanding cellular 
processes. One such tool, which allows the identification of enrichment of genes sharing a common 
biological function, is the GSEA. 
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5.2.1. The enrichment of GSs in the individual human and porcine CP 
5.2.1.1. GS enrichment in infected primary PCPEC 
In the GSEA, a total of 28 GSs was identified to be significantly enriched in S. suis-infected PCPEC.  
The top enriched GSs are implicated in the immune response, which corresponded and 
complemented the data obtained in the DEG analysis. In a previous transcriptome study analyzing 
apically S. suis-infected PCPEC cells, Gene Ontology (GO) analysis, which evaluates high through-put 
data, based on biological processes, molecular functions, and cellular components, also identified 
many enriched cellular processes to be involved in inflammation (Ashburner et al., 2000; Schwerk et 
al., 2011). This is revealed by the over-represented GO terms for cytokine activity, inflammatory 
response, defense response, and IκB kinase/NFκB cascade, as well as programmed cell death, which 
can be induced as a consequence of inflammation (Schwerk et al., 2011). 
 
5.2.1.2. GS enrichment of infected HIBCPP cells 
For the HIBCPP cell samples set, 18 GSs were found to be significantly enriched, with the most 
significant enrichment being for the GS containing genes in the hypoxia cellular stress response. As 
observed with the PCPEC, the GSEA for the HIBCPP cell samples confirmed its corresponding DEG 
analysis as well, since this also identified hypoxia related genes. In addition to the gene enrichment in 
hypoxia, the GSEA revealed an enrichment of GSs participating in inflammation. A previous GSEA and 
a GO analysis of N. meningitides-infected HIBCPP cells revealed a predominant inflammatory 
response, with cytokine and chemokine activity playing a significant role (Borkowski et al., 2014). 
Additionally, a GS involved in wound healing was identified (Borkowski et al., 2014), which is often 
associated with EMT. The EMT GS was identified in the present study to be the third most enriched 
GS in infected HIBCPP cells. In a different study investigating the transcriptome of a human monocyte 
cell line (THP-1 cells) exposed to S. suis, GO analysis revealed a cellular response including the 
participation of intracellular signaling pathways involved in inflammation, such as apoptosis and host 
defense and immunity, as well as other cellular processes involving cellular metabolism, gene 
transcription, and gene translation (Liu et al., 2011b). 
 
5.2.1.3. GS enrichment of the CP from in vivo infected piglets with meningitis 
The GSEA of the CP isolated from in vivo-infected piglets identified 21 significantly enriched GSs. The 
majority of the GSs displayed involvement in the inflammatory host response, as was also observed 
with the PCPEC samples. A previous porcine in vivo investigation revealed that the brains of S. suis-
infected piglets displayed gene enrichment also involved in inflammation, and could be categorized 
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into the GO terms of biological processes responding to a stimulus via signal transducer activity, 
cytokine activity and binding, defense response, inflammatory response, immune response, and 
innate immune response (Liu et al., 2011a). However, it was noted that many GO categories 
overlapped, due to the same genes being involved in multiple biological processes (Liu et al., 2011a). 
A further transcriptome study utilizing a zebrafish S. suis-infection model, underscored the role of 
inflammation and host defense during infection, and highlighting the zebrafish as a suitable model to 
study S. suis infection (Wu et al., 2010). 
When comparing the overlapping GSs of the CP samples from the porcine in vivo studies subject of 
conventional RNA-seq and MACE sequencing, the GSEA revealed a high overlap in the detected 
enriched biological functions during infection. This further underlines the MACE sequencing method 
as a suitable alternative. For both sequencing methods, a total of 21 significantly enriched GSs were 
identified. 17 GSEA GSs were found to overlap between both analyzed sequencing methods, with 
non-overlapping GSs being enriched in the androgen response, Myc gene targets, cholesterol 
homeostasis, and late estrogen response for the conventional sequenced samples, and apoptosis, 
allograft rejection, mTORC1 signaling, and complement GSs for the MACE analysis. 
 
5.2.1.4. Down-regulated GSs at the CP during S. suis infection 
Not only were enriched GSs evaluated in infected or meningitis samples, but GSs, which were 
enriched in uninfected samples in comparison to infected samples, were also evaluated. The number 
of significantly enriched GSs was observed to be overall fewer in uninfected or meningitis-free 
samples than in the infected or meningitis samples. The majority of the significantly enriched GS 
identified in the uninfected samples can be categorized into cellular metabolism or cellular 
proliferation. One enriched GS, which contains genes regulated by family members of E2F 
transcription factors, was found to overlap between all of the samples. The E2F transcription factors 
are important for the regulation of genes involved in DNA replication and the cell division cycle, and 
in the context of infection, they were investigated during viral infections, such as human 
immunodeficiency virus and adenovirus (Bracken et al., 2004; Kundu et al., 1997; Zheng et al., 2016). 
It is noteworthy, that the enrichment of the GS containing E2F targets corresponds to the GS 
containing genes involved in the G2/M checkpoint of the cell division cycle. 
Furthermore, the enrichment of the GS constituted by gene targets of the Myc transcription factor 
was observed in the HIBCPP cell samples. Myc is often involved in the development in cancer, due to 
the role it plays in cellular growth, but in the context of infection Myc was shown to be manipulated 
during infection with the intracellular parasite Toxoplasma gondii, which is known to implicate the CP 
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during infection of the CNS (Dang, 2012; Falangola and Petito, 1993; Franco et al., 2014). The 
enrichment of these GSs, especially in the HIBCPP cell samples, is indicative that cellular proliferation 
is altered or stopped during S. suis ST2 infection.  
Additionally, the enrichment of GSs involved in cellular metabolism was observed for the in vivo 
analyzed CP samples of meningitis-free pigs. These GSs include genes involved in oxidative 
phosphorylation, as well as the metabolism of fatty acids and bile acids and salts. Oxidative 
phosphorylation plays an important role in aerobic ATP synthesis, and its down-regulation is found in 
association with a hypoxic environment (Fuhrmann and Brune, 2017). In an in vivo zebrafish infection 
model for S. suis, a down-regulation of metabolic pathways was also observed following infection 
(Wu et al., 2010). However, the identified genes were involved in glycolysis, and the metabolism of 
amino acids and carbohydrates (Wu et al., 2010). The enrichment of these GSs gives insight into 
metabolic alterations which occurred in vivo at the CP during S. suis infection. 
 
5.2.2. The overlap of enriched GSs found in all infected CP models 
Through the GSEA analysis, 18, 28, and 21 hallmark GSs were identified to be significantly enriched in 
infected HIBCPP cells, PCPEC, and the CP of pigs suffering from meningitis, respectively (Figure 21 A). 
Of these GSs, eight GSs were found to be significantly enriched in all three samples sets and are 
summarized in Figure 21 B. These included the five GSs TNFα signaling via NFκB, inflammatory 
response, IL2-STAT5 signaling, IL6-JAK/STAT3 signaling, TGFβ signaling, which were previously 
implicated during S. suis-infection, whereas the three GSs for hypoxia, EMT, and a set of genes up-
regulated by KRAS signaling, were not. Furthermore, the previously S. suis-implicated GSs identified 
in this study, had also been demonstrated to be involved in the brains of in vivo S. suis-infected pigs 
(Liu et al., 2011a). 
Discussion 
104 
 
    
Figure 21. Overlap of the GSEA identified GSs for S. suis ST2 infected HIBCPP cells, PCPEC, and the 
CP of pigs suffering from S. suis-induced meningitis. The Venn diagram depicts the number of 
significantly enriched GSs attributed to each sample set with the number of GSs which were found 
to overlap between the infected epithelial cells (HIBCPP cells and PCPEC) and the epithelial cells 
with the in vivo CP tissue from meningitis cases, as well as the number of GSs overlapping between 
all three samples sets analyzed (A). Eight GSs were found to overlap in the three analyzed samples 
sets, and the name of the enriched GS is listed in (B), where the green boxes are indicative of 
cellular process previously implicated with S. suis ST2 infection, whereas the cellular processes in 
the red boxes have not been previously associated with the infection of S. suis. 
 
It is well described that the activation of the transcription factor NFκB regulates the expression of 
genes involved in the inflammatory response, including the expression of cytokines and chemokines, 
such as TNFα (Liu et al., 2017). An increase of TNFα, along with other pro-inflammatory cytokines, 
was detected in the brain, blood, and kidney of S. suis infected mice, as well as in a porcine in vivo 
infection model, which investigated the brain, mononuclear cells, and lung (Liu et al., 2011a; 
Nakayama et al., 2011). Furthermore, the virulence associated factor, SLY, of S. suis was shown to 
induce the release of TNFα in human monocytes (Lun et al., 2003). However, not just experiments 
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performed in vivo or using whole-blood cells demonstrated the TNFα response, but by utilizing 
PCPEC, microarray analysis following S. suis infection from the apical cell side, also elicited a strong 
induction of TNFα and other inflammatory cytokines, thereby implying the contribution of the CP 
epithelial cells in the immune response at the BCSFB (Schwerk et al., 2011). Interestingly, the release 
of TNFα was found to promote the permeability in a human BCSFB in vitro model, by inducing cell 
death (Schwerk et al., 2010). The release of cytokines is known to elicit a down-stream cellular 
signaling cascade. One such signaling cascade is the IL6 induction of JAK/STAT3 signaling, which has 
been described to influence cell growth and differentiation, and is therefore often implicated in 
cancer when dysregulated (Huynh et al., 2017). Furthermore, as with IL6, IL2 has been described to 
stimulate the STAT5 signaling cascade, which is known to mainly regulate cellular proliferation and 
modulate the immune response of T cells (Lin and Leonard, 2000). In the context of S. suis infection, 
STAT3 and STAT5 were found up-regulated in the porcine brain in vivo (Liu et al., 2011a). However, 
the role of these signaling cascades during S. suis infection have not been further investigated. 
Another well described signaling cascade can be induced by the cytokine TGFβ, which was previously 
found to be upregulated in the porcine spleen and brain of S. suis in vivo infected piglets (Li et al., 
2010; Liu et al., 2011a). The induction of TGFβ signaling was previously implicated during the 
colonization of S. pneumoniae and H. influenzae, which are other common bacterial meningitis-
causative agents,  in lung epithelial cells and was accompanied by an inflammatory response 
(Beisswenger et al., 2009). However, this signaling cascade can impact distinct cell types in different 
ways depending on the context, and it was described to regulate cellular proliferation and 
differentiation, as well as other functions that include cell adhesion, migration, survival, as well as 
tissue homeostasis (Massague, 2012). 
To date, hypoxia, EMT, and genes regulated by KRAS signaling have not been directly linked to S. suis 
infection. KRAS signaling is important in the regulation of cellular proliferation and a mutation of the 
KRAS gene is often implicated in cancer development (Downward, 2003). Its role during infection is 
not clear, however, in one study it was observed that gastric cancer patients infected with the 
carcinogenic bacterium, Helicobacter pylori, were significantly more likely to exhibit a mutation of 
KRAS (Jabini et al., 2019). It should be considered that an enrichment of the KRAS GS in this present 
study was observed due to overlapping genes found with the GS EMT, since genes participating in 
the cellular EMT program can depend on, among other signaling cascades, the RAS signaling cascade. 
For example, KRAS was previously shown to regulate EMT in a colon cancer cell line (Kalluri and 
Weinberg, 2009; Shao et al., 2014). EMT is a cellular program which reverts epithelial cells to 
mesenchymal cells, and is often implicated in cancer, since it promotes metastasis and invasion, 
which is easier for mesenchymal cells than epithelial cells to perform (Kalluri and Weinberg, 2009). 
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EMT is also often involved in wound healing and tissue regeneration, which occurs following a 
physical trauma or injury caused by inflammation as a result of, e.g., an infection (Hofman and 
Vouret-Craviari, 2012; Kalluri and Weinberg, 2009). Furthermore, previous studies, especially in 
cancer research, have demonstrated that a hypoxic environment is a prerequisite in order for EMT to 
occur (Cannito et al., 2008). 
 
5.3. A new avenue of S. suis-induced meningitis: S. suis ST2 infected CP 
epithelial cells exhibit a stress response to the hypoxic environment 
A hypoxic microenvironment is often associated in infected tissues or with tumors, and is known to 
elicit a stress response due to oxygen being a necessity in order for animal cells to carry out their 
normal physiological functions (Taylor and Colgan, 2017). Furthermore, hypoxia has been implicated 
during injury to the CNS, which includes stroke or infection (Mukandala et al., 2016; van der Flier et 
al., 2003). Once a low-oxygen environment occurs, the induction of the hypoxia transcription factors  
is initiated in order to regulate specific genes, with the main goal of sustaining cell survival by 
reprograming cellular metabolism (anaerobic glycolysis), increase red blood cell production 
(erythropoiesis), or promote new blood vessel formation (angiogenesis) (Chen and Sang, 2016). 
Another interesting aspect of hypoxia is that it is known to affect the global transcription and 
translation of mRNA molecules by reducing both of these molecular processes, which allows for 
energy conservation during cellular stress (Koritzinsky and Wouters, 2007). Since the hypoxia GS was 
the top significantly enriched GS in the infected HIBCPP samples, it could be speculated as a reason 
for why the HIBCPP cells did not exhibit a strong fold change in the DEG analysis, with a maximal up-
regulation of 3.6-fold for ZFP36L1 and the strong down-regulation of 8-fold for MIR3648 was 
observed, as compared to the PCPEC 6 h post-infection. 
Hypoxia stress response can be induced either in a HIF-dependent or HIF-independent manner, most 
notably via the NFκB transcription factor, with complex overlaps and cross-talks described between 
these two pathways (Rius et al., 2008; Schaffer and Taylor, 2015). Furthermore, cytokine release, 
most notable being IL1β and TNFα, is known to be associated in the acute phase of hypoxia, as well 
as NFκB activation (Mukandala et al., 2016). Additionally, IL1β and TNFα have been shown to activate 
the HIF transcription factor in an oxygen-independent and NFκB-dependent pathway during 
inflammation (Lin and Simon, 2016). Interestingly, the inflammatory cytokine IL1β was observed to 
affect BBB permeability by influencing blood vessel plasticity via HIF regulation in the angiogenesis 
program in multiple sclerosis patients (Argaw et al., 2006). A further study investigating the cytokine 
presence in the CSF of infants who suffered a perinatal hypoxia event, found that infants who 
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displayed an elevated amount of TNFα and IL6 in the CSF, were significantly more likely to suffer 
from severe neurological abnormalities 12 months post-partum; a phenomenon, which was also 
observed in survivors of bacterial meningitis and cerebral malaria (John et al., 2008; Perdomo-Celis et 
al., 2015; Sumanovic-Glamuzina et al., 2017). 
Hypoxia does not only induce a cellular stress response, but is also described to modulate cell 
functions. For example, in an in vitro hypoxic environment, changes of the immune response in 
extracellular trap formation, which is a cellular process that releases the intracellular content known 
to contain antimicrobial properties, and phagocytosis were observed. This included a decrease of 
NET formation by neutrophil immune cells and an increase of extracellular traps stemming from mast 
cells, along with a reduced phagocytic activity (Branitzki-Heinemann et al., 2016; Mollerherm et al., 
2017). However, in a limited number of studies, hypoxia was also described to modulate and affect 
other cell types, such as epithelial cells during infection (Schaffer and Taylor, 2015; Taylor and 
Colgan, 2017). In two previous studies, it was demonstrated that a hypoxic environment during the 
infection with Pseudomonas aeruginosa of lung epithelial cells reduced the host’s cellular uptake of 
the pathogen, thereby diminishing host cell death, as well as causing a decline in the invasion of 
Yersinia enterocolitica into intestinal epithelial cells in vitro (Schaible et al., 2013; Zeitouni et al., 
2016). Furthermore, hypoxia also negatively affected the virulence factor expression (Schaible et al., 
2017). These studies demonstrate that a hypoxic environment was able to aid in containing the 
infection. 
In this present study, it was observed for the first time to our knowledge, that hypoxia-related 
cellular processes were significantly increased in relation to S. suis ST2 infection in vitro with human 
CP epithelial cells and PCPEC, as well as in the in vivo infected porcine CP samples. Since the HIF1α 
subunit of the heterodimeric HIF transcription factor is known to have a very short half-life of 
approximately 5 minutes, future studies could examine the impact of hypoxia over a time course 
caused by S. suis infection on its host cells at the BCSFB in the context of acute and chronic hypoxia 
(Chatard et al., 2017; Mukandala et al., 2016). In vitro models of the BBB are in place to study hypoxic 
effects on the BBB cells and the barrier, and this application should be applied to BCSFB in vitro 
models with human and porcine cells (Chatard et al., 2017). Additionally, a previously established 
monitoring system is in place for investigating mammalian cell culture pH and oxygen presence 
(Naciri et al., 2008). Noteworthy, one gene in particular stood out in the enriched hypoxia GS in all 
three analyzed samples sets. VEGF was found to be one of the top enriched genes in the hypoxia GS 
of all analyzed samples (data not shown), which is indicative of angiogenesis, and in turn has been 
implicated in chronic hypoxia response (Mukandala et al., 2016). 
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Lastly, the hypoxia transcription factor HIF has be discussed as a potential target for adjunctive 
therapy options, with already successful candidates against methicillin-sensitive and -resistant 
Staphylococcus aureus strains, in order to improve outcome or potentially replace antimicrobial 
therapeutics due to a rise in microbial resistance (Okumura et al., 2012; Santos and Andrade, 2017; 
Zinkernagel et al., 2008). Importantly, HIF therapy would not be solely limited to infections, but could 
also be applied in the setting of cancer treatment or chronic inflammatory disorders (Santos and 
Andrade, 2017). 
 
Figure 22. Hypoxia, its role during S. suis ST2 infection, and future avenues of research. S. suis 
infection was shown to induce genes involved during a hypoxic state, along with cytokines and 
NFκB known to also play a role during hypoxia, leading to multiple consequences of the cell 
response. In order to gain a deeper understanding of hypoxia during S. suis infection, multiple 
avenues relevant to hypoxia are suggested. 
 
The future avenues involving the investigation of hypoxia during S. suis infection are summarized in 
Figure 22. By investigating the role of hypoxia in the context of S. suis infection, with a focus on the 
significance of the BCSFB, a long-term aim could be explored of alternative therapy options. Those 
alternative therapy options could potentially limit infection severity, which is often found 
corresponding to long-term sequelae of survivors, such as full or partial auditory loss frequently 
associated with S. suis infection in humans, or death. 
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6. Conclusion and Future Perspectives 
Despite the availability of vaccines and antibiotic therapeutic agents, bacterial meningitis remains a 
leading cause of morbidity worldwide, frequently resulting in long-term neurological impairments or 
death. The zoonotic pathogenic agent S. suis is a leading cause for adult bacterial meningitis in south-
east Asia, and occurrences in other large pig-husbandry nations, but is also responsible for major 
economic losses worldwide due to post-weaned piglets being at a particularly high risk for disease 
development. 
From this study, the vital role the CP plays during infection was further elucidated. With a state-of-
the-art bioinformatic approach, which evaluated the global transcriptome response via RNA-seq, 
new insights were gained on how different host cells respond to S. suis in vitro and in vivo. Not only 
was the contribution by the CP to the immune response observed, but new cellular processes 
occurring at the transcriptome level were identified, such as hypoxia. Therefore, these novel insights 
lay a new foundation for future perspective studies in order to aid in further elucidating cellular 
mechanisms playing an essential role during an infection with S. suis. 
However, one main limiting factor of this study was that a transcriptome snapshot was obtained 
following a 6 hour infection time point. Therefore, it would be of interest to evaluate the 
transcriptional changes occurring over time in vitro, as well as at different stages in vivo, in order to 
further clarify how the inflammatory response is initiated and progresses. This is important, since an 
exasperated immune response and infection progression is linked to a bleak outcome, early 
intervention could result in the most ideal outcome and counteract debilitating sequelae. 
Furthermore, the development of improved treatment options should be established. Although the 
use of antibiotics, and in some cases the use of dexamethasone as adjunctive therapy to reduce 
inflammation, is currently in place, the rise of antibiotic resistance remains a global threat. One 
alternative therapy option was presented by Shen and colleagues, who suggested the use of a 
natural compound found to limit virulence and inflammation specifically during S. suis in vitro and in 
vivo infections, and with the use of this compound simultaneously decreased the selection pressure 
towards antibiotic resistant genes (Shen et al., 2018). However, since hypoxia was observed in the 
present thesis to play a significant role during infection with S. suis, especially in the human in vitro 
BCSFB, further investigations to fully elucidate this role need to be performed to understand the 
impact during infection and consequences for the host. This would be especially relevant since 
studies investigating the effective pharmaceutical targeting of the hypoxia pathway have been 
described. 
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Understanding the cellular processes occurring at the BCSFB is one of the first steps for development 
of effective therapeutics. The CP is not only pivotal in producing the CSF of the CNS, but evidence 
exists which implicates the CP beyond infections, in debilitating diseases, such as multiple sclerosis 
and cancer metastasis. Therefore, for the future, more research needs to be dedicated to this small 
tissue structure, which plays a vital role in maintaining a healthy CNS. 
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